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Summary 
 
In this thesis, three aspects of downbeat nystagmus (DBN) were examined. First, changes of 
its intensity during daytime; second, an analysis of the underlying mechanisms, in particular, 
the modulation of otolith input; and third, the effects of a pharmacotherapy with potassium 
channel blockers 4-aminopyridine in comparison with 3,4-diaminopyridine. 
Downbeat nystagmus consists of ocular drifts upwards. These upward drifts cannot be 
deliberately controlled. As a correcting mechanism, the upward drifts are followed by 
downward saccades. Downbeat nystagmus is either due to lesions in the cerebellum, due to 
lesions to the brainstem or due to cryptogenic/idiopathic causes. In order to reduce symptoms 
effectively, it is of particular importance to increase our knowledge about DBN.  
In chapter 1 of this thesis it is shown that the intensity of DBN decreases during 
daytime. In chapter 2, it is demonstrated that resting positions have an influence on the extent 
of DBN. During daytime, where people are generally in upright body position, DBN 
decreases effectively when people remain upright during their resting periods, i.e. when 
people sit instead of lying down to rest. There is a possible reason why DBN in upright 
position significantly decreases when people rest upright. This could have been due to otoliths 
exerting a stabilizing influence on the central vestibular neurons of the patients while 
remaining upright for a continuous period. Moreover, it does not make a difference whether 
patients with DBN rest with the light switched on or with the light switched off. Chapters 1 
and 2 also have implications for symptomatic treatment. It can be suggested to patients to rest 
in an upright position during the day, and to engage in activities such as reading or screen-
related work in the afternoon rather than in the morning. In chapter 3, another way of 
symptom reduction is presented, where the aminopyridines 4-AP and 3,4-DAP are compared 
against each other. The efficacy of reducing DBN had previously been demonstrated 
individually for both aminopyridines. In this thesis, the efficacy of both aminopyridines was 
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examined in a double-blind study with cross-over design. The major finding was that 4-AP is 
more effective than 3,4-DAP in terms of reducing the intensity of DBN. Moreover, 4-AP 
revealed a tentative trend towards a particular efficacy for cerebellar patients, which is in line 
with experimental evidence, where it had been reported to better cross the blood-brain barrier 
and to have at least the same (probably even a longer) half-life than 3,4-DAP. In conclusion, 
no causative treatment is in sight for DBN, but clinical studies can lead to a better 
understanding of DBN and may contribute to symptom alleviation. 
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Zusammenfassung 
 
In dieser Doktorarbeit werden drei Apekte des Downbeatnystagmus (DBN) analysiert. Erstens 
werden Änderungen des DBN im Tagesverlauf untersucht. Zweitens werden die zugrunde 
liegenden Mechanismen, insbesondere die Modulation durch Otolithen, analysiert. Drittens 
wird die Pharmakotherapie mit Hilfe der Kaliumkanalblocker 4-aminopyridin und 3,4-
diaminopyridin miteinander verglichen. 
Downbeatnystagmus besteht aus einem wiederkehrenden, nach oben gerichteten 
Abdriften der Augen, das nicht willkürlich kontrolliert werden kann, sowie darauf folgenden, 
nach unten gerichteten, schnellen Sakkaden. Downbeatnystagmus entsteht entweder aufgrund 
von Kleinhirn- oder Hirnstammläsionen, oder aufgrund von kryptogenen/idiopathischen 
Ursachen. Um DBN-Symptome zu lindern, ist es in erster Linie notwendig, mehr über DBN 
zu wissen. 
In Kapitel 1 dieser Arbeit wird gezeigt, dass die DBN-Intensität über den Tag hinweg 
abnimmt. In Kapitel 2 wird demonstriert, dass unterschiedliche Ruhepositionen einen Einfluss 
auf die Intensität des DBN haben. Während des Tages befinden sich Menschen meist in 
aufrechter Körperhaltung. In diesem Fall nimmt der DBN am effektivsten ab, wenn die 
Patienten auch Ruhepausen wählen, bei denen sie in aufrechter Körperhaltung bleiben, z.B. 
wenn sie sitzen anstelle sich auf den Bauch oder Rücken zu legen. Es gibt einen möglichen 
Grund, weshalb DBN in aufrechter Position signifikant abnimmt, nachdem Patienten sich in 
aufrechter Position ausgeruht haben (während es im Gegensatz dazu keine signifikante 
Abnahme gibt, wenn sich die Patienten zum Ausruhen hingelegt haben). Der Grund dafür ist, 
dass die Otolithen einen stabilisierenden Einfluss auf zentral-vestibuläre Neurone der 
Patienten hatten, wenn die aufrechte Position kontinuierlich aufrechterhalten wird. Ferner 
existiert hinsichtlich der Ausprägung des DBN kein Unterschied, ob Patienten sich bei Licht 
oder in Dunkelheit ausruhen. Kapitel 1 und 2, deren primäres Ziel das genauere Verständnis 
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des DBN war, haben jeweils auch Implikationen für die symptomatische Behandlung. Es 
kann den Patienten nahegelegt werden, sich im Tagesverlauf in aufrechter Körperposition 
auszuruhen, bzw. Aktivitäten wie z.B. Lesen oder Bildschirmarbeit am Nachmittag anstelle in 
den Morgenstunden zu planen. In Kapitel 3 werden die Aminopyridine 4-AP und 3,4-DAP 
miteinander verglichen. Die Effektivität beider Aminopyridine in der Reduktion des DBN 
wurde bereits in der Vergangenheit individuell sowohl für 4-AP, als auch für 3,4-DAP 
demonstriert. Basierend auf den vorherigen Studien stellt meine Arbeit einen 
Effektivitätsvergleich beider Aminopyridine in einer Doppelblindstudie mit cross-over Design 
dar. Das Hauptresultat von Kapitel 3 war, dass 4-AP die Intensität von DBN effektiver als 
3,4-DAP reduziert. Ferner zeigte 4-AP einen Trend hinsichtlich einer vermehrten 
Wirksamkeit bei Patienten mit Kleinhirnläsionen, was mit experimentellen Daten vereinbar 
ist, die gezeigt haben, dass 4-AP die Bluthirnschranke besser überwindet bzw. eine zumindest 
ebenso lange (vermutlich jedoch längere) Halbwertszeit hat als 3,4-DAP. Zusammenfassend 
bleibt festzuhalten, dass zwar keine ursächliche Heilung für DBN in Sicht ist. Klinische 
Studien können jedoch zu einem besseren Verständnis von DBN führen und zu einer 
Symptomlinderung beitragen. 
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1. Introduction 
 
Nystagmus can be understood as rhythmic eye movements that most often cannot be 
deliberately controlled (Kalla et al., 2008). It can be due to either peripheral or central 
vestibular or cerebellar dysfunction or due to a neurovascular compression of the eigth cranial 
nerve, i.e. the vestibular nerve (Brandt, 1990). Examples of peripheral vestibular dysfunction 
include the vestibular labyrinth, such as benign paroxysmal positioning vertigo, perilymphatic 
fistula, or Menière’s disease or the vestibular nerve as in vestibular neuritis etc. (Brandt, 1990; 
Strupp & Brandt, 2006). Examples of central vestibular dysfunction include positional 
downbeat nystagmus, central positional nystagmus without major vertigo/dizziness, central 
positional vertigo/dizziness with nystagmus due to cerebellar and brainstem disorders (Brandt, 
1990; Strupp & Brandt, 2006). An overview is presented in Brandt (1990). Based on prior 
work, e.g. Brandt (2000; 2003) or Brandt and Dieterich (1994; 1995), Heide and Kömpf 
(2005) describe central vestibular dysfunction in relation to the vestibulo-ocular reflex (VOR) 
in yaw, pitch and roll planes, often abbreviated as “yaw”, “pitch”, “roll”. These planes were 
derived from the spatial configuration of vestibular receptors in the inner ear of humans and 
other vertebrates (Brandt & Dieterich, 1994; 1995; Heide & Kömpf, 2005). The VOR moves 
the eyes in the direction opposite to that of the head, compensating for high-frequency head 
perturbations including sudden movements, single or multiple positional changes of the head, 
vibrations or head unsteadiness (Heide & Kömpf, 2005), for example when recognising a face 
while walking, the harbour when navigating a boat, the handlebar when doing acrobatics or 
stunts on a BMX-bike, or a street sign when driving a bumpy road (e.g. Brandt, 2003). 
Following Brandt (2003), a tone difference of the VOR in horizontal plane (= yaw) is 
characterised by horizontal nystagmus, past pointing, rotational and lateral body falls, 
stumbling or just moving to the side, and a horizontal deviation of the perceived image 
straight ahead. A tone difference of the VOR in the sagittal plane (= pitch) is characterised by 
 13 
DBN or upbeat nystagmus (UBN), forward/backward tilts and falls (forward/backward 
stumbling or just moving to the front/back), vertical deviation of the perceived image straight 
ahead, and finally, a tone difference of the VOR in the frontal plane (= roll) is characterised 
by torsional nystagmus, skew deviation, ocular torsion, tilts of head, body and perceived 
vertical, which may ultimately be associated with stumbling as well. The advantage of this 
classification is that, although tone differences in all three planes could be associated with 
stumbling, it allows for a topographic diagnosis of brainstem lesions with regard to their level 
and with regard to their side (Brandt, 2003). Based on Brandt and Dieterich (1994; 1995), a 
tone imbalance in yaw is associated with lesions of the lateral medulla including the 
vestibular nuclei and/or the entry zone of the root of Nervus vestibulocochlearis (the root of 
the eight’s cranial nerve). A tone imbalance in pitch is topographically associated with 
bilateral paramedian lesions or topographically and functionally associated with a bilateral 
dysfunction of the flocculus / the floccular lobes (Brandt & Dieterich, 1994; 1995). According 
to the same authors, a tone imbalance in roll is topographically associated with unilateral 
lesions (these lesions would be ipsiversive at the pontomedullary level and contraversive at 
the pontomesencephalic level). A detailed overview is provided by Brandt (2003). 
In nystagmus, the eye movements typically consist of an involuntary, slow 
(pathological) eye-drift and a fast compensatory saccade, leading to impaired acuity (Kalla et 
al., 2008; Spiegel et al, 2009a; 2009b; 2010; Strupp & Brandt, 2006). Nystagmus is frequently 
linked to a severe loss in terms of quality of life, e.g. people face difficulties when trying to 
read, work on a computer screen, watch TV or through postural state and gait instability 
(Kalla et al., 2008). This thesis is dedicated to DBN, which is the most frequent type of an 
acquired and persisting fixation nystagmus in central eye movement disorders (Baloh & 
Spooner, 1981; Kalla et al., 2007; Spiegel et al., 2009a; Wagner et al., 2008), though it has to 
be kept in mind that the absolute number of people suffering from DBN is rather low. DBN is 
named after its fast, correcting saccade, which beats downwards (Kalla et al., 2008). DBN is a 
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fixation nystagmus, which beats downwards in primary position and is enhanced in prone 
position or through downward gaze, as has been demonstrated by Marti et al. (2002). DBN 
often leads to impaired vision due to vertical oscillopsia1 (Bronstein, 2004; Kalla et al., 2007; 
Leigh & Zee, 2006), blurred vision (Marti et al., 2008), and is associated with a postural state 
and gait instability in 80 percent of all patients (Kalla et al., 2008; Wagner et al., 2008). DBN 
is the consequence of an upward directed drift that typically increases in downward gaze and 
decreases or even reverses in upward gaze (Jeffcoat et al.; 2008, Marti et al., 2008; Robinson 
et al., 1984; Spiegel et al., 2009a). According to Alexander’s law, slow-phase velocity (SPV) 
increases as gaze moves in the direction of the fast phase, which is downward in DBN, and 
decreases as gaze moves away from the direction of the fast phase, i.e. as gaze moves 
upwards (Jeffcoat et al.; 2008, Marti et al., 2008; Robinson et al., 1984; Spiegel et al., 2009a). 
When relating to eye movements during viewing, the correcting fast phases of DBN redirect 
gaze in the direction where patients attempt to fixate (Marti et al., 2008; Spiegel et al., 2009a). 
During gaze straight ahead, ocular drift is upward followed by fast phases beating downward 
(Leigh & Zee, 2006; Spiegel et al., 2009a). As was first reported in Straumann et al. (2000) 
and Glasauer et al. (2003) and later summarised in Spiegel et al. (2009a), ocular drift is 
composed of two components, (1) a vertical gaze-evoked drift, which is being caused by the 
leakiness of the mechanism for vertical gaze-holding, and (2) an upwards directed bias drift, 
for which a number of explanations have been proposed. The following pathomechanisms and 
their locations were made responsible for the bias drift (explained in Leigh and Zee, 2006; 
Kalla et al., 2004; Straumann et al., 2000; Glasauer et al., 2003; and summarised in Spiegel et 
al., 2009a): (1) pathomechanisms within the pathways associated with the vertical vestibulo-
ocular reflex (Baloh & Spooner 1981; Böhmer & Straumann, 1998; Chambers et al., 1983; 
Gresty et al., 1986; Halmagyi et al., 1983; Pierrot-Deseilligny & Milea 2005), (2) 
                                                 
1
 According to Mosby's Medical Dictionary, 8th edition. (2009), Elsevier: “Oscillopsia consists of abnormal 
jerky eye movements … They create a subjective sensation that the environment is oscillating.” Oscillopsia 
could thus be described as an illusionary movement of the visually perceived sensation. 
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pathomechanisms within the pathways associated with the vertical smooth pursuit (Zee et al. 
1974), or (3) pathomechanisms within the internal coordinate systems dealing with vertical 
saccade generation and gaze holding, as proposed by Straumann et al. (2000) and Glasauer et 
al. (2003). As demonstrated by Marti et al. (2008) and later summarised in Spiegel et al. 
(2009a) and Kalla et al. (2011 in press), the bias drift of DBN may be due to a reduced 
function of inhibitory vertical gaze velocity sensitive Purkinje cells (PCs) located in the 
cerebellar flocculus. Following Marti et al. (2008), these PCs show a physiological 
asymmetry that is also present in non-clinical populations, causing a greater weight of cells 
with downward on-directions. Hence, a loss of vertical floccular PCs leads to a disinhibition 
of neurons in the superior vestibular nucleus and the adjacent Y group, which will result in a 
spontaneous upward drift (Marti et al., 2008, summarised in Spiegel et al., 2009a). 
Thus so far, the pathophysiology of DBN is not completely understood. According to 
Kalla et al. (2007; 2008), the following three hypotheses are currently discussed: 1. a 
vestibulo-oculomotor cause with an imbalance of graviceptive vestibulo-ocular pathways, 2. 
an imbalance between a functionally disturbed neural-oculomotor integrator and the saccade 
burst generator, which is supported in animal experiments by an integrator deficit in DBN 
after a bilateral lesion to the cerebellar flocculus, 3. a central disorder of slow eye movements 
and smooth pursuit, which was first reported in Zee et al. (1981) and summarised by Kalla et 
al. (2007; 2008). According to the presently favoured hypothesis (Kalla et al., 2008), DBN is 
based on a bilateral damage to the flocculus and associated disorders of the vertical smooth 
pursuit (Glasauer et al., 2005a; Kalla et al., 2006; 2008). Following Kalla et al. (2008), these 
findings are further supported by functional magnetic resonance imaging studies (fMRI) in 
cerebellar DBN-patients, which showed a bilateral hypofunction of the flocculus (Kalla et al., 
2006). Kalla et al. (2008) further report that fMRI studies with voxel-based morphometry 
indicated an atrophy of ocular-motor centres in the cerebellum, as was first discovered by 
Hüfner et al. (2007). In the following section, two recent approaches to explain the 
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pathomechanisms of DBN will be described. It will include the putative model on the 
pathomechanism of DBN by Hüfner et al. (2007) as well as a theory on the origin of DBN 
based on a theoretical model by Marti et al. (2008), which was implemented as a 
computational model by Stefan Glasauer (Sarah Marti, personal communication by email, 6th 
of July, 2009). 
 
1.1. Two approaches to explain the origin of downbeat nystagmus 
 
1.1.1. The putative model 
 
Hüfner et al. (2007) proposed a putative model of the pathomechanism of DBN, which is 
depicted in Figure 1.1. According to the authors of this model, all patients with DBN share a 
pathway, which consists of a disinhibition of the Y-group brainstem neurons as well as a 
disinhibition of the superior vestibular nucleus (see Y/SVN in Figure 1.1). The ocular-motor 
circuitries have the Roman numbers I to III and consist of the smooth pursuit eye movement 
pathways (I/II) and the vertical gaze-holding pathway (III). For smooth pursuit eye 
movements, one pathway (grey line I) runs from the cortex via the dorsolateral pontine nuclei 
(DLPN) to the floccular/parafloccular lobe (FL/PFL), and subsequently to the superior 
vestibular nucleus. This last projection is depicted as the red solid line. In particular, the 
authors assume this pathway to be important in smooth pursuit maintenance. The other 
pathway (grey line II) runs via the nucleus reticularis tegmenti pontis (NRTP) and ocular 
motor vermis (dorsal vermis, DV) to the fastigal nucleus (FN). This last projection is again 
depicted as a red solid line. The authors assume this pathway to be particularly important in 
smooth pursuit adaptation and initiation. The third pathway, i.e. the vertical gaze-holding 
pathway (grey dashed line III) runs from the interstitial nucleus of Cajal, which is not 
depicted in Figure 1.1., via the nucleus of the paramedian tract (PMT) or alternatively by 
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going directly via the paramedian tract (Hüfner et al., 2007). According to the authors, this 
pathway projects to the floccular lobe/parafloccular lobe. This last projection is depicted as 
the red dashed line. As the name of this pathway suggests, the authors assume it to be of 
particular importance for vertical gaze-holding. Hüfner and colleagues report a number of 
different diseases that can damage one or several of these three pathways. These diseases 
include inflammatory diseases, cerebellar degeneration or ischemia, craniocervical 
malformation, tumors, episodic ataxia type 2 (EA 2) or diseases responsible for 
demyelinisation such as multiple sclerosis (Hüfner et al., 2007). According to the authors, it 
can just as well happen that no pathway is damaged, but that the floccular/parafloccular lobes 
have lesions themselves, e.g. in cerebellar degeneration or craniocervical malformation. 
Another example provided by the authors is that an atrophy or a lesion of the ocular motor 
vermis, which plays a vital role in smooth pursuit, might lead to deficits in smooth pursuit 
initiation and impair the execution of smooth pursuit eye movements. Hüfner et al. point out 
that hypofunction of the floccular/parafloccular lobe (leading to DBN) may be the 
consequence of this process. They also mention that lesions of the ocular motor vermis may 
even lead to DBN without the involvement of the floccular/parafloccular lobe itself, because 
the ocular motor vermis contains Purkinje cells (PCs). Based on research of Shinmey et al. 
(2002), Hüfner et al. (2007) conclude that these Purkinje-cells fire more extensively with 
downward than they fire with upward smooth pursuit, which is also the case for the 
floccular/parafloccular Purkinje-cells. Finally, Hüfner and colleagues point out that 
lesions/damage to the vertical gaze-holding pathway or its related structures in the brainstem 
can have DBN as a consequence, e.g. if the paramedian tract (PMT) or its nucleus contains 
lesions. As an explanation how this could happen, they state that it might be due to interfering 
with the PMT by putting localised midline ponto-medullary lesions, which would then result 
in less floccular/parafloccular input (i.e. FL/PFL hypofunction). As the authors derive, this 
reduced input would in turn lead to less Purkinje cell output, so that DBN would be the 
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consequence. The different lesion sites leading to DBN are indicated by the red stars with 
Arabic numbers 1 to 3. 
 
 
Figure 1.1 A putative model of the pathomechanism of DBN by Hüfner et al. (2007). The 
graph was slightly modified by the author of this thesis. Permission to display the figure in 
this thesis was obtained from the publisher. A detailed description of the pathomechanisms 
identified by Hüfner et al. (2007) can be found in the text of this introduction. Abbreviations: 
DLPN= dorsolateral pontine nuclei, DV= dorsal vermis (ocular motor vermis), FL/PFL= 
floccular/parafloccular lobe, FN= fastigal nucleus, NRTP= nucleus reticularis tegmenti pontis, 
PMT= paramedian tract, Y/SVN= neurons of the Y-group/superior vestibular nucleus. 
 
The pathomechanisms described by Hüfner et al. (2007) are in line with the findings 
of other authors, e.g. it was reported by Kalla et al. (2008) that DBN is often caused by 
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cerebellar atrophy, different degenerative cerebellar diseases or ischemia, EA 2, Arnold-
Chiari malformations or that it is caused by bilateral paramedian lesions in the medulla 
oblongata (referring to Wagner et al., 2008). 
 
1.1.2. A model-based theory on the origin of downbeat nystagmus 
 
Marti et al. (2008) developed a new theory (implemented in a computational model by Stefan 
Glasauer) that says that the ocular motor symptoms of DBN are due to a damage of the 
inhibitory gaze-velocity sensitive Purkinje cells (PCs) in the floccular lobe. Consequently, this 
computational model is not in opposition to the clinical model developed by Hüfner and 
colleagues, but rather based on common grounds. According to Marti et al. (2008), the PCs 
show spontaneous activity with a physiological asymmetry, where most of these PCs have 
downward on-directions. The authors conclude that a spontaneous upward drift results if 
vertical floccular PCs get damaged, because this would lead to disinhibition of the PCs’ 
brainstem target neurons. The authors further conclude that the correcting saccade to this 
upward drift results in DBN. Similar as it had been described in the discussion of the clinical 
model by Hüfner et al. (2007), the floccular lobe in the model by Marti et al. (2008) is also 
associated with generating and controlling smooth pursuit and gaze holding. Therefore, a 
lesion to vertical floccular PCs could not only shed light on ocular-motor dysfunction in the 
model of Marti et al. (2008), but also in the model of Hüfner et al. (2007). To test the 
plausibility of the floccular involvement in the previously described ocular-motor functioning, 
Marti et al. (2008) created a computational model of vertical eye movements derived from 
experimental findings in neuroanatomy and neurophysiology. The aim of the model by Marti 
and colleagues was to show how the regions from cortex, cerebellum and brainstem interact to 
create the vertical eye movements typical for healthy participants, and to simulate the 
resulting ocular-motor effects after a large number of floccular PCs got damaged (Marti et al., 
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2008). As a result of the simulation by Marti et al. (2008), ocular-motor symptoms evolved 
that are a characteristic of DBN: a spontaneous upward drift, which was the consequence of a 
lower spontaneous activity of PCs, a gaze-evoked DBN consistent with Alexander’s law as 
previously described in this introduction for upward gaze and downward gaze (further details 
can be found in Jeffcoat et al.; 2008, Marti et al., 2008; Robinson et al., 1984; Spiegel et al., 
2009a), a vertical smooth pursuit dysfunction due to asymmetries in the firing of PCs (Marti 
et al., 2008), and finally, a DBN-intensity dependent on gravity due to an interaction between 
a diminished function of the neural integrator and otolith-ocular pathways (Marti et al., 2008). 
The purpose to develop such an extensive model as this one was that none of the previous 
models to explain DBN covered all ocular-motor symptoms without the prior assumption of 
two or more alternative mechanisms, nor was any of the previous models (except Hüfner et 
al., 2007) able to explain the upwards-directed drift (Marti et al., 2008). Hence, the authors 
intend to (a) shed light on these issues and (b) aim at presenting a unifying theory to explain 
those mechanisms leading to DBN (Marti et al., 2008). The model (see Figure 1.2) is built 
around floccular Purkinje cells (PCs), which form the only output of the floccular lobe and 
appear right in the centre of the model (Marti et al., 2008). PCs are inhibitory. Hence, in the 
model of Marti et al. (2008), they have inhibitory connections to the vestibular nuclei, which 
are located in the brainstem (in the figure, the inhibitory connection goes to the superior 
vestibular nucleus). According to Marti et al. (2008), floccular PCs modulate their activity 
with the movements of the eyes, in particular with gaze velocity, and have different 
directional sensitivities, i.e. vertical or horizontal sensitivities. Whilst the overwhelming 
majority of vertical PCs in the model of Marti and colleagues are linked to downward on-
directions by increasing their firing rate to eye movements caused by downward visual 
motion, almost no PCs with upward on-directions exist in their model (Marti et al., 2008). The 
distributional asymmetry relating to on-directions of vertical gaze-velocity PCs forms the 
heart of the model (Marti et al., 2008). According to the authors, the hypothesis is that the 
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spontaneous upward drift in DBN is due to a substantial loss of vertical PCs and the 
distributional asymmetry mentioned in the previous sentence. This process might be best 
understood when describing the entire model in detail (see Figure 1.2), and how the model 
simulates functioning in healthy people. Subsequently, it will be referred to the model’s 
predictions when specific lesions are set to the model. In Figure 1.2, a number of boxes can be 
seen. According to the authors, these boxes indicate the responses of the model (and its 
individual elements) to VOR cancellation during head rotation (Marti et al., 2008). The 
process is displayed not only in the leftmost boxes, where the target rotates with the head, but 
also in the rightmost box, where the eye remains stable (Marti et al., 2008). While this process 
happens, i.e. target rotating with the head and eye remaining stable, the authors assume that a 
modulation to floccular PCs takes place in the central box of Figure 1.2, because the 
suppression of the VOR happens by pursuit commands. The next paragraph provides details 
to understand the model structure. 
According to Marti et al. (2008), the bold connections/arrows indicate a negative 
feedback loop. Via this negative feedback loop, the authors assume that the flocculus inside 
the cerebellum augments the time constant (5 seconds) of the leaky brainstem integrator, the 
so-called interstitial nucleus of Cajal (INC). From the ocular-motor neurons, the outgoing 
motor command is copied back to the cerebellum by an efference copy via the paramedian 
tract neurons (PMT) or/and the neurons of the Y-group (as was initially hypothesised by 
Stefan Glasauer and subsequently implemented in the model of Marti et al., 2008, where 
Stefan Glasauer is a co-author). As assumed by the authors, the cerebellum also estimates the 
eye velocity on behalf of the eye plant’s internal model. On the left side of the figure, the 
authors state that the head position in space (upper box) is processed not only by the otoliths 
leading to utricular discharge, but also by the semicircular canals (SCC) resulting in angular 
head velocity. The authors further assume that target position in space (lower box on the left 
side of the figure) is translated into retinal coordinates and further processed and analysed by 
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the visual system including the retina, area V1 and the middle temporal area (MT), eventually 
resulting in a retinal target position and retinal slip velocity. From the retinal slip, Marti et al. 
(2008) assume that a spatial estimate of target velocity is processed via the dorsolateral 
pontine nuclei (DLPN) and calculated in the middle superior temporal area (MST) making use 
of an efference copy feedback mechanism about estimated gaze velocity, which is processed 
back to the MST via floccular PCs to deep nuclei and from there via thalamic relay neurons. 
The authors further implemented a mechanism into their model where canal afferents from the 
semicircular canal (SCC) are also sent to the cerebellum as well as to the velocity-position 
integrator of the brainstem (INC: interstitial nucleus of Cajal) and from there to the ocular 
motor neurons (OMN) and the eye plant (Marti et al., 2008). As an alternative route, Marti et 
al. (2008) propose a direct pathway (i.e. not via the brainstem integrator), where the canal 
afferents project to the ocular motor neurons and from there to the eye plant. As was 
previously mentioned, the cerebellum in the model of Marti et al. (2008) has an internal 
model of the eye plant (see box titled “forward model of eye plant”). According to the 
authors, this internal model has the purpose to estimate the eye velocity coming from the 
motor command and to compare this estimate to the desired eye velocity in an error correcting 
way, for details on experimental data and error correction, refer to Spiegel and McLaren 
(2006). The desired eye velocity in Marti et al. (2008) consists of estimates of head velocity 
as well as target velocity. In their model, this comparison yields an error signal titled eye 
velocity error, which is returned back via the floccular PCs to the brainstem. In order to test 
the hypothesis that DBN is due to the previously mentioned asymmetric distribution in terms 
of vertical gaze-velocity sensitive PCs in the floccular lobe, Marti et al. (2008) lesioned a 
substantial part of the floccular PCs in their model. The authors’ lesions set to the model had 
the consequence that the simulated vertical eye movements provided by the model showed all 
ocular-motor symptoms typical of DBN, i.e. diminished functioning of vertical smooth 
pursuit, problems with vertical gaze-holding as well as the upward directed drift suddenly 
 23 
being influenced by gravity (Marti et al., 2008). Hence, the model’s output was in line with 
clinical findings. Marti et al. (2008) come to the conclusion that fMRI studies by Stephan et 
al. (2005) and Kalla et al. (2006) found some evidence for the hypothesised 
 
“…inherently asymmetric distribution of on-directions of vertical gaze-velocity 
sensitive Purkinje cells (PC) in the cerebellar flocculus”, (Marti et al., 2008, p. 622). 
 
Further evidence for the authors’ model comes from the study of gravitational influences on 
patients with DBN and healthy individuals (Marti et al., 2002), which provided conclusive 
evidence for gravity dependence of the upward directed drift. These results will be 
summarised in a separate section (see section 1.4), because the influence of gravity plays a 
large role in the clinical studies of this thesis. The model of Marti and colleagues also explains 
why a continuous administration of aminopyridines is a successful treatment for DBN, as 
aminopyridines enhance the activity of the floccular PCs (Etzion & Grossman, 2001; Kalla et 
al., 2007; 2008; 2011; Strupp et al., 2003; Strupp & Brandt, 2006). Before referring to 
pharmacological approaches, mechanisms from daily life (daytime dependence of DBN, 
resting in different body positions) will be discussed that also have the potential to alleviate 
the symptoms of DBN (e.g. Marti et al., 2002; Spiegel et al., 2009a). Although these 
mechanisms are not part of the two summarised models, they do not stand in contrast to them. 
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Figure 1.2 The theory on the origin of DBN by Marti et al. (2008). The graph was slightly 
modified and therefore slightly differs from the original figure. Permission to display the 
figure in this thesis was obtained from the publisher. A detailed description of the 
pathomechanisms identified by Marti et al. (2008) can be found in the text of this 
introduction. Abbreviations: DLPN= Dorsolateral pontine nuclei, FL= Floccular lobe, INC= 
Interstitial nucleus of Cajal, MT= Middle temporal area, MST= Middle superior temporal 
area, OMN= ocular-motor neurons, PMT= Paramedian tract, SCC= semicircular canal, SVN= 
superior vestibular nucleus, V1= Visual area 1, VOR= vestibulo-ocular reflex, Y-group= 
neurons of the Y-group, c=canal afferents. 
Physical feedback loop of eye position 
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The mechanisms will be described in chapters 2 and 3 of this thesis, where the intensity of 
DBN will be analysed throughout the day. The goal is to find out whether the intensity of 
DBN shows a circadian modulation and whether this modulation is directly related to time or 
rather the result of the patients’ body-position relative to gravity (e.g. usually people lie in bed 
at night and are in upright position during the day). The consideration of circadian changes of 
DBN might even add further information to these models and include the dimension time, 
which could be considered for future model updates in the clinical model by Hüfner and 
colleagues and in the theoretical model by Marti and colleagues. The inspiration to analyse 
DBN throughout the day came from individual patients reporting to the clinical research 
group of Michael Strupp that their vertical oscillopsia typically becomes weaker in the course 
of the day. If this is the case, it still does not prove that it is a mere mechanism of time. It 
could, in turn, also result from adaptive changes of DBN, as DBN is strongly influenced by 
gravity, e.g. Brandt (1990), Marti et al. (2002), Spiegel et al. (2009a), Spiegel et al. (2010), 
Sprenger et al. (2006). In order to determine whether these circadian changes will also hold in 
situations that modify DBN, slow phase velocity was analysed in different body positions 
relative to gravity, with gaze in different directions, and with or without visual targets. As will 
be seen in the next chapter, the resting body position throughout the intervals between video-
oculographic measurements (VOG-measurements) were held constant, i.e. the patients rested 
in upright position. In the chapter following the next chapter, the resting body position (i.e. in 
the intervals when patients took a break between the VOG-measurements) was varied so that 
patients were assessed under three different resting positions: in upright position, in supine 
position and in prone position. It was analysed whether these three different resting positions 
relative to gravity had an influence on DBN. A short summary of the VOG-technique is 
provided now. This is followed by a description of how to calculate slow phase velocity. 
Subsequently, it will be referred to the gravity dependence of DBN. 
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1.2. The technique for video-oculographic (VOG) measurements 
 
Based on prior research with three-dimensional VOG (Schneider et al., 2002; 2003; Zingler et 
al., 2006), this technique was applied in the studies of the following chapters in order to assess 
the intensity of DBN. What follows is a description of this method as it was applied by 
Zingler et al. (2006) inspired by prior research of Schneider et al. (2002; 2003). The technique 
is summarised here because it was adapted for the studies described in this thesis. There are 
small differences between the technique applied by Zingler and colleagues and the one 
applied in the studies of the following chapters. These differences will be mentioned as well. 
Zingler et al. (2006) assessed the eye movements of the right eye with 3D-VOG, where 
patients had to fixate a small fluorescent spot in front of each particular eye. Apart from this 
spot, participants were exposed to complete darkness (Zingler et al., 2006). The difference in 
the clinical studies of this thesis is that the fluorescent spot was generated by a laser and that, 
depending on condition, the fixation spot only appeared when the light was switched on and 
did not appear in darkness. In Zingler et al. (2006) as well as in the studies for this thesis, a 
VOG-mask (Hortmann, Münster, Germany) was applied where the fixation points were 
located on the inner surface of this mask and appeared in a straight-ahead position. Prior to 
each recording in Zingler et al. (2006), local anaesthesia was applied to the right eye of each 
patient; following the anaesthesia, the sclera was marked with two black markers. In Zingler 
et al. (2006), they were made of a cosmetic pigment absorbing infrared (Chronos Vision, 
Berlin, Germany). The rotation of the two marks was applied to measure ocular torsion in the 
work of Zingler and colleagues. Because ocular torsion was not assessed for the purpose of 
measuring DBN in the following studies of my thesis, this step was skipped. In both Zingler 
et al. (2006) and the studies of my thesis, the recording of the images on videotape was 
conducted with a sampling rate of 50Hz. They were later analysed with X-Binocle (Erich 
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Schneider, Munich, Germany) and Matlab (The Mathworks, Natick, MA, USA) software. The 
calibrated data were low-pass filtered applying a digital Gaussian filter, i.e. a filter based on a 
Gaussian (“bell-shaped”) distribution (e.g. Spiegel et al., 2009a; Spiegel et al., 2010). This 
filter had a bandwidth of 30 Hz (the same as in Spiegel et al., 2009a; Spiegel et al., 2010; 
Kalla et al., 2011 in press). Interactive software allowed to detect and remove saccades and 
fast phases using a combined velocity–acceleration criterion (this process is also described in 
Spiegel et al., 2010 and Kalla et al., 2011 in press). The mean slow phase velocity was 
computed from de-saccaded data and was averaged over a measurement period of 30 seconds 
in each condition. Following the description of assessing DBN via VOG, it will now be 
referred to the calculation of slow phase velocity, because this will be taken to indicate the 
extent of DBN. 
 
1.3. The calculation of slow phase velocity 
 
The following explanations on how to calculate slow phase velocity are all based on prior 
work by Barin (2004). Following this author, slow phase velocity is typically measured for a 
single nystagmus beat. In DBN, the slow phase describes the upward drift, because DBN is 
termed after its fast phase, which is downward. Because the recording consists of a potentially 
large number of updrifts and downbeats in the measurement period of 30 seconds per 
condition, it makes sense to measure the mean slow phase velocity. In order to assess slow 
phase velocity for a single downbeat, Barin points out that the distance that the eye travels 
during the slow phase will have to be determined and divided by the amount of time (slow 
phase velocity = ∆distance / ∆time). According to Barin (2004), an even easier way is to draw 
a line that represents the slow phase best and to subsequently measure the slope of this line. 
This permits to assess the eye movement for a predetermined time, which is one second in the 
explanation provided by Barin (2004). It also is one second in the analysis of this thesis. This 
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measurement will result in slow phase velocity = degrees/second. In order to complete this 
calculation, Barin (2004) points out that it is vital to know the scale of the time and eye 
movement axes. He explains that these values are chosen by the setting of the 
electronystagmographic equipment as well as during the calibration at the start of each 
measurement process. Having described details with regard to the measurement process, it 
will now be referred to the influence of gravity on DBN. 
 
1.4. Gravity dependence of downbeat nystagmus 
 
Brandt (1990) describes central positional nystagmus, which is nystagmus occurring or being 
altered by different head positions, to be linked to the brainstem or the vestibulo-cerebellum. 
It can be linked to DBN, but it can just as well beat diagonally or beat upwards such as in 
upbeat nystagmus (UBN), details appear in Brandt (1990) as well as Strupp and Brandt 
(2006). Marti et al. (2002) focused on the gravity dependence of eyeball drift particularly in 
patients with DBN due to cerebellar aetiology. The patients had lesions in their vestibulo-
cerebellum. Marti et al. (2002) reveal that the rapid change of positions as well as static 
headhanging positions when the participant is placed on a turntable both increase the slow 
phase velocity of DBN, and rolling the head from ear to shoulder could have a similar effect. 
As the most likely cause for the influence of gravity on DBN, Marti and colleagues consider 
lesions in the pathways connecting the otoliths with the eyes. As an alternative explanation 
they regard DBN being due to an asymmetry of vertical vestibulo-ocular reflexes, possibly 
being modulated by signals coming from the otoliths. Their work was based on two 
mechanisms: a gaze-evoked drift which they consider to be due to an impaired vertical neural 
integrator (1), and a velocity-related bias (2), (Marti et al., 2002). With the help of a three-
dimensional turntable, Marti and colleagues analysed what impact gravity had on these two 
mechanisms. In their work, the whole body of the patients was positioned in roll, pitch, and 
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yaw planes of the head and patients were recorded binocularly with dual search coils (Marti et 
al., 2002). According to the authors, it turned out that no gravity dependence of the vertical 
gaze-evoked drift was found, but the vertical velocity bias had the following two components: 
an upwards-directed component that was independent of gravity, the so-called gravity-
independent (GI) component, and a component being gravity-dependent, hence named 
gravity-dependent component (GD). This GD-component was related to the vector of gravity 
in the pitch- (but not in the roll-) plane, being a result of sinusoidal modulation (Marti et al., 
2008). In their work, combining the two components resulted in an overall drift being 
minimal in supine position, where the GD component’s downward drift was maximal, which 
counteracted the DBN’s upward drift (Marti et al., 2002). In the article of Marti and 
colleagues, it had also been shown that in prone position, the maximal vertical drift velocity 
was assessed, because both drift components were in upward direction. Added together, this 
resulted in stronger DBN. When patients were in upright position, the authors found that the 
GD component was near zero, which they interpreted as the vertical ocular drift almost being 
exclusively based on the GI component. In healthy participants, the authors were able to 
observe the same modulation of the GD component, but they also noticed that the amplitude 
of this component was much larger among their cerebellar patients. Marti et al. (2002) draw 
the following conclusions based on their results: an intact vestibulo-cerebellum is able to 
minimise an overacting otolith-reflex, which is being elicited by pitch tilt. They also point out 
that an intact vestibulo-cerebellum cancels an inherent upward ocular drift. According to 
Marti et al. (2002), this drift does not depend on otolith signals modulated by gravity. Marti et 
al. (2002) provide the following explanation: 
 
“The sinusoidal modulation of the GD component of vertical drift velocity in the pitch 
plane is most likely otolith driven and may represent an overacting otolith-ocular reflex. 
The normal function of the otolith-ocular reflex at low frequencies driven by pitch tilt is 
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to keep the vertical gaze direction stable in space (Paige & Seidman, 1999). Thus, when 
the head is pitched downward, the eyes move upward and vice versa. The direction of 
the GD component is consistent with this pattern. The finding that healthy subjects 
showed the very same pattern of the GD component, but in a scaled-down version, 
supports the notion that the intact cerebellum minimizes the overacting otolith-ocular 
reflex driven by pitch tilt. In fact, previous clinical studies have demonstrated a 
substantial role of the cerebellum in controlling translational vestibuloocular reflex 
(Baloh et al., 1995; Crane et al., 2000; Zee et al., 2002). In electrophysiological studies, 
both the flocculus (Snyder & King, 1996) and the nodulus (Precht et al., 1976) 
modulated otolith-ocular reflexes“, (Marti et al., 2002, p. 720). 
 
As a practical application of their results, Marti et al. (2002) recommend that patients with 
DBN due to cerebellar aetiologies should be advised that the best body position for reading is 
the supine position. This recommendation definitely makes sense on the basis of these results. 
The following chapters of this thesis will also relate to these three body positions (upright, 
supine and prone). It will be focused on DBN during measurement. In addition, it will also be 
focused on the question whether DBN during measurement is modulated by various resting 
positions (upright, supine and prone resting positions) in between the measurements or prior 
to the measurements. The hope is to give additional practical recommendations to patients, 
e.g. what resting position is optimal during the day, where people are usually in upright 
position (see chapter 3). Following chapter 3, a clinical study with aminopyridines will be 
described in chapter 4. The reason why aminopyridines are a promising treatment in DBN and 
what other pharmacological approaches exist will be discussed now. 
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1.5. Pharmacological approaches of downbeat nystagmus treatment 
 
The following review of pharmacological approaches is mainly based on a literature review 
for my thesis, which also appeared in Kalla et al. (2008). As the second author of the 
publication, I contributed aspects of the text in this article that overlap with the following 
chapter of the thesis. Hence, there is an overlap between the publication and this chapter. The 
pathophysiology of DBN is probably based on a floccular dysfunction, which leads to a 
reduced release of gamma-amino-butter-acid (GABA) and a disinhibition of the vestibular 
nuclei (Kalla et al., 2008). Based on this assumption, a number of GABAergic substances 
were applied for treatment. In a dose of 1.5 to 3 mg per day, the GABAA-agonist Clonazepam 
(which belongs to the group of benzodiazepines) is capable of alleviating DBN symptoms 
(Currie & Matsuo, 1986; Kalla et al., 2008; Young & Huang, 2001). Following Kalla and 
colleagues, it has to be considered, though, that the studies on Clonazepam were not placebo-
controlled. Moreover, the use of benzodiazepines often leads to sleepiness and patients run the 
risk of benzodiazepine dependency if they take Clonazepam regularly (Kalla et al., 2008). 
Apart from Clonazepam, the GABAB-agonist Baclofen can also alleviate the symptoms of 
DBN (Dieterich et al., 1991; Kalla et al., 2008). According to a double-blind cross-over trial, 
however, the symptoms of DBN only became less in one out of a total of six patients after 
administration of Baclofen (Averbuch-Heller et al., 1997; Kalla et al., 2008). On the basis of 
single observations, it was assumed that Gabapentine would also lead to a decrease in DBN 
symptoms, because Gabapentine acts as a ligand to the alpha-2-delta-subunit of voltage-gated 
N-type calcium ion channels (Davies et al., 2007; Kalla et al., 2008). Testing Gabapentine in a 
double-blind cross-over trial, however, only alleviated the symptoms of DBN in one out of six 
patients. Taken together, in no placebo-controlled study was it thus far possible to 
demonstrate a clinically relevant improvement of symptoms for either Clonazepam, Baclofen 
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or Gabapentine or any of the related substances (for a review see Kalla et al., 2008; Straube et 
al., 2004; Strupp & Brandt, 2006; Strupp et al., 2011a). Additional medications having been 
tested in a randomised, double-blind, crossover trial for the treatment of acquired nystagmus 
are the anticholinergic agents Trihexyphenidyl and Tridihexethyl chloride (Leigh et al., 1991, 
Kalla et al., 2008). Initially, ten patients were included in the clinical trial, but due to 
intolerance of medication or trial-intermitting illness, only five patients were able to complete 
the trial with both drugs. When considering the drugs separately, there were six patients 
having completed the tests in either drug. In Trihexyphenidyl, only one out of these six 
patients showed improvements. In Trihexethyl chloride, four out of these six showed 
improvement, but had experienced substantial side effects, which undermined the benefit of 
the treatment. Taken together, these results indicate that Trihexyphenidyl is not a suitable 
medication for acquired nystagmus, whereas Trihexethyl chloride seems suitable based on 
symptom alleviation, but at the cost of adverse side reactions, which makes it hard to justify 
the use of either medication should an individual patient experience serious adverse reactions. 
Moreover, it has to be kept in mind that these drugs were not tested for DBN in particular, but 
rather for acquired nystagmus in general. To conclude, none of the medications mentioned so 
far present a convincing treatment option for DBN. 
 
1.5.1. Prior studies on the influence of the aminopyridines 3,4-Diaminopyridine and 4-
Aminopyridine on the intensity of DBN 
 
The review of the following subchapter has mainly appeared in the article of Kalla et al. (2011 
in press), where my name is part of a shared first-authorship and where I contributed, among 
other aspects, substantial parts of the text. Hence, there is an overlap between the text in this 
chapter and the publication. Based on the pathomechanism of DBN, the potassium-channel 
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blockers 3,4-diaminopyridine (3,4-DAP) and 4-aminopyridine (4-AP) are an alternative way 
to achieve a clinically relevant improvement. One mechanism being made responsible for 
DBN is the loss of Purkinje-cells due to cerebellar damage. To understand this mechanism, it 
is important to consider that Purkinje-cells are the only cells leaving the cerebellum. 
Moreover, their signals are inhibitory, i.e. a loss of Purkinje-cells will result in less inhibitory 
signals leaving the cerebellum. 
The two aminopyridines are non-selective blockers of the potassium channels (Hille, 
2001), which also blocks potassium channels of the remaining Purkinje-cells, i.e. the ones not 
having been lost due to damage (Judge & Bever, 2006). In particular, they block the Kv-
family of potassium channels, which consist of a heterogeneous group of integral membrane 
proteins (Judge & Bever, 2006). According to the authors, the ion channel can be either 
conducting, i.e. open, or non-conducting, i.e. closed. The authors conclude that the 
transmembrane electric field can result in a structural re-arrangement of the Kv-channels, so 
that their pore opens. According to Judge and Bever (2006), the aminopyridines can block the 
pore by inducing a structural rearrangement of the Kv-channels, so that their pore stays closed. 
As a consequence, there will be a higher resting activity and excitability of the Purkinje-cells 
(Etzion & Grossman, 2001). The higher resting activity as well as the increased excitability 
was confirmed in Purkinje-cells of guinea pigs by Etzion and Grossman (2001). As a 
consequence of being excited, Kalla et al. (2004; 2011) expect the remaining Purkinje-cells to 
restore the inhibitory influence on deep cerebellar and vestibular nuclei. The subsequent 
inhibitory effect on vertical eye movements is assumed to result in a reduced vertical ocular 
drift and therefore less DBN (Leigh, 2003; Kalla et al., 2004; 2011). The positive effects of 
aminopyridines on DBN (Strupp et al., 2003) and EA 2 (Strupp et al., 2004; 2011b) were first 
discovered clinically by Strupp and colleagues and later explained by this pathomechanism 
(Kalla et al., 2011). Additional clinical studies have shown that aminopyridines improve DBN 
(Helmchen et al., 2004; Kalla et al., 2004; Kalla et al., 2007; Sprenger et al., 2005). Relating 
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to Kalla et al. (2011), it turned out that not only DBN was reduced in patients with EA 2, but 
also the frequency of attacks (Strupp et al., 2004) as well as interictal cerebellar ataxia (Löhle 
et al., 2008).  More recently, new evidence for the clinical discoveries of Michael Strupp was 
found. According to this new evidence, therapeutic concentrations of 4-aminopyridine restore 
the diminished precision of pacemaking in Purkinje cells of the ataxic P/Q channel mutant 
mouse (Kalla et al., 2011). This works by prolonging the action potential and by increasing 
the action potential after hyperpolarization (Alviña & Khodakhah, 2010; Kalla et al., 2011). 
This new evidence now acts as the currently assumed mechanism by which aminopyridines 
improve DBN (Kalla et al., 2011). Effects of 4-AP on the cerebellum were confirmed in a 
PET study demonstrating that 4-AP increased metabolic activity bilaterally in the floccular 
lobes of the cerebellum (Bense et al., 2006; Kalla et al., 2011). 
Referring to the history of aminopyridine treatment in DBN, it is now worth having a 
closer look at the first double-blind, placebo-controlled cross-over trial with aminopyridines, 
conducted by Strupp et al. (2003) and comprising 17 patients with DBN due to cerebellar 
atrophy, Arnold-Chiari malformation, cerebellar infarction or due to idiopathic or cryptogenic 
causes. When measuring the mean peak slow phase velocity of DBN prior to and 30 minutes 
after ingestion of 20 mg 3,4-DAP or after ingestion of the placebo, DBN reduced from 7.2 
deg/s to 3.1 deg/s (p<0.001) in the 3,4-DAP group, whilst placebo had no relevant effect 
(Strupp et al., 2003). In addition, the mean peak slow phase velocity in Strupp et al. (2003) 
decreased in 10 out of a total of 17 patients by over 50 percent and in 12 out of 17 patients by 
over 40 percent. These positive effects were not entirely independent of aetiology. According 
to the authors, the three patients with cerebellar infarctions only showed a minor reduction in 
mean peak slow phase velocity. Taken together, however, DBN-symptoms improved 
substantially after ingestion of 3,4-DAP (Strupp et al., 2003). Likewise, there was an 
improvement in postural stability and oscillopsia according to the authors. The advantages of 
3,4-DAP clearly seemed to outweigh the side effects of three patients experiencing peri-oral 
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or digital paresthesias and one patient experiencing a headache and nausea. Another study by 
Kalla et al. (2004) analysed the effect of 4-AP by applying the magnetic search-coil 
technique. This case study showed that 4-AP not only improved DBN, but also VOR-gain and 
smooth pursuit. VOR-gain refers to the vestibulo-ocular reflex and should optimally equal one 
(Angelaki, 2004; Crawford & Vilis, 1991; Encyclopaedia Britannica, 1987). In this case, the 
ratio of the eye and head rotations is equal, i.e. if the head rotates in one direction, the eye 
should rotate in the other direction by an equal amount (Angelaki, 2004; Crawford & Vilis, 
1991). In central neurological disorders, VOR-gain often differs from 1, i.e. shows a larger or 
smaller value (Angelaki, 2004; Crawford & Vilis, 1991; Kalla et al., 2004; Encyclopaedia 
Britannica, 1987). After the administration of 4-AP, however, it came closer to the optimal 
value. Likewise, smooth pursuit, which can be described as smooth, i.e. non-disruptive, eye 
movements when attempting to follow a target with the eyes smoothly (in contrast to 
saccaded pursuit as demonstrated by Grasse & Lisberger, 1992), also improved after the 
administration of 4-AP in the study of Kalla et al. (2004). An additional study by Kalla et al. 
(2007) including 15 patients with DBN of various aetiologies (cerebellar degeneration, 
cerebellar infarction, cerebellar meningioma, EA 2, multiple sclerosis, vascular causes or 
idiopathic aetiologies) led to reduced DBN during gaze straight ahead in 12 out of a total of 
15 patients (before therapy: -4.99 +/- 1.07 deg/s (mean +/- SE). 45 minutes after 
administration of a 10 mg capsule of 4-AP the values were: -0.60 +/- 0.82 deg/s). A multiple 
regression analysis of slow-phase velocity (SPV) in different eye positions across all patients 
revealed that vertical and horizontal gaze-evoked drift was significantly lower irrespective of 
aetiology. On average, it led to perfect performance in terms of gaze holding, where a change 
of vertical eye position sensitivity towards zero was found in 13 out of a total of 15 patients. 
Because the results did not depend on target visibility, Kalla and colleagues concluded that 4-
AP improved fixation by helping to restore the ability of gaze-holding. According to the 
authors, patients with cerebellar atrophy benefited the most out of the treatment. In EA 2, 
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which also belongs to central ocular-motor disorders, a case study by Strupp et al. (2004) 
could show that the daily dose of 5mg 4-AP resulted in a long-lasting effect, i.e. an absence of 
symptoms for a prolonged period. As reported in Strupp et al. (2004), the symptoms, 
however, recurred after treatment had been provisionally terminated. According to the 
authors, subsequent administration of 4-AP once more was associated with symptom 
alleviation. These effects were later confirmed in a placebo-controlled trial (Strupp et al., 
2011b). Positive effects of aminopyridines also included research on the gravity dependence 
of DBN (Helmchen et al., 2004; Sprenger et al., 2006). An improvement in terms of postural 
instability was also confirmed by Sprenger et al. (2005). Thus far, aminopyridines have the 
most clinically relevant effects in the treatment of DBN, for a review see Kalla et al. (2008), 
Rucker (2005), Straube (2007), Strupp and Brandt (2006), or Strupp et al. (2011a). 4-AP 
seems to have several advantages over 3,4-DAP: it can cross the blood-brain barrier more 
easily and has a longer half life (Hayes, 1994; Hayes et al., 2003; Judge & Bever, 2006; Kalla 
et al., 2009; Kalla et al., 2011; Leigh, 2003), which is 3 to 4 hours according to Hayes et al. 
(2003) for 4-AP and 2 hours according to Witz et al. (2009) for 3,4-DAP. Its effects can be 
quickly measured in the plasma, where it reaches its maximal concentration approximately 
one hour after oral capsule intake (Judge & Bever, 2006; Kalla et al., 2011). Patients often 
realise a symptom reduction only half an hour after swallowing the capsule (Kalla et al., 
2008). Following Kalla et al. (2008), the positive effects of 4-AP were also independently 
confirmed in an imaging study by Bense et al. (2006), who applied PET-scans (positron 
emission tomography) to show a 4-AP-dependent improvement of metabolic activity in the 
flocculus in a patient with DBN. Because of their positive effects on alleviating DBN 
symptoms, the aminopyridines 4-AP and 3,4-DAP will be subject to this thesis. After both 
aminopyridines showed positive effects in placebo-controlled trials, they will be compared to 
each other to see whether one reduces DBN better than the other. Following Judge and Bever 
(2006) and based on a review by Hayes (1994), 4-AP and 3,4-DAP have a long history for a 
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variety of diseases and phenomena, including multiple sclerosis treatment, botulinum 
poisoning, post-surgical antagonism of neuromuscular blockade, dementia such as 
Alzheimer’s disease, myasthenia gravis, or Lambert-Eaton syndrome. According to Judge and 
Bever (2006), both 4-AP and 3,4-DAP have multi-compartment pharmacokinetics with serum 
half-lives ranging from one to three hours. They are rapidly absorbed after ingestion with 
peak serum levels from 20 to 60 minutes after administration (Judge & Bever, 2006; Hayes, 
1994; Kalla et al., 2011). Based on Judge and Bever (2006) and Hayes (1994), 4-AP is lipid 
soluble to a high degree, i.e. it easily crosses the blood-brain-barrier. Hence, Judge and Bever 
(2006) conclude that it can be applied as a potassium channel blocker not only in the 
peripheral nervous system, but also in the central nervous system. On the contrary, 3,4-DAP 
is only soluble in aqueous solution and does not cross the blood-brain barrier so easily (Judge 
& Bever, 2006). Hence, its dominant application is the peripheral nervous system (Judge & 
Bever, 2006). As a result, it can be expected that 4-AP is better suited than 3,4-DAP due to its 
longer half-life and its ability to better cross the blood-brain barrier, but this still has to be 
shown in a clinical study. Therefore, chapter 4 of this thesis is dedicated to this comparison. 
Figure 1.3 shows the structure of both aminopyridines. The structure of 4-AP can be accessed 
in Yang et al. (2008), the structure of 3,4-DAP in Rubin-Preminger and Englert (2007). 
 
 
 
 
 
Figure 1.3 The chemical structures of 4-AP (left) and 3,4-DAP (right). The chemical 
structures were created using ChemWriter (Metamolecular, La Jolla, CA, USA). 
 
4-AP 3,4-DAP 
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2. The intensity of downbeat nystagmus during daytime 
 
In the following own study, the intensity of DBN during daytime, i.e. in the course of the day, 
was analysed. It has been published in Spiegel et al. (2009a). Because I had written the text of 
the publication and as I am the author of this thesis, part of the written text shows an overlap. 
The same holds true for the tables, figures, and their legends. 
 
2.1. Methods 
 
2.1.1. Patients  
 
This study comprised 12 patients with DBN due to different aetiologies (for details see Table 
2.1). In 5 patients, DBN was associated with cerebellar syndrome, whilst cerebellar atrophy 
was present in 4 out of these 5 patients. In 7 patients the aetiology of DBN was unknown. The 
mean duration since DBN was first diagnosed was 5.75 years (with a range of 0 to 17 years). 
The patients were 44 to 76 years old (with a mean of 65.75 years ± a standard deviation of 8.9 
years). Neuro-ophthalmological findings (for details see Table 2.1) included disturbed visual 
fixation suppression of VOR, pathological head-thrust test, incomplete ocular tilt reaction, 
impaired horizontal and vertical opto-kinetic nystagmus, impaired horizontal and downward 
pursuit, provocation nystagmus, etc. In this study, the patients’ eye movements were recorded 
four times on a single day: at 9am, 11am, 1pm and 3pm. During the intervals between VOG-
measurements, patients were sitting upright (see Figure 2.1). All patients underwent a 
complete clinical examination that included neuro-otological, neuro-ophthalmological, and 
neurological tests, MRI (including high resolution MRI of the brainstem and the cerebellum), 
electronystagmography (including caloric irrigation), an electrocardiogram and laboratory 
tests (including vitamin B12 and Mg2+). At the time of the measurements, no patient was 
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taking medication affecting the vestibular or ocular motor systems. None of the patients in 
this study had DBN caused by metabolic disorders or drugs. Informed consent to participate 
in this study was given by all patients. The VOG-measurements were done in accordance with 
the Helsinki II Declaration and approved by the local ethics committee of the Ludwig-
Maximilians-University Medical Faculty. 
 
2.1.2. Recording of eye movements 
 
As mentioned before, people were tested four times on a single day. Each time, patients were 
monitored in the following sequence: (see Figure 2.1). 
1. they were sitting in upright position, 2. they were lying in supine position, 3. they 
were lying in prone position, all conditions either with the light switched on or off. In the 
resting intervals between the assessments (titled intermission in Figure 2.1), patients were in 
upright position with the light switched on. Based on previous research by Zingler et al. 
(2006) (a detailed description can be found in the introduction of this thesis), each position 
consisted of a 30 seconds eye movement recording with a three-dimensional video-
oculography in the following order: a calibration in 8.5° position, 1. gaze straight ahead with 
fixation turned on, 2. gaze straight ahead with no possibility to fixate on a fixation point, i.e. 
in darkness, 3. 17° gaze to the right, 4. 17° gaze to the left, 5. 17° gaze upwards 6. 17° gaze 
downwards. The target was projected by a laser on a white cardboard at a distance of 60 cm in 
front of the participant. The leftward and rightward gazes were only recorded for 
completeness purposes, e.g. in order to generate hypotheses for possible future studies. In the 
Spiegel et al. (2009a) manuscript, no hypotheses with respect to leftward and rightward gazes 
existed. The only gazes of interest were gaze straight ahead, upward gaze and downward 
gaze. 
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Table 2.1. The clinical data of the patients where DBN was measured during daytime (see 
Spiegel et al., 2009a). 
No./Sex/ 
Age 
Neuro-ophthalmological findings MRI 
findings 
Aetiology Disease 
duration 
No 1M, 76 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and vertical opto-
kinetic nystagmus with horizontal and 
vertical saccades, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
White 
matter 
lesions 
Idiopathic 
cerebellar 
syndrome 
2 years 
No. 2F, 51 
 
Disturbed visual fixation suppression of 
VOR, incomplete ocular tilt reaction, 
impaired upward opto-kinetic nystagmus, 
impaired horizontal and downward pursuit, 
pathological HTT bilaterally, provocation 
nystagmus downwards and to the right, 
hypermetric saccades to the right. 
Cerebellar 
atrophy 
Cerebellar de-
generation 
7 years 
No. 3F, 66 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and non-existing 
vertical opto-kinetic nystagmus, impaired 
horizontal and downward pursuit, 
pathological HTT bilaterally. 
Cerebellar 
atrophy 
Idiopathic 
cerebellar ataxia 
4 years 
No. 4F, 69 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and upward opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally, provocation DBN. 
Cerebellar 
atrophy 
Idiopathic 
cerebellar ataxia 
17 years 
No. 5M, 64 
 
Disturbed visual fixation suppression of 
VOR, non-existing upright opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
Cerebellar 
atrophy 
Cerebellar de-
generation 
3 years 
No. 6M, 69 
 
Disturbed visual fixation suppression of 
VOR, impaired upward opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT on the 
left. 
Normal Unknown 6 years 
No. 7M, 65 
 
Impaired upward opto-kinetic nystagmus, 
impaired horizontal and downward pursuit, 
hypometric upward saccades. 
Normal Unknown 10 years 
No. 8F, 69 
 
Disturbed vertical visual fixation 
suppression of VOR, impaired upward 
opto-kinetic nystagmus, impaired horizontal 
and downward pursuit. 
Normal Unknown 3 years 
No. 9M, 44 
 
Disturbed visual fixation suppression of 
VOR, impaired upward opto-kinetic 
nystagmus, impaired horizontal and vertical 
pursuit. 
Normal Unknown 10 years 
No. 10F, 74 
 
Horizontal and impaired downward opto-
kinetic nystagmus with DBN when looking 
upwards, impaired horizontal and 
downward pursuit 
Normal Unknown 3 years 
No. 11F, 70 
 
Horizontally impaired and vertically 
nonexistent opto-kinetic nystagmus, 
impaired horizontal and downward pursuit. 
Normal Unknown 4 years 
No. 12M, 72 
 
DBN, incomplete ocular tilt reaction to the 
right, pathological HTT.  
Normal Unknown 0 years 
 
VOR=vestibulo-ocular reflex; HTT=head-thrust test developed by Halmagyi and Curthoys 
(1988). The permission to display the table was received from the publisher of Spiegel et al. 
(2009a). 
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Figure 2.1 An overview describing the testing conditions for all patients. The eye movements 
of the patients were monitored in the following order: 1. sitting in upright position in 
light/dark, 2. lying in supine position in light/dark, 3. lying in prone position in light/dark. All 
measurements took place at 9am, 11am, 1pm and 3pm. In between the measurements, patients 
rested in upright position with the room-light switched on (see Spiegel et al., 2009a). The 
permission to display the figure was received from the publisher of Spiegel et al. (2009a). 
 
2.1.3. Data acquisition and calibration 
 
In each body orientation, the eye position was measured with 3D video-oculography for 30 
seconds. An off-line analysis of the data was carried out using Matlab (The Mathworks, 
Natick, MA, USA). Subsequently, the calibrated data were low-pass filtered applying a digital 
Gaussian filter with a bandwidth of 30 Hz. Usually, saccades and fast phases were 
automatically detected and removed from the data making use of a combined velocity–
acceleration criterion in interactive software. Subsequently, saccades and fast phases that were 
not recognised automatically were removed manually. From the desaccaded data, mean slow 
phase velocity was computed. An explanation how slow phase velocity is computed can be 
found in the introduction. 
 42 
 
2.1.4. Statistical data analysis 
 
The statistical analysis consisted of repeated measurement ANOVAs (Statistica 6.1, Statsoft, 
Tulsa OK, USA) with post-hoc Scheffé tests for individual comparisons. The dependent 
variable was mean slow phase velocity (SPV). On all following figures in this thesis with 
SPV as the dependent variable, values have been transformed so that DBN indicated by SPV 
degrees/second occur as negative values on the scale, whereas no DBN would occur as a zero 
value on the scale. This also implies a specific terminology. Whenever in this thesis the terms 
higher or more pronounced are applied to SPV-values, it is meant more negative in spite of 
the fact that, in mathematical notation, -5 deg/s would be lower or less pronounced than for 
instance -4 deg/s. The same applies when it is said that SPV decreased from -5 deg/s to -4 
deg/s. In mathematical notation, this would be an increase, because more negative values 
increase to less negative values. Nevertheless, the word decreased will be applied here, 
because of the scale transformation from positive to negative and because of the fact that a 
change from more negative to less negative SPV-values is associated with a decrease in DBN. 
The dependent variable SPV was measured in three gaze directions (straight ahead, upward, 
downward, more details are provided in 2.1.2. Recording of eye movements). The first 
analysis consisted of the within subjects factors vertical versus horizontal measurement and 
daytime (9am, 11am, 1pm, 3pm). The dependent variable was mean slow phase velocity 
(SPV). All analyses following the first analysis had the dependent variable vertical SPV, i.e. 
not including horizontal measurements. The second analysis included the within subjects 
factors light (light on = fixation is possible versus light off = viewing in the dark with no 
possibility to fixate) and daytime (9am, 11am, 1pm, 3pm). The third analysis consisted of the 
within subject factors gaze direction (straight, upwards, downwards) and daytime (9am, 
11am, 1pm, 3pm). The fourth analysis had the within subject factors body orientation 
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(upright, supine and prone) and daytime (9am, 11am, 1pm, 3pm). Finally, the same analyses 
were carried out with the inclusion of the between subjects factor aetiology (cerebellar 
aetiology versus unknown aetiology). 
 
2.2. Results 
 
2.2.1. Daytime dependency of downbeat nystagmus 
 
It turned out that DBN during daylight significantly depends on daytime (Figure 2.2a, F(3, 
33)=6.89, p<0.001) with vertical SPV decreasing from the first to all other measurements 
(Scheffé tests for individual comparisons p<0.01). Horizontal and vertical SPV were 
significantly different from each other, F(1, 11)=13.775, p<0.01. As revealed by Scheffé post-
hoc tests, the 9am measurements (p<0.00001) as well as the 11am (p<0.05) and 1pm (p<0.05) 
measurements differed from each other. As can be seen in Figure 2.2a, horizontal SPV was 
much lower and close to zero. The daytime effect was less evident for horizontal SPV, but the 
interaction daytime times vertical versus horizontal measurement was still significant despite 
lower slow-phase velocities in this direction, F(3, 33)=4.34, p<0.01. From now on, it will be 
focused on vertical eye movements only, since the daytime effect was less evident for 
horizontal SPV. Another reason for analysing vertical eye movements stems from the fact that 
patients with DBN had reported a daytime-dependent decrease in vertical oscillopsia, which 
was already mentioned in the introduction of this thesis. All following figures within this 
chapter display the mean slow phase velocity along with the standard error bars of the mean. 
 44 
 
2.2.2. The influence of fixation on daytime dependency of downbeat nystagmus 
 
In the second analysis (Figure 2.2b), DBN assessed by vertical SPV was significantly smaller 
in the presence of a visible fixation point, F(1, 11)=19.32, p<0.01. However, the daytime 
dependence showed no significant difference between the two conditions (light on versus 
light off, i.e. no significant (though a marginally significant) interaction between daytime 
dependence and the possibility to fixate), F(3, 33)=2.645, p=0.065. This is a tentative sign that 
daytime dependence is not due to an increasing ability to suppress the nystagmus, but rather 
to a generic decrease in the slow phase velocity. Although there was only a marginally 
significant interaction, the probabilities of Scheffé post-hoc tests were revealed in order to 
provide a better comparison between Figure 2.2a and 2.2b). 
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Figure 2.2 Comparing DBN intensity changes throughout the day. Display of mean slow 
phase velocities along with the standard error bars of the mean. In both cases, measurements 
took place in upright position with gaze straight ahead, see Spiegel et al. (2009a): 
a Vertical and horizontal slow phase velocity with fixation (=light on) throughout the day. 
b Vertical slow phase velocity: Fixation (= light on) and viewing in darkness (= light off) 
throughout the day. Permission to display the figure was received from the publisher. 
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When referring to the main effect of daytime, as was found in the first analysis, DBN once 
more decreased throughout the day (9am: -5.59 deg/s, 11am: -3 deg/s, 1pm: -2.58 deg/s, 3pm: 
-2.64 deg/s), F(3, 33)=7.99, p<0.001 (see Figure 2.3), which confirms the finding from the 
previous analysis. 
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Figure 2.3 Comparing overall DBN intensity changes (across light on / light off condition) 
throughout the day (between 9am, 11am, 1pm, 3pm) in upright position with gaze straight 
ahead. Display of mean slow phase velocities along with the standard error bars of the mean. 
Permission to display the figure was received from the publisher. 
 
2.2.3. The influence of gaze-direction on daytime dependency of downbeat nystagmus 
 
The purpose of the third analysis was to find out whether gaze-direction had an influence on 
daytime dependence of DBN. Patients were sitting upright with the light switched on. The 
analysis showed a clear dependence of nystagmus SPV on gaze direction, F(2, 22)=14.45, 
p<0.0001 (Figure 2.4). Standing in line with Alexander’s law, upward gaze showed the 
smallest SPV and was significantly different from gaze straight ahead and downward gaze 
(with Scheffé post-hoc tests revealing p-values <0.01). SPV in gaze straight ahead and in 
downward gaze, however, were not significantly different from each other. 
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Figure 2.4 Comparing overall DBN intensity between gaze straight ahead, upward gaze and 
downward gaze, across daytime. All measurements took place in upright position. Display of 
mean slow phase velocities along with the standard error bars of the mean. 
 
The figure 2.5a along with the significant gaze times daytime interaction, F(6, 66)=2.39, 
p<0.05, both indicate that daytime dependence reduces mean slow phase velocity towards 
zero, instead of shifting it towards positive values by a constant amount. As far as these data 
are concerned, gaze in the direction of the fast phase did not reverse the nystagmus from DBN 
to UBN (= upbeat nystagmus). At the 9am measurements, upward gaze is associated with 
significantly less DBN than downward gaze (p<0.01) and gaze straight ahead (p<0.00001). 
Only in gaze straight ahead, there is a significant reduction in DBN (from 9am to 11am, 1pm 
and 3pm each p<0.01). 
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Figure 2.5a Dependence of SPV on gaze direction throughout the day whilst gaze was 
compared in three different positions: straight, upwards and downwards and fixation was 
possible (= light on). All measurements were performed in upright position with fixation on 
target (= light on), 
b Comparing overall DBN intensity changes (across all gaze directions) throughout the day 
(between 9am, 11am, 1pm, 3pm). All measurements were performed in upright position with 
fixation on target (= light on). Display of mean slow phase velocities along with the standard 
error bars of the mean. Permission to display the figure was received from the publisher. 
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As was found in the previous two analyses, DBN once more decreased throughout the day, 
F(3, 33)=5.56, p<0.01, from -2.875 deg/s at 9am to -1.685 deg/s at 11am, -1.21 deg/s at 1pm 
and -1.47 deg/s at 3pm (Figure 2.5b). Scheffé post-hoc tests revealed that the differences 
between 9am and 1pm (p<0.01) and between 9am and 3pm (p<0.05) were statistically 
significant. 
 
2.2.4. The influence of body-orientation on daytime dependence of downbeat nystagmus 
 
The fourth analysis aimed at finding out whether body-orientation has an influence on 
daytime dependence of DBN. The light was switched on to enable patients the possibility to 
fixate. The analysis indicated a highly significant dependence of nystagmus SPV on body 
orientation, F(2, 22)=21.03, p<0.00001, Figure 2.6, with higher DBN in prone position (-6.84 
deg/s) compared to upright (-2.61 deg/s) or supine positions (-0.88 deg/s, both Scheffé post-
hoc tests p<0.001), but no significant difference between upright and supine position 
(p>0.05). 
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2.6 Comparing DBN intensity between upright position, supine position and prone position, 
across time. All measurements were performed with gaze straight ahead and fixation on target 
(= light on). Display of mean slow phase velocities along with the standard error bars of the 
mean. 
 
As in the previous three analyses, DBN decreased throughout the day, F(3, 33)=6.01, p<0.01, 
but the daytime decrease did not depend on body orientation, F(6, 66)=1.04, p=0.41. The 
absence of a significant interaction shows that the time course of this decrease did not depend 
on the orientation of the body (upright vs. supine position vs. prone position). The overall 
daytime decrease can be found in Figure 2.7a, the decrease separated by positions in Figure 
2.7b. When considering the overall daytime decrease, the difference from 9am (-5.31 deg/s) to 
11am (-3.22 deg/s) was only marginally significant (p=0.06), whilst the decrease from 9am to 
1pm (-2.47 deg/s, p<0.01) and from 9am to 3pm (-2.775 deg/s, p<0.05) were significant in the 
absence of any other significant Scheffé post-hoc tests. 
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Figure 2.7a Daytime decrease of DBN between 9am, 11am, 1pm and 3pm, across body 
position. All measurements were performed in upright position with fixation on target (= light 
on), 
b Dependence of SPV on body orientation throughout the day when comparing the three 
positions upright, supine and prone. All measurements were performed in upright position 
with fixation on target (= light on). Display of mean slow phase velocities along with the 
standard error bars of the mean. Permission to display the figure was received from the 
publisher. 
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2.2.5. Testing the influence of aetiology on the intensity of downbeat nystagmus during 
daytime 
 
Because DBN in patients No. 1 to No. 5 was associated with cerebellar aetiologies, whereas 
DBN in patients No. 6 to No. 12 was associated with unknown causes, it was tested whether 
there was a significant difference in SPV-values based on the two different aetiologies. 
Neither in the first analysis, where horizontal and vertical SPV-values were included, nor in 
the second, third or fourth analysis of this study did the between subjects factor aetiology or 
any interaction including the between subjects factor aetiology turn out statistically 
significant. The first analysis neither resulted in a main effect for the between subjects factor 
aetiology, F(1, 10)=1.825, p=0.21, nor in an aetiology times daytime interaction, F(3, 
30)=0.79, p=0.51, nor in an aetiology times vertical versus horizontal measurement 
interaction F(1, 10)=0.78, p=0.4, nor in an aetiology times vertical versus horizontal 
measurement times daytime interaction, F(3, 30)=1.76, p=0.18. Overall, however, the 
cerebellar patients had a descriptively higher average SPV-value (-2.015 deg/s) than the 
patients with unknown aetiology (-1.15 deg/s). Including the between subjects factor 
aetiology did not make any difference with respect to the overall interpretation of the results, 
as the same within subjects factors and their interaction became significant. This was also the 
case in the analysis where no between subjects factor had been included. 
Turning to the second analysis, there was no significant main effect for the between 
subjects factor aetiology, F(1, 10)=1.27, p=0.29, nor an aetiology times light interaction, F(1, 
10)=0.41, p=0.54, nor an aetiology times daytime interaction F(3, 30)=1.22, p=0.32, nor an 
aetiology times light times daytime interaction, F(3, 30)=0.25, p=0.86. Overall, however, the 
cerebellar patients had a descriptively higher average SPV-value (-4.13 deg/s) than the 
patients with unknown aetiology (-2.97 deg/s). Once more, the inclusion of the between 
subjects factor aetiology did not make any difference with respect to the overall interpretation 
 53 
of the results, as the same within subjects factors and their absence of an interaction were 
present in the previous analysis with respect to light where no between subjects factor had 
been included. 
In the third analysis, there was no significant main effect for the between subjects 
factor aetiology, F(1, 10)=1.66, p=0.23, nor an aetiology times gaze direction interaction, F(2, 
20)=0.3, p=0.74, nor an aetiology times daytime interaction F(3, 30)=1.17, p=0.34, nor an 
aetiology times gaze direction times daytime interaction, F(6, 60)=1.53, p=0.18. Overall, 
however, the cerebellar patients had a descriptively higher average SPV-value (-2.43 deg/s) 
than the patients with unknown aetiology (-1.36 deg/s). Once more, the inclusion of the 
between subjects factor aetiology did not make any difference with respect to the overall 
interpretation of the results, because the same within subjects factors and their interaction 
became significant as in the previous analysis referring to gaze direction (where no between 
subjects factor had been included). 
The fourth analysis did not reveal a significant main effect for the between subjects 
factor aetiology, F(1, 10)=1.53, p=0.24. Likewise, there was no aetiology times body 
orientation interaction, F(2, 20)=0.285, p=0.755, no aetiology times daytime interaction F(3, 
30)=0.93, p=0.44, no aetiology times body orientation times daytime interaction, F(6, 
60)=0.33, p=0.92. Overall, however, the cerebellar patients had a descriptively higher average 
SPV-value (-4.54 deg/s) than the patients with unknown aetiology (-2.66 deg/s). As in the 
previous analyses, the inclusion of the between subjects factor aetiology did not make any 
difference with respect to the overall interpretation of the results, because the same within 
subjects factors became significant (just like the previous analysis where no between subjects 
factor had been included). In the previous analysis referring to body orientation as well as in 
this analysis, none of the interactions had become significant. 
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2.3. Discussion 
 
Based on patients with DBN who reported that their vertical oscillopsia symptoms are worst 
during the morning hours and become better in the course of the day, it was evaluated whether 
the intensity of DBN indeed changes throughout the day. To the best of my knowledge, no 
study thus far had reported on circadian changes of DBN. In the first analysis, it was therefore 
focused on changes in DBN intensity. It was demonstrated that DBN decreases throughout the 
day. This was investigated in greater detail in the second analysis, where it turned out that 
DBN decreases throughout the day irrespective of the possibility to fixate (= light switched 
on) or not (= light switched off). However, one has to be careful and should avoid over-
interpreting this finding, as the interaction was very close to becoming statistically significant 
at the type one error level of five percent. It therefore does not mean that fixation has 
definitely no influence on daytime decrease of DBN. Future studies will be necessary to 
confirm that daytime dependence is indeed not dependent on a visible fixation point. 
According to the results of this chapter and Spiegel et al. (2009a), DBN was significantly 
higher (= worse) when people were not able to fixate, (i.e. with the light switched off), but the 
changes during daytime were not significantly affected by this difference. The finding that 
visual fixation can suppress DBN does not mean that it makes DBN completely vanish, 
though, as it needs to be acknowledged that DBN can also persist after fixation (e.g. Kalla et 
al., 2008). Given that, as far as the results of this study are concerned, fixation on target is 
associated with a lower DBN than no fixation, this finding is new when compared to current 
literature (e.g. Heide & Kömpf, 2005), where it is said that DBN is not suppressed by fixation. 
In summary, it is probably best to argue that DBN can at least be partly suppressed by 
fixation, although this effect does not necessarily have to occur. In the following chapters 3 
and 4 it will also be seen that DBN during fixation is lower than DBN in the absence of 
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fixation. Given that the results of daytime-dependent decrease of DBN are also new, it might 
be worth to speculate about possible underlying mechanisms. Recall that in the first analysis, 
DBN at 9am was significantly worse than at all other measurements (11am, 1pm, 3pm), 
where DBN did not significantly differ between the measurements. Consequently, sleep 
inertia might be a possible explanation of this result. Sleep inertia is a transitional state of 
lowered arousal occuring after awakening from sleep (Ferrara & De Gennaro, 2000; Jewett et 
al. 1999; Tassi & Muzet, 2000). It is capable of producing a performance decrement spanning 
several cognitive functions that can last up to 4 hours (especially after an early wake-up when 
the person is sleep-deprived). To the best of my knowledge, the effect of sleep inertia on the 
cerebellum (especially the Purkinje cells) and central vestibular pathways has not yet been 
formally assessed, so at this time a possible effect of sleep inertia is nothing more than mere 
speculation. If it is assumed, however, that sleep inertia has a negative influence on the 
function of the Purkinje cells (which are inhibitory and therefore responsible for alleviating 
DBN), this would explain why DBN is relatively high at 9am and lower at the other times of 
the day. This corresponds to the previously mentioned successful pharmacological approaches 
to treat DBN with the potassium channel blockers 3,4-diaminopyridine (3,4-DAP) by Strupp 
et al. (2003) and Helmchen et al. (2004) or with 4-Aminopyridine (4-AP) by Kalla et al. 
(2004, 2007). As mentioned in the introduction, these drugs lead to an increase in the 
excitability of the Purkinje cells inside the cerebellum, and therefore they have an inhibitory 
effect on vertical eye movements. As an alternative explanation one could assume the 
possibility of a non-visual error signal such as extraocular proprioception (Büttner-Ennever & 
Horn, 2002) or efference copy (Glasauer et al. 2005b; Klier et al. 2008). According to these 
explanations, it might be the case that DBN becomes less because patients were able to adapt 
throughout the day. Since patients were allowed to keep their eyes open and the light switched 
on during the resting intervals between testing and because they were able to rest in upwards 
position, these conditions might have contributed to the adaptation process, which might itself 
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have alleviated the intensity of DBN. In order to investigate this issue in greater detail, more 
studies were carried out (see next chapter), where the conditions during the intervals between 
testing were varied (e.g. comparing patients who rested with the light switched on / off or 
patients in different body positions, e.g. upright, supine and prone).  
In the third analysis, it turned out that, in line with Alexander’s law, upward gaze 
exhibited the smallest DBN values expressed by vertical slow phase velocity, whilst gaze 
straight ahead or downward gaze did not differ significantly from each other. The last finding 
is not entirely consistent with Alexander’s law, however, where it would be expected that 
slow phase velocity decreases as gaze moves away from the direction of the fast phase 
(Jeffcoat et al., 2008, Marti et al., 2002; Robinson et al., 1984), i.e. it should be lower in gaze 
straight ahead than in downward gaze. Albeit dependent on gaze direction, focusing on a 
potential gaze times daytime interaction showed that DBN also decreased in the course of the 
day, where the absence of a significant interaction revealed a constant improvement rather 
than a gaze dependent improvement. 
The fourth analysis showed the dependence of DBN on body orientation, which 
complements earlier research on head position in relation to the gravitational vector by Brandt 
(1990), or experimental and theoretical work on gravity dependence of ocular drift in patients 
with DBN by Marti et al. (2002, 2008), or the treatment of gravity dependence of DBN with 
3,4-DAP by Sprenger et al. (2006). Along with Marti et al. (2002), it was found that DBN was 
far more pronounced in prone position than in supine position. Furthermore, DBN was more 
pronounced in prone position than in upright position, whilst no significant difference was 
found between upright and supine position. The explanation of Marti et al. (2002) that the 
combination of a gravity-dependent and a gravity-independent component leads to an overall 
drift that is minimal in supine position, because the gravity-dependent component shows its 
maximal downward drift in supine position, counteracting the upward drift of the gravity-
independent component in DBN, is entirely consistent with the finding in this study. 
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Likewise, the maximal vertical drift velocity is observed in prone position according to Marti 
et al. (2002), because both drift components are directed upward, hence resulting in stronger 
DBN. This finding is also consistent with the results in the study presented in this chapter. 
When patients are in upright position, the gravity-dependent component should be near zero, 
so that the vertical ocular drift is almost exclusively based on the gravity-independent 
component, i.e. according to Marti et al. (2002), the intensity of DBN in upright position 
should lie between the intensities in supine and prone position. Once more, this result was 
confirmed in this study. In all three positions, DBN decreases throughout the day. To evaluate 
whether this change in body orientation also has a positive effect after patients return to their 
original position, this was further analysed in another study (see the following chapter 3). 
Another study was necessary because the previously demonstrated study had the same resting 
interval in all four analyses, where patients were sitting upright with the light switched on. It 
is vital to know, however, whether the resting interval per se has an influence on DBN. As a 
result, chapter 3 will investigate three different resting positions (upright, supine and prone) as 
well as a condition where the light is switched off. 
To conclude, this study shows that DBN decreases throughout the day (irrespective of 
the presence of a visual fixation point), that it is less pronounced when looking upward and 
less in supine / upright position than in prone position. It also suggests a more detailed study 
(see chapter 3) to test the clinical efficacy of different prolonged day time positions in order to 
further modulate the intensity of DBN throughout the day. The results in this chapter are not 
dependent on the aetiology of DBN, as the inclusion of a between subjects factor aetiology 
did not make any difference to the overall results. None of the analyses revealed a significant 
effect with respect to the between subjects factor aetiology, nor was there any significant 
interaction with respect to aetiology. It needs to be acknowledged, though, that according to 
the descriptive trend, the SPV-values were more pronounced in the group of cerebellar 
patients than in the group of patients with unknown aetiology. The absence of a significant 
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value in the comparison between both groups could also be due to the fact that the sample size 
was rather small, and therefore lacked power to reveal a significant result. On the other hand, 
DBN is a very rare condition and it is difficult to find a large number of patients for clinical 
studies. In spite of the small sample size, the results of the first two analyses have the practical 
consequence that they permit to make immediate suggestions to patients. Given that DBN 
decreases throughout the day, patients might benefit from the following advice: they should 
rather engage in activities such as reading, working on a computer or watching TV at a later 
time of the day, and spend the morning hours with activities that depend less on the ocular-
motor system. 
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3. An analysis of positional effects on the changes of intensity of downbeat nystagmus 
during daytime 
 
A large part of the results of the following chapter has been published in Spiegel et al. (2010). 
For that reason, part of the text shows an overlap. The same holds true for the tables, figures, 
and their legends, for which I also received permission from the publisher, Neurology®. As 
mentioned in the previous chapter, the intensity of DBN may also depend on prolonged 
positions (e.g. resting positions during the day). Another interesting aspect is whether it is 
better to rest in darkness or with the light switched on. For this reason, it will be first focused 
on an upright resting position with the light switched on versus an upright resting position 
with the light switched off (part 1) under conditions that come closest to the daily routine of 
the patients (i.e. being measured in upright position with the light switched on and comparing 
the two resting intervals upright light on versus upright light off). Subsequently, part 2 will 
focus on the same measurement in upright position with the light switched on, but will 
compare the three resting intervals upright, supine position and prone position, each with the 
light switched off. The major results of parts 1 and 2 were published in Spiegel et al. (2010). 
Parts 3 to 6 will then focus on the same analyses as the ones in the previous chapter, but with 
different resting positions (upright light on versus upright light off as well as upright, supine 
and prone, each with the light switched off). These analyses will be carried out to see whether 
the results including different resting positions are congruent with the results from the 
previous chapter, where resting position was not varied. Based on the results of this chapter it 
might be possible to derive insights with clinical relevance. These insights could be suggested 
to patients with DBN, e.g. they could be informed how to rest in order to alleviate their 
intensity of DBN. 
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3.1. Measurement in upright position with gaze straight ahead and the light switched on 
intermitted by the resting intervals upright with the light switched on and upright with 
the light switched off (part 1) 
 
In order to find out whether resting upright with fixation on target (= light on) or not (= light 
off) makes a difference to the measurement in upright position with fixation on target (which 
can be regarded as the typical position during the day), the following analysis was carried out. 
3.1.1. Methods 
3.1.1.1. Patients 
 
In the present part of this study, the eye movements of eight patients with a history of DBN 
due to different aetiologies were recorded three times on a single day: at 9am, 11am and 1pm. 
To vary the resting positions from upright with fixation on target to upright in complete 
darkness, there was an interval of one week between the two days where patients were either 
measured in light or in darkness. The aetiologies were idiopathic cerebellar syndrome (n = 1), 
idiopathic cerebellar ataxia (n = 1), cerebellar degeneration (n = 1), or unknown (n = 5), see 
Table 3.1. The mean duration of DBN was 6.81 years (range 2-17 years, see Table 3.1). The 
patients (6 males, 2 females) were 44 to 82 years old, with a mean of 67.25 years and a 
standard deviation of ± 10.365 years. The purpose of this part of the study was to analyse the 
intensity of DBN to find out whether it differs between the two resting intervals (upright with 
the light on versus upright with the light off). The intensity of DBN was assessed by vertical 
mean slow phase velocity. Patients’ eye movements were recorded with 3D videooculography 
(VOG). All patients underwent a complete clinical examination. The clinical examination, the 
laboratory tests, the approval by the ethics committee and the study being in line with the 
Helsinki II Declaration were identical to the previous study (for details see chapter 2). 
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Table 3.1 Clinical data of the patients with DBN where upright positions in light and 
darkness were compared with each other 
No./Sex/ 
Age 
Neuro-ophthalmological findings MRI 
findings 
Aetiology Disease 
duration 
No. 1M, 76 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and vertical opto-
kinetic nystagmus with horizontal and 
vertical saccades, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
White matter 
lesions 
Idiopathic 
cerebellar 
syndrome 
2 years 
No. 2M, 64 
 
Disturbed visual fixation suppression of 
VOR, non-existing upright opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
Cerebellar 
atrophy 
Cerebellar de-
generation 
3 years 
No. 3F, 69 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and upward opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally, provocation DBN. 
Cerebellar 
atrophy 
Idiopathic 
cerebellar 
ataxia 
17 years 
No. 4M, 82  Deviant SVV, non-existing upward opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, provocation downward 
nystagmus. 
Normal Unknown 3.5 years 
No. 5M, 69 
 
Disturbed visual fixation suppression of 
VOR, impaired upward opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT on the 
left. 
Normal Unknown 6 years 
No. 6M, 44 
 
Disturbed visual fixation suppression of 
VOR, impaired upward opto-kinetic 
nystagmus, impaired horizontal and vertical 
pursuit. 
Normal Unknown 10 years 
No. 7M, 65 
 
Impaired upward opto-kinetic nystagmus, 
impaired horizontal and downward pursuit, 
hypometric upward saccades. 
Normal Unknown 10 years 
No. 8F, 69 
 
Disturbed vertical visual fixation 
suppression of VOR, impaired upward 
opto-kinetic nystagmus, impaired horizontal 
and downward pursuit. 
Normal Unknown 3 years 
 
VOR = vestibulo-ocular reflex; SVV = subjective visual vertical axis, HTT = head-thrust test 
developed by Halmagyi and Curthoys (1988). 
 
3.1.1.2. Recording of eye movements 
 
Patients were tested three times on a single day in upright position with the light switched on 
(see Figure 3.1). After a calibration in 8.5° position, people where measured in gaze straight 
 62 
ahead with the light switched on (i.e. with the possibility to fixate). The target was projected 
by a laser on a white cardboard at a distance of 60 cm in front of the participant. The 
recordings with regard to the different resting intervals took place with the same patients (in 
each patient, the recordings in the different resting intervals were separated by approximately 
one week). 
 
 
                     time 
 
 
 
 
Figure 3.1. An overview describing the testing conditions for all patients. All measurements 
took place at 9am, 11am, and 1pm. In between the measurements, patients were sitting in 
upright position with the light switched on or off. 
 
3.1.1.3. Data acquisition and calibration 
 
The eye position was measured with 3D video-oculography for 30 seconds. An off-line 
analysis of the data was carried out using Matlab (The Mathworks, Natick, MA, USA). 
Subsequently, the calibrated data were low-pass filtered applying a digital Gaussian filter with 
a bandwidth of 30 Hz. Saccades and fast phases, as had already been described in the methods 
section of the previous chapter, were automatically detected and removed from the data using 
a combined velocity–acceleration criterion in interactive software. This was followed by a 
manual task, where saccades and fast phases not having been recognised automatically were 
removed manually. From the desaccaded data, mean slow phase velocity was computed in the 
same way as described in the introduction and the previous chapter. 
or or 
Pretest 
at 9am 
Test 
at 11am 
Test 
at 1pm 1st 
resting 
interval 
2nd 
resting 
interval 
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3.1.1.4. Statistical data analysis 
 
The statistical analysis consisted of an ANOVA (Statistica 6.1, Statsoft, Tulsa OK, USA) with 
post-hoc Scheffé tests for individual comparisons. The dependent variable was mean slow 
phase velocity (SPV). The first analysis had the within subject factors resting interval (upright 
with the light on versus upright with the light off) and daytime following the resting intervals 
(11am, 1pm). The second analysis was identical, but also included the 9am measurement. Due 
to the low number of patients with cerebellar symptoms, the nonparametric Kolmogorov-
Smirnov test was taken to compare the two independent samples. The two independent groups 
were the two different aetiologies (cerebellar patients versus patients with unknown 
aetiology). The two groups were compared with respect to their overall SPV-values. The test 
was developed by Andrej Nikolaevič Kolmogorov and Nikolaj Vasilevič Smirnov and aims to 
find out whether the differences between two empirical distributions are significant. Details 
can be found in Toutenburg et al. (2008). 
 
3.1.2. Results 
 
The analysis showed no significant main effect of resting interval, F(1, 7)=1.81, p=0.22, no 
main effect of daytime (F(1, 7)=0.85, p=0.39) and no interval times daytime interaction, F(1, 
7)=1.58, p=0.25. Having previously rested with the light switched off was associated with a 
descriptively lower intensity of DBN (average SPV=-1.16 deg/s) than having rested with the 
light switched on (average SPV=-1.89 deg/s). When including the 9am measurements (i.e. 
prior to the first resting interval), there was no significant main effect for resting interval, F(1, 
7)=1.15, p=0.32 and no interval times daytime interaction, F(2, 14)=1.14, p=0.35. Consistent 
with chapter 2, there was a significant overall daytime improvement of DBN (F(2, 14)=15.24, 
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p<0.001), which was obviously not present in the first analysis, as the first analysis did not 
include the 9am measurements. Hence, DBN decreased from 9am (where SPV was -3.75 
deg/s) to 11am (SPV=-1.65 deg/s) and to 1pm (SPV=-1.39 deg/s). Scheffé post-hoc tests 
indicated that the decrease from 9am to 11am (p<0.01) and the one from 9am to 1pm 
(p<0.001) turned out statistically different, whilst no significant difference turned out between 
11am and 1pm (p=0.86), Figure 3.2a. Although the interval times daytime interaction was not 
significant, the overall results will be displayed in Figure 3.2b, as this gives the reader an idea 
of the results in both resting intervals. Because the interval times daytime interaction was not 
significant, no post-hoc Scheffé tests had been carried out. Consequently, it is not indicated 
within Figure 3.2 whether there were significant post-hoc results. 
With regard to the comparison between cerebellar patients and patients with unknown 
aetiology, cerebellar patients had an average SPV-value of -3.77 deg/s, whilst patients with 
unknown aetiology had an average SPV-value of -1.36 deg/s. According to the Kolmogorov-
Smirnov test (p>0.1), this is not a significant difference. When excluding the 9am 
measurements, because they had taken place before the first intermission, cerebellar patients 
had an average SPV-value of -2.78 deg/s, whilst patients with unknown aetiology had an 
average SPV-value of -0.77 deg/s. According to the Kolmogorov-Smirnov test (p>0.1), this 
descriptive difference is not significant. 
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Figure 3.2a Comparing SPV in upright position and gaze straight ahead with the light 
switched on between 9am, 11am and 1pm across both resting intervals (resting upright in light 
vs. darkness). Display of mean slow phase velocities along with the standard error bars of the 
mean, b The same comparison as in 3.2a, but between the two resting intervals (upright with 
the light switched on versus upright with the light switched off). 
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3.1.3. Discussion 
 
As far as upright measurements with the light switched on are concerned, it does not make a 
statistically significant difference whether people previously rest upright with the light 
switched on or whether they previously rest with the light switched off. It is noteworthy that 
the data cannot be explained by visual input, as there was no significant difference when 
patients were able to fixate a target during their resting period (where the light was switched 
on) and when they were in complete darkness and hence, fixation was impossible (= light 
off). From a descriptive point of view, however, a slightly lower DBN is associated with the 
resting condition where the light was switched off. Hence, the following comparisons 
between the different resting positions were all in the light off condition. Moreover, the 
daytime decrease in the intensity of DBN from the previous chapter was confirmed. There is a 
significant decrease from 9am to 11am and from 9am to 1pm, but the decrease is not 
differentially affected by the resting positions, as the interaction did not turn out significant. 
Although the between-subjects factor aetiology does not have a significant effect on the 
results, it is obvious that patients with cerebellar aetiology have a more pronounced intensity 
of DBN. In a larger sample size with more statistical power, the descriptive difference 
between the two groups could have become statistically significant. 
 
3.2. Measurement in upright position with gaze straight ahead and the light switched on 
intermitted by the resting intervals upright, supine and prone (part 2) 
 
According to the results from the previous chapter (chapter 2), different body positions seem 
to have an influence on the intensity of DBN. This might be due to gravitational influences 
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(e.g. Brandt, 1990; Marti et al., 2002). In the previous chapter, however, patients rested in 
upright position between the measurements. It will now be analysed whether the resting 
positions per se have an influence on the daytime decrease of DBN. Because there was a 
descriptive trend towards lower intensity of DBN in the darkness upright resting position as 
compared to the upright resting position with fixation on target (= light on), patients in this 
study rested with the light switched off in all three positions (upright, supine and prone). 
 
3.2.1. Methods 
 
3.2.1.1. Patients 
 
Nine patients (4 males, 5 females, aged 44 to 72 years, mean 63.67 years, SD ± 7.92 years, 
mean duration of DBN 6.81 years, range 3 to 17 years, see Table 3.2.) were included. They 
were tested at 9am, 11am and 1pm. In the intermissions between testing, they either rested in 
upright, supine or prone position. In all cases, the light was switched off, i.e. they rested in 
darkness. The intensity of DBN was assessed by vertical mean slow phase velocity. Patients’ 
eye movements were recorded with 3D-videooculography (VOG). All patients underwent a 
complete clinical examination. The clinical examination, the laboratory tests, the approval by 
the ethics committee and the study being in line with the Helsinki II Declaration were 
identical to the previous study (for details see chapter 2). 
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Table 3.2 Clinical data of the patients with DBN 
No./Sex/ 
Age 
Neuro-ophthalmological findings MRI 
findings 
Aetiology Disease 
duration 
No. 1M, 64 
 
Disturbed visual fixation suppression of 
VOR, non-existing upright opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
Cerebellar 
atrophy 
Cerebellar de-
generation 
3 years 
No. 2F, 69 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and upward opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally, provocation DBN. 
Cerebellar 
atrophy 
Idiopathic 
cerebellar 
ataxia 
17 years 
No. 3M, 69 
 
Deviant SVV, impaired horizontal and 
downward pursuit, saccades with rebound 
after gaze to the right, provocation DBN. 
Normal Unknown 4.5 years 
No. 4F, 60  Disturbed visual fixation suppression of 
VOR, DBN overran horizontal opto-kinetic 
nystagmus, non-existing upward opto-
kinetic nystagmus, deviant SVV, impaired 
horizontal and downward pursuit. 
Normal Unknown 12 years 
No. 5F, 61  Disturbed visual fixation suppression of 
VOR, deviant SVV, provocation DBN, 
vertical saccades and saccades to the left. 
Normal Unknown 5 years 
No. 6M, 44 
 
Disturbed visual fixation suppression of 
VOR, impaired upward opto-kinetic 
nystagmus, impaired horizontal and vertical 
pursuit. 
Normal Unknown 10 years 
No. 7M, 65 
 
Impaired upward opto-kinetic nystagmus, 
impaired horizontal and downward pursuit, 
hypometric upward saccades. 
Normal Unknown 10 years 
No. 8F, 69 
 
Disturbed vertical visual fixation 
suppression of VOR, impaired upward 
opto-kinetic nystagmus, impaired horizontal 
and downward pursuit. 
Normal Unknown 3 years 
No. 9F, 72 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and non-existing 
upward opto-kinetic nystagmus, impaired 
horizontal and downward pursuit. 
Normal Unknown 6 years 
 
VOR = vestibulo-ocular reflex; SVV = subjective visual vertical axis, HTT = head-thrust test 
developed by Halmagyi and Curthoys (1988). See Spiegel et al. (2010). 
 
3.2.1.2. Recording of eye movements 
 
Patients were tested three times on a single day in upright position with the light switched on 
(see Figure 3.3). After a calibration in 8.5° position, people where measured in gaze straight 
ahead with the light switched on (i.e. with the possibility to fixate). The target was projected 
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by a laser on a white cardboard at a distance of 60 cm in front of the participant. The 
recordings with regard to the different resting intervals took place with the same patients (in 
each patient, the recordings in the different resting intervals were separated by approximately 
one week). 
 
 
 
                     time 
 9am     Inter-          11am      Inter-   1pm   
       mission           mission               
 
Figure 3.3. An overview describing the testing conditions for all patients. All measurements 
took place at 9am, 11am, and 1pm, in upright position, with gaze straight ahead and the light 
switched on. In the resting intervals between the measurements, patients were sitting in 
upright position, lying in supine position or lying in prone position, in all cases with the light 
switched off. 
 
3.2.1.3. Data acquisition and calibration 
 
The eye position was measured with 3D video-oculography for 30 seconds. An off-line 
analysis of the data was carried out using Matlab (The Mathworks, Natick, MA, USA). 
Subsequently, the calibrated data were low-pass filtered applying a digital Gaussian filter with 
a bandwidth of 30 Hz. As in the previous chapter, saccades and fast phases were 
automatically detected and removed from the data using a combined velocity–acceleration 
criterion in interactive software. Those saccades and fast phases that were not recognised 
automatically were subsequently removed manually. From the de-saccaded data, mean slow 
phase velocity was computed from a 30 seconds long measurement period. 
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3.2.1.4. Statistical data analysis 
 
The statistical analysis consisted of an ANOVA with post-hoc Scheffé tests for individual 
comparisons. The dependent variable was mean slow phase velocity (SPV). The first analysis 
had the within subject factors resting interval (upright, supine and prone) and daytime 
following the resting intervals (11am, 1pm). The second analysis was identical, but also 
included the 9am measurement. As in part 1, an analysis with the nonparametric Kolmogorov-
Smirnov test was applied to compare patients with different aetiologies (i.e. two independent 
samples) in terms of their overall SPV-values (the two cerebellar patients versus the seven 
patients with unknown aetiology). 
 
3.2.2. Results 
 
The first analysis (excluding the 9am measurements) showed a significant main effect for 
resting interval, F(2, 16)=5.54, p=0.01, no main effect for daytime, F(1, 8)=0.06, p=0.805, and 
no interval times daytime interaction, F(2, 16)=1.5, p=0.25. When being measured in the 
typical daytime position (= upright), having previously rested in upright position was 
associated with a significantly lower average SPV-value (-0.65 deg/s) than having previously 
rested in prone position (-2.22 deg/s, Scheffé post-hoc test: p<0.05) or supine position (-2.1 
deg/s; Scheffé post-hoc test: p<0.05). The overall results are displayed in Figure 3.4a and the 
results separated by the time of the measurement in Figure 3.4b. In Figure 3.4b, the results of 
the post-hoc tests are not indicated separately, because the interval times daytime interaction 
did not become significant. 
The 9am measurements, i.e. prior to the first resting interval, were comparable 
(p>0.98) in all three conditions (prior to the upright resting interval: -3.05 deg/s, SE=0.65, the 
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supine resting interval: -3.12 deg/s, SE=0.98, the prone resting interval: -3.6 deg/s, SE=1.2). 
Integrating the 9am measurement (i.e. prior to the first resting interval) showed identical 
overall results with respect to resting interval, F(2, 16)=3.97, p<0.05, but also included a 
significant effect with respect to daytime decrease of DBN, F(2, 16)=4.33, p<0.05, in the 
absence of a significant interval times daytime interaction, which was marginally significant, 
F(4, 32)=2.6, p=0.054, where only upright resting position was associated with a significant 
decrease of DBN from 9am to 11am (p<0.01) and from 9am to 1pm (p<0.001), though it 
needs to be kept in mind that, strictly speaking, post-hoc significance tests are not permitted 
due to the marginal nature of the interaction. Post-hoc tests following the significant main 
effects in the second analysis (interval, daytime) did not turn out significant, though. Because 
this information is redundant to previous information, i.e. the daytime decrease known from 
the previous chapter as well as the main effect for interval displayed in Figure 3a, no separate 
figure will be displayed for the second analysis. 
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Figure 3.4a Comparing SPV differences in upright measurement during straight ahead gaze 
between the three different resting intervals across time, b Comparing SPV differences in 
upright measurement during straight ahead gaze between the three different resting intervals 
and between time (11am, 1pm). Display of mean slow phase velocities along with the 
standard error bars of the mean. 
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When turning to the comparison between cerebellar patients and patients with unknown 
aetiology in the first analysis (excluding the 9am measurements), cerebellar patients had an 
average SPV-value of -3.01 deg/s, whilst patients with unknown aetiology had an average 
SPV-value of -1.27 deg/s. According to the analysis with the Kolmogorov-Smirnov test for 
the two independent samples (p>0.1), this is not a significant difference (despite the obvious 
descriptive trend). When the 9am measurements were considered, cerebellar patients turned 
out to have an average SPV-value of -4.48 deg/s, whereas patients with unknown aetiology 
reached an average SPV-value of -1.54 deg/s. According to the Kolmogorov-Smirnov test for 
two independent samples (p>0.05), this descriptive difference, however large it seems, is not 
significant either. 
 
3.2.3. Discussion 
 
This analysis has shown that resting position influences the known spontaneous decrease of 
DBN during daytime. When measured in upright position, the intensity of DBN is lower after 
resting in an upright position than after resting in a supine or prone position. Although the 
overall extent of DBN did not differ between patients with cerebellar and idiopathic 
aetiologies, it needs to be acknowledged that there was a clear descriptive trend towards DBN 
being larger in cerebellar patients. This trend could have turned out significant had the sample 
size been larger. 
The results complement earlier studies reporting that DBN was modulated by head 
position relative to gravity (Marti et al., 2002) and it is in line with experimental results in 
primates showing the activity of otolith-related central vestibular neurons (Eron et al., 2008) 
and the incorporation of otolith-related neurons in the model of Marti et al. (2008). Hence, it 
could be the case that the otoliths have exerted a stabilizing influence on the central vestibular 
neurons (and therefore on vertical eye movements) during prolonged upright resting. The 
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clinical relevance of these results is to advise patients with DBN to rest in an upright position 
during the day. This is likely to alleviate distressing oscillopsia due to the involuntary retinal 
slip being caused by the fixation nystagmus. This is a particularly interesting finding, as it 
complements earlier research on head position relative to the gravitational vector, where it 
was postulated that a change in head position relative to the gravitational vector could be 
responsible for DBN (Brandt, 1990; Marti et al., 2002; 2008). According to this explanation 
(Brandt, 1990), the positional response is a vestibular tone imbalance caused by a 
disinhibition of the vestibular reflexes on perception, head, eye and the position of the body. 
Although the patients in this study already had DBN prior to the positional changes, this 
explanation could also account for an increased intensity of DBN following positional 
changes. Future research will be necessary, though, to find out what resting position suits 
patients best prior to transitioning into a body orientation in supine or prone position, e.g. 
prior to a massage. Another explanation would be an adaptation of the one by Marti et al. 
(2002), where DBN in upright position is only due to the gravity-independent component, 
whereas DBN resulting from supine or prone position are modulated by the gravity-dependent 
component. Although one would assume DBN to be lower in supine position than in prone or 
upright position, this assumption only refers to being measured in supine or prone position. If 
people are resting in supine/prone position and switching to upright position for the 
measurement, the rotation relative to the gravitational vector could have an impact on otolith-
related vestibular neurons. This impact might be able to explain why DBN during daytime 
improves significantly when resting in upright position, but is significantly worse when 
resting in supine or prone position. The rotation relative to the gravitational vector might exert 
an absolute influence (i.e. a modulus in mathematical terms) on otolithic function, which 
could explain why resting in supine and prone position is associated with a similar intensity of 
DBN when being measured in upright position. It is of particular interest that the data in this 
sub-chapter (part 2 of chapter 3) cannot be explained by visual input, as the previous sub-
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chapter (part 1 of chapter 3) had already demonstrated that there was no significant difference 
when patients were able to fixate a target during resting and when they were in complete 
darkness and fixation was therefore made impossible. 
 
3.3. Replicating the study on daytime dependence of downbeat nystagmus mediated by 
upright resting positions with the light switched on / off (part 3) 
 
The study in chapter 2 analysed daytime dependence of DBN by including comparisons 
where patients fixated on a target (= light switched on) or not (= light switched off), as well as 
other comparisons with respect to gaze direction or body position. It did not include different 
resting positions, though. Hence, the following analyses will be identical to the ones in 
chapter 2 with the additional inclusion of different resting positions in order to find out 
whether the intensity of DBN is mediated by different resting positions. The first analysis 
compares upright resting positions in light and darkness. 
 
3.3.1. Methods (part 3) 
 
3.3.1.1. Patients 
 
In the present part of this study, the eye movements of eight patients with a history of DBN 
due to different aetiologies were recorded three times on a single day: at 9am, 11am and 1pm.  
The aetiologies were idiopathic cerebellar syndrome (n = 1), idiopathic cerebellar 
ataxia (n = 1), cerebellar degeneration (n = 1), or unknown (n = 5), see Table 3.3. With the 
exception of patient No. 4, all of these patients had already participated in the study of the 
previous chapter. The study in the previous chapter had several additional patients, however. 
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The mean duration of DBN was 6.81 years (range 2-17 years, see Table 3.3, which is identical 
to Table 3.1, because the patients were the same). The patients were 44 to 82 years old, with a 
mean of 67.25 years and a standard deviation of ± 10.365 years. The purpose of this part of 
the study was to analyse the intensity of DBN at the three times of measurement and to find 
out whether it differs between the two resting intervals (upright with the light on versus 
upright with the light off). All other procedures (clinical examination, laboratory tests and the 
approval from the ethics committee) were identical to the previous study and parts 1 and 2 of 
this study. 
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Table 3.3 Clinical data of the patients with DBN where upright positions in light and 
darkness were compared with each other 
No./Sex/ 
Age 
Neuro-ophthalmological findings MRI 
findings 
Aetiology Disease 
duration 
No. 1M, 76 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and vertical opto-
kinetic nystagmus with horizontal and 
vertical saccades, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
White matter 
lesions 
Idiopathic 
cerebellar 
syndrome 
2 years 
No. 2M, 64 
 
Disturbed visual fixation suppression of 
VOR, non-existing upright opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
Cerebellar 
atrophy 
Cerebellar de-
generation 
3 years 
No. 3F, 69 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and upward opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally, provocation DBN. 
Cerebellar 
atrophy 
Idiopathic 
cerebellar 
ataxia 
17 years 
No. 4M, 82  Deviant SVV, non-existing upward opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, provocation downward 
nystagmus. 
Normal Unknown 3.5 years 
No. 5M, 69 
 
Disturbed visual fixation suppression of 
VOR, impaired upward opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT on the 
left. 
Normal Unknown 6 years 
No. 6M, 44 
 
Disturbed visual fixation suppression of 
VOR, impaired upward opto-kinetic 
nystagmus, impaired horizontal and vertical 
pursuit. 
Normal Unknown 10 years 
No. 7M, 65 
 
Impaired upward opto-kinetic nystagmus, 
impaired horizontal and downward pursuit, 
hypometric upward saccades. 
Normal Unknown 10 years 
No. 8F, 69 
 
Disturbed vertical visual fixation 
suppression of VOR, impaired upward 
opto-kinetic nystagmus, impaired horizontal 
and downward pursuit. 
Normal Unknown 3 years 
 
VOR = vestibulo-ocular reflex; SVV = subjective visual vertical axis, HTT = head-thrust test 
developed by Halmagyi and Curthoys (1988). 
 
3.3.1.2. Recording of eye movements 
 
Patients were tested three times on a single day. Each time, patients were monitored in the 
following sequence: (see Figure 3.5). 
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1. they were sitting in upright position, 2. they were lying in supine position, 3. they were 
lying in prone position. In the intervals between testing, people rested in upright position, 
either with the light switched on or with the light switched off. The same patients were 
measured with the light switched on / off, i.e. they came to the hospital twice with a delay of 
approximately one week between these two measurements. As in the previous chapter and 
prior publications (e.g. Spiegel et al., 2009a; Zingler et al., 2006), a 30 seconds eye movement 
recording with 3-D VOG took place in the following order: Calibration in 8.5° position, 1. 
gaze straight ahead with fixation turned on, 2. gaze straight ahead in darkness (with no 
possibility to fixate on a fixation point), 3. 17° rightward gaze, 4. 17° leftward gaze, 5. 17° 
upward gaze 6. 17° downward gaze. The projection of the target occurred with a laser onto a 
white cardboard placed 60 cm in front of the patient. The horizontal gaze directions were only 
recorded for completeness purposes, e.g. to have a collection of these data should they be of 
interest for future studies, e.g. to generate possible hypotheses on gaze direction and 
medication. 
 
 
                     time 
 
 
 
Figure 3.5. An overview describing the testing conditions for all patients. The eye 
movements of the patients were monitored in the following order: 1. sitting in upright position 
in light/dark, 2. lying in supine position in light/dark, 3. lying in prone position in light/dark. 
All measurements took place at 9am, 11am, and1pm. In between the measurements, patients 
rested in upright position with the room-light either switched on or switched off. 
Pretest 
at 9am 
Test 
at 11am 
Test 
at 1pm 1st 
resting 
interval 
2nd 
resting 
interval 
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3.3.1.3. Data acquisition and calibration 
 
Data acquisition and calibration was done in exactly the same way as described in the 
previous chapter, i.e. eye position was measured with 3D-VOG for 30 seconds as in Zingler et 
al. (2006). The data were analysed off-line using Matlab (The Mathworks, Natick, MA, 
USA). The calibrated data were low-pass filtered applying a digital Gaussian filter with a 
bandwidth of 30 Hz. Interactive software allowed to detect and remove saccades and fast 
phases using a combined velocity–acceleration criterion. Consequently, it was possible to 
exclude detection errors manually. The mean slow phase velocity was computed from de-
saccaded data. 
 
3.3.1.4. Statistical data analysis 
 
The statistical analysis consisted of repeated measurement ANOVAs (Statistica 6.1, Statsoft, 
Tulsa OK, USA) with post-hoc Scheffé tests for individual comparisons. The dependent 
variable was mean slow phase velocity (SPV). The dependent variable SPV was measured in 
three gaze directions (straight ahead, upward, downward, more details are provided in 3.3.1.2. 
Recording of eye movements). The first analysis consisted of the within subjects factors light 
(light on = fixation on target versus light off = no fixation), interval (resting upright with the 
light switched on versus resting upright with the light switched off) and daytime (9am, 11am, 
1pm). The second analysis consisted of the within subject factors gaze direction (straight, 
upward, downward), interval (resting upright with the light switched on versus resting upright 
with the light switched off), and daytime (9am, 11am, 1pm). The third analysis had the within 
subject factors body orientation (upright, supine and prone), interval (resting upright with the 
light switched on versus resting upright with the light switched off), and daytime (9am, 11am, 
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1pm). Due to the low number of three patients with cerebellar symptoms, a nonparametric test 
for two independent samples was applied, i.e. the Kolmogorov-Smirnov test. 
 
3.3.2. Results 
 
3.3.2.1. First section including the within subjects factor fixation versus viewing in the 
dark 
 
During the measurement, patients were sitting in upright position with gaze straight ahead. 
During the resting intervals, patients were in upright position either with the light switched on 
or with the light switched off. As in the previous chapter, the analysis revealed a significant 
main effect for the within-subjects factor light, F(1, 7)=14.81, p<0.01 (Figure 3.6), where 
fixation on target (= light turned on) resulted in lower average SPV-values than viewing in the 
dark (-2.26 deg/s vs. -4.0 deg/s). 
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Figure 3.6 Comparing SPV across both intervals (resting upright in light vs. darkness) and 
daytime (9am, 11am, 1pm) between light (= fixation on target) and darkness conditions (= 
patients cannot fixate) in upright position with gaze straight ahead. Display of mean slow 
phase velocities along with the standard error bars of the mean. 
 
In addition, the analysis replicated the daytime decrease reported in Spiegel et al. (2009a) and 
in the previous chapter, because there was a significant main effect for the within subjects 
factor daytime (9am vs. 11am vs. 1pm), F(2, 14)=17.19, p<0.001 (Figure 3.7), where average 
SPV decreased from 9am (-5.03 deg/s) to 11am (-2.41 deg/s) and 1pm (-1.96 deg/s). As 
revealed by post-hoc Scheffé tests, the decrease from 9am to 11am (p<0.01) and from 9am to 
1pm (p<0.001) was statistically significant, whereas there was no significant difference 
between 11am and 1pm (p=0.73). 
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Figure 3.7 SPV between daytime (9am versus 11am versus 1pm) and across both light 
conditions (light during testing switched on or off) and intervals (resting upright in light vs. 
darkness) in upright position with gaze straight ahead. Display of mean slow phase velocities 
along with the standard error bars of the mean. 
 
Referring to the two different intervals between testing, i.e. whether patients rested in upright 
position with the light switched on or whether they rested in upright position with the light 
switched off, resulted in a significant main effect for the within subjects factor interval, F(1, 
7)=5.715, p<0.05 (Figure 3.8a), where resting in darkness (-2.67 deg/s) was associated with 
significantly lower average SPV values than resting with the light switched on (-3.6 deg/s). 
To have an additional comparison on how the measurements were influenced by the intervals, 
the measurements at 9am (prior to the first resting interval) were skipped and the results were 
analysed across 11am and 1pm. This step was carried out even though the 9am measurements 
prior to the upright-light on interval (-5.39 deg/s) and the upright-light off interval (-4.675 
deg/s) were not significantly different from each other (p=0.85). The subsequent analysis 
(across 11am and 1pm) confirmed the earlier finding, where the within subjects factor interval 
again resulted in a significant main effect, F(1, 7)=16.9, p<0.01 (Figure 3.8b). 
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Figure 3.8a SPV between both intervals (resting upright with the light switched on vs. resting 
upright with the light switched off) and across light (light during testing switched on or off) 
and daytime (9am, 11am, 1pm) in upright position with gaze straight ahead, b SPV across 
light (light during testing switched on or off) and daytime (11am, 1pm) between both intervals 
(resting upright with the light switched on vs. resting upright with the light switched off) in 
upright position with gaze straight ahead. Display of mean slow phase velocities along with 
the standard error bars of the mean. 
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Resting in darkness (-1.66 deg/s) was associated with significantly lower average SPV values 
than resting with the light switched on (-2.7 deg/s). 
Going back to the original analysis (including the 9am measurements), none of the 
other statistical tests revealed a significant finding. Only the light times daytime interaction 
came close to approaching statistical significance, F(2, 14)=3.21, p=0.07. Neither the light 
times interval interaction, F(1, 7)=1.44, p=0.27, nor the interval times daytime interaction, 
F(2, 14)=1.06, p=0.37, nor the light times interval times daytime interaction, F(2, 14)=0.34, 
p=0.72 approached statistical significance. With regard to the comparison between cerebellar 
patients and patients with unknown aetiology, cerebellar patients had an average SPV-value 
of -4.51 deg/s, whilst patients with unknown aetiology had an average SPV-value of -2.31 
deg/s. This is a significant difference according to the Kolmogorov-Smirnov test (p<0.05). 
 
3.3.2.2. Second section including the within subjects factor gaze direction 
 
As in the previous chapter, it turned out that there was a main effect with respect to the within 
subjects factor gaze direction, F(2, 14)=13.43, p<0.001 (Figure 3.9), where Scheffé post-hoc 
tests revealed that gaze upwards (-0.065 deg/s) was associated with significantly lower 
average SPV values than gaze straight ahead (-2.265 deg/s) and gaze downwards (-2.32 
deg/s), (both Scheffé post-hoc tests: p<0.01), whereas gaze straight ahead and downwards did 
not significantly differ from each other (p=0.99). 
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Figure 3.9 Comparing SPV between gaze straight ahead, upward and downward and across 
both intervals and time, in upright position and with the light switched on. Display of mean 
slow phase velocities along with the standard error bars of the mean. 
 
Consistent with the previous chapter, the analysis revealed a significant daytime decrease in 
SPV-values, F(2, 14)=14.82, p<0.001 (Figure 3.10), where average SPV decreased from -
2.545 deg/s at 9am to -1.28 deg/s at 11am to -0.82 deg/s at 1pm. Scheffé post-hoc tests 
revealed that the decrease from 9am to 11am had a p-value of p<0.01, whereas the decrease 
from 9am to 1pm had a p-value of p<0.001. There was no significant difference between 
11am and 1pm (p=0.4). 
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Figure 3.10 Daytime decrease in SPV across all three gaze conditions and both intervals, in 
upright position and with the light switched on. Display of mean slow phase velocities along 
with the standard error bars of the mean. 
 
In addition, there was a significant gaze times daytime interaction, F(4, 28)=3.475, p<0.05 
(Figure 3.11), where upward gaze and downward gaze showed an almost parallel SPV-
decrease throughout time (with upward gaze even shifting towards UBN), whilst gaze straight 
ahead showed a steep decrease from 9am to 11am. As revealed by Scheffé post-hoc tests, only 
gaze straight ahead showed a significant decrease from 9am to 11am (p<0.001) and from 
from 9am to 1pm (p<0.0001), whilst downward gaze also showed a significant effect from 
9am to 1pm (p<0.01). 
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Figure 3.11 Daytime decrease in SPV between all three gaze conditions and across both 
intervals, in upright position and with the light switched on. Display of mean slow phase 
velocities along with the standard error bars of the mean. 
 
Turning to the remaining findings of this analysis, there was a marginally significant interval 
times daytime interaction, F(2, 14)=3.61, p=0.054, where resting upright with the light 
switched off appeared to have a steeper SPV-decrease than resting upright with the light 
switched on. Nevertheless, it needs to be considered that this was only a marginally 
significant interaction. Even when excluding the 9am measurement (where no resting interval 
had taken place yet), there was no significant main effect with respect to interval, F(1, 
7)=4.165, p=0.08 and no significant interval times daytime interaction, F(1, 7)=5.49, p=0.052. 
Going back to the original analysis in this chapter (i.e. including the 9am measurements), 
there was no significant main effect for the within subjects factor interval either, F(1, 7)=1.92, 
p=0.21 (the descriptive trend when resting in upright position with the light switched off was 
associated with a lower average SPV (-1.24 deg/s) than resting in upright position with the 
light switched on (-1.86 deg/s)). In addition, there was no significant gaze times interval 
interaction, F(2, 14)=0.17, p=0.84, and no significant gaze times interval times daytime 
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interaction, F(4, 28)=1.26, p=0.31. With regard to the comparison between cerebellar patients 
and patients with unknown aetiology, cerebellar patients had an average SPV-value of -2.64 
deg/s, whilst patients with unknown aetiology had an average SPV-value of -0.89 deg/s, 
which is a significant difference according to the Kolmogorov-Smirnov test (p<0.05). 
 
3.3.2.3. Third section including the within subjects factor body orientation 
 
Consistent with the findings from the previous chapter, the analysis with respect to body 
orientation resulted in a significant main effect, F(2, 14)=20.1, p<0.0001 (Figure 3.12). The 
Scheffé post-hoc comparisons between upright (-2.26 deg/s), supine (-0.62 deg/s) and prone (-
6.44 deg/s) led to a significant difference between upright and prone position (p<0.01) and to 
a significant difference between supine and prone position (p<0.001), but no significant 
difference between upright and supine position (p=0.255). 
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Figure 3.12 Comparing SPV between upright, supine and prone positions and across both 
intervals and daytime, in gaze straight ahead and with the light switched on. Display of mean 
slow phase velocities along with the standard error bars of the mean. 
 89 
Once more, there was a significant main effect for the within-subjects factor daytime, F(2, 
14)=6.34, p<0.05 (Figure 3.13), where average SPV decreased from -4.54 deg/s at 9am to -
2.64 deg/s at 11am and -2.15 deg/s at 1pm. Scheffé post-hoc tests revealed that only the 
difference between 9am and 1pm was statistically significant (p<0.05), whereas the difference 
between 9am and 11am was marginally significant (p=0.055) and the difference between 
11am and 1pm did not reach significance (p=0.79). 
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Figure 3.13 Daytime decrease in SPV across all three body positions and both intervals, in 
gaze straight ahead and with the light switched on. Display of mean slow phase velocities 
along with the standard error bars of the mean. 
 
Among the interactions, only the body orientation times interval interaction became 
statistically significant, F(2, 14)=3.95, p<0.05 (Figure 3.14), where post-hoc Scheffé tests 
revealed that there was a significant difference between resting upright with the light switched 
on and resting upright with the light switched off only in prone position (p<0.05). 
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Figure 3.14 Comparing SPV differences across daytime between the within subjects factors 
interval (light on/off) and position (upright, supine and prone), in gaze straight ahead and with 
the light switched on. Display of mean slow phase velocities along with the standard error 
bars of the mean. 
 
Among the remaining tests, only the within subjects factor interval became marginally 
significant, F(1, 7)=3.74, p=0.09, where resting in upright position with the light switched off 
was associated with a descriptively lower average SPV (-2.625 deg/s) than resting in upright 
position with the light switched on (-3.59 deg/s). Neither the body orientation times daytime 
interaction became significant, F(4, 28)=0.13, p=0.97, nor the interval times daytime 
interaction, F(2, 14)=1.34, p=0.29, nor the body orientation times interval times daytime 
interaction, F(4, 28)=0.53, p=0.715. With regard to the comparison between cerebellar 
patients and patients with unknown aetiology, cerebellar patients had an average SPV-value 
of -5.305 deg/s, whilst patients with unknown aetiology had an average SPV-value of -1.79 
deg/s. This descriptive difference is not significant according to the Kolmogorov-Smirnov test 
(p>0.1). 
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3.3.3. Discussion 
 
This part of the study confirmed a couple of findings that were reported in the previous 
chapter as well as in Spiegel et al. (2009a): 
The first section of the analysis included the within subjects factor light (fixation 
versus viewing in the dark). It showed that DBN (as measured by SPV) decreases in the 
course of the day. In addition, the ability to fixate (when the light is switched on) is associated 
with a lower intensity of DBN. As a result, this outcome is consistent with the earlier findings 
and the finding that visual fixation can suppress DBN. A new finding in this section of the 
analysis is related to the resting position during the intervals between the tests. Resting 
upright with the light switched off was associated with significantly less DBN (as expressed 
by SPV) than resting upright with the light switched on. Given that the 9am measurements 
were prior to the first resting interval, an additional test was carried out where only those two 
measurements (11am and 1pm) were included that immediately followed a resting interval. 
This test confirmed that resting with the light switched off led to a lower intensity of DBN. It 
has to be kept in mind that this effect is across the light conditions during the measurement, 
i.e. it includes the measurements with the light switched on as well as the measurements with 
the light switched off. In part 1 of this study, where only light-on data were included, there 
was only a descriptive trend towards light-off being associated with lower DBN. When 
considering practical applications of this finding, one could say that it does not make a 
difference whether people rest upright with the light switched on or off as long as they engage 
in usual daytime activities under light conditions. If they, for example, work in an 
environment where they are intermittently exposed to both light and darkness, it would be 
better to rest upright with the light switched off, i.e. in darkness. 
The second section of this analysis included the within subjects factor gaze direction. 
Consistent with the study of the previous chapter, there was a significant main effect of gaze 
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direction, where upward gaze was associated with significantly lower average SPV-values 
than downward gaze or gaze straight ahead. Although this finding is consistent with 
Alexander’s law, it is interesting that downward gaze and gaze straight ahead did not 
significantly differ from each other. According to the descriptive findings, downward gaze 
had more pronounced DBN than gaze straight ahead, i.e. at least the descriptive trend is 
consistent with Alexander’s law, where slow phase velocity decreases when gaze moves away 
from the direction of the fast phase (Jeffcoat et al., 2008, Robinson et al., 1984). As in the 
previous analyses, the intensity of DBN decreased throughout daytime. In addition, there was 
a significant gaze times daytime interaction, where upward gaze and downward gaze showed 
an almost parallel SPV-decrease throughout time, whilst gaze straight ahead showed a steeper 
decrease from 9am to 11am and the only decrease that was statistically significant between 
9am and 11am. It is difficult to interpret this kind of interaction, though, as there was no 
hypothesis with regard to such an interaction prior to carrying out this study. It is entirely 
unclear why there should be a steeper decrease from 9am to 11am only in gaze straight ahead 
and not in the other gaze directions. 
The third section of this analysis included the within subjects factor body orientation. 
In line with Marti et al. (2002), the study in the previous chapter and Spiegel et al. (2009a), 
there was a significant main effect with respect to body orientation. The intensities of DBN 
between upright and supine position were not significantly different from each other, but 
prone position had a significantly higher intensity of DBN than upright and supine positions. 
Hence, the finding was in line with the earlier reported gravitational influence through 
different body positions. As in the previous analyses of this and the previous chapter, the 
intensity of DBN also decreased throughout daytime. Among the interactions, only the body 
orientation times interval interaction became statistically significant, where a significant 
difference could only be found in prone position between resting upright with the light 
switched on and resting upright with the light switched off. One possible interpretation is that 
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prone position was generally associated with more pronounced SPV-values. As a result, small 
variations of the values in prone position (e.g. due to chance) could result in more pronounced 
differences than in the other two body positions. 
Only a nonparametric comparison between patients with cerebellar and unknown 
aetiologies was carried out, because the number of three cerebellar patients was considered 
too low to carry out a parametric comparison. As it turned out, aetiology had a significant 
influence in the first two sections of part 3, but not in the third section. In all three sections, 
however, it appears that patients with cerebellar aetiology have stronger symptoms of DBN 
than patients with unknown aetiology. 
Having looked at the influence of light and darkness during the resting intervals in 
upright position, it will now be interesting to look at the positional effects. Because part 1 and 
part 3 of this study had shown that resting in darkness is at least descriptively associated with 
a lower intensity of DBN, all resting positions (upright, supine and prone) will be compared 
with each other in darkness. 
 
3.4. Replicating the study on daytime dependence of downbeat nystagmus mediated by 
upright and prone resting positions with the light switched off (part 4) 
 
Having compared upright resting positions with the light switched on / off, the following 
comparisons will refer to the light off condition only. The first comparison will be upright 
versus prone resting position. 
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3.4.1. Methods 
 
The method of part 4 overlaps one to one with the method of part 3. The only differences are 
with respect to the participants and the intervals between testing. 
 
3.4.1.1. Patients 
 
In part 4, a total number of 9 participants were tested at 9am, 11am and 1pm. In the 
intermissions between testing, they rested in either upright or prone position. In both cases, 
the light was switched off, i.e. they rested in darkness. All patients were identical to part 2 of 
this study. Five of the patients were the same as in parts 1 and 3, four patients had not been 
tested in parts 1 and 3. In addition, patients No. 7 and No. 8 had already participated in the 
study of the previous chapter. The mean duration of DBN was 6.81 years (range 3-17 years, 
see Table 3.4). The patients were 44 to 72 years old, with a mean of 63.67 years and a 
standard deviation of ± 7.92 years. All other factors and clinical examinations to the previous 
parts of this study and the study of the previous chapter. 
 
3.4.1.2. Recording of eye movements 
 
Patients were tested three times on a single day. Each time, patients were monitored in the 
following sequence: (see Figure 3.15). 
1. they were sitting in upright position, 2. they were lying in supine position, 3. they were 
lying in prone position. In the intermissions between testing, people rested in prone position 
and upright position, in both cases with the light switched off. The same patients were 
measured in prone position and upright position, i.e. they came to the hospital twice with a 
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delay of approximately one week between these two measurements. The VOG-measurements 
were identical to those in the study of the previous chapter and the previous parts of this 
study. 
 
 
Table 3.4 Clinical data of the patients with DBN where upright and prone positions in 
darkness were compared with each other 
No./Sex/ 
Age 
Neuro-ophthalmological findings MRI 
findings 
Aetiology Disease 
duration 
No. 1M, 64 
 
Disturbed visual fixation suppression of 
VOR, non-existing upright opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
Cerebellar 
atrophy 
Cerebellar de-
generation 
3 years 
No. 2F, 69 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and upward opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally, provocation DBN. 
Cerebellar 
atrophy 
Idiopathic 
cerebellar 
ataxia 
17 years 
No. 3M, 69 
 
Deviant SVV, impaired horizontal and 
downward pursuit, saccades with rebound 
after gaze to the right, provocation DBN. 
Normal Unknown 4.5 years 
No. 4F, 60  Disturbed visual fixation suppression of 
VOR, DBN overran horizontal opto-kinetic 
nystagmus, non-existing upward opto-
kinetic nystagmus, deviant SVV, impaired 
horizontal and downward pursuit. 
Normal Unknown 12 years 
No. 5F, 61  Disturbed visual fixation suppression of 
VOR, deviant SVV, provocation DBN, 
vertical saccades and saccades to the left. 
Normal Unknown 5 years 
No. 6M, 44 
 
Disturbed visual fixation suppression of 
VOR, impaired upward opto-kinetic 
nystagmus, impaired horizontal and vertical 
pursuit. 
Normal Unknown 10 years 
No. 7M, 65 
 
Impaired upward opto-kinetic nystagmus, 
impaired horizontal and downward pursuit, 
hypometric upward saccades. 
Normal Unknown 10 years 
No. 8F, 69 
 
Disturbed vertical visual fixation 
suppression of VOR, impaired upward 
opto-kinetic nystagmus, impaired horizontal 
and downward pursuit. 
Normal Unknown 3 years 
No. 9F, 72 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and non-existing 
upward opto-kinetic nystagmus, impaired 
horizontal and downward pursuit. 
Normal Unknown 6 years 
 
VOR = vestibulo-ocular reflex; SVV = subjective visual vertical axis, HTT = head-thrust test 
developed by Halmagyi and Curthoys (1988). 
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Figure 3.15. An overview describing the testing conditions for all patients. The eye 
movements of the patients were monitored in the following order: 1. sitting in upright position 
in light/dark, 2. lying in supine position in light/dark, 3. lying in prone position in light/dark. 
All measurements took place at 9am, 11am, and1pm. In between the measurements, patients 
were lying in prone position or sitting in upright position, in both cases with the light 
switched off. 
 
3.4.1.3. Data acquisition and calibration 
 
Data acquisition and calibration was identical to the study of the previous chapter and the 
previous parts of this study. 
 
3.4.1.4. Statistical data analysis 
 
The statistical analysis consisted of repeated measurement ANOVAs (Statistica 6.1, Statsoft, 
Tulsa OK, USA) with post-hoc Scheffé tests for individual comparisons. The dependent 
variable was slow phase velocity (SPV). The first analysis consisted of the within subjects 
factors light (= light on, where fixation is possible vs. light off, where no fixation is possible), 
interval (resting in prone position with the light switched off versus resting in upright position 
with the light switched off) and daytime (9am, 11am, 1pm). The second analysis consisted of 
the within subject factors gaze condition (straight, upwards, downwards), interval (resting in 
prone position with the light switched off versus resting in upright position with the light 
switched off) and daytime (9am, 11am, 1pm). The third analysis had the within subject factors 
body orientation (upright, supine and prone), interval (resting in prone position with the light 
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switched off versus resting in upright position with the light switched off) and daytime (9am, 
11am, 1pm). Due to the low number of patients with cerebellar symptoms, the previously 
mentioned nonparametric Kolmogorov-Smirnov test was applied for two independent 
samples. The two independent groups were the two different aetiologies (cerebellar patients 
versus patients with unknown aetiology). The two groups were compared with respect to their 
overall SPV-values. 
 
3.4.2 Results 
 
3.4.2.1. First section including the within subjects factor fixation versus viewing in the 
dark 
 
In the first section of part 4, patient No. 4 was missing, because in prone position, she was not 
assessed in the dark. As a result, no comparison for the within subjects factor light (fixation 
versus viewing in the dark) would have been possible for this patient. Hence, this patient is 
not included in this part of the analysis. As in the previous chapter, the analysis revealed a 
significant main effect for the within-subjects factor light, F(1, 7)=6.475, p<0.05 (Figure 
3.16), where the possibility of fixation (= light turned on) resulted in lower average SPV-
values than viewing in the dark (-2.06 deg/s vs. -3.19 deg/s). 
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Figure 3.16 Comparing SPV between light (= fixation on target) and darkness conditions (= 
patients cannot fixate), across both intervals (resting upright or prone) and daytime (9am, 
11am, 1pm), measured in upright position and during gaze straight ahead. Display of mean 
slow phase velocities along with the standard error bars of the mean. 
 
Consistent with the previous chapter and the first part of this study, the analysis revealed a 
significant daytime decrease in SPV-values, F(2, 14)=12.58, p<0.001 (Figure 3.17), where 
average SPV decreased from -4.44 deg/s at 9am to -1.94 deg/s at 11am to -1.5 deg/s at 1pm. 
Scheffé post-hoc tests revealed that the decrease from 9am to 11am and from 9am to 1pm 
each had a p-value of p<0.01. There was no significant difference between 11am and 1pm 
(p=0.79). 
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Figure 3.17 Daytime decrease in SPV across both light conditions (light on / light off) and 
both intervals (upright/prone), measured in upright position and during gaze straight ahead. 
Display of mean slow phase velocities along with the standard error bars of the mean. 
 
None of the other comparisons revealed a significant result. The within subjects factor 
interval (resting in prone position versus resting in upright position, both in darkness) did not 
reveal a significant result, F(1, 7)=1.69, p=0.23. According to the descriptive trend, resting in 
upright position (-2.29 deg/s) was associated with slightly lower average SPV-values than 
resting in prone position (-2.97 deg/s). Among the interactions, the light times interval 
interaction, F(1, 7)=5.21, p=0.056, the light times daytime interaction, F(2, 14)=3.53, 
p=0.0575, the interval times daytime interaction, F(2, 14)=2.91, p=0.087, all became 
marginally significant only. The light times interval times daytime interaction did not become 
significant either, F(2, 14)=0.69, p=0.52. With regard to the comparison between cerebellar 
patients and patients with unknown aetiology, cerebellar patients had an average SPV-value 
of -4.98 deg/s, whilst patients with unknown aetiology had an average SPV-value of -1.84 
 100 
deg/s. This descriptive difference is not significant according to the Kolmogorov-Smirnov test 
(p>0.05). 
 
3.4.2.2. Second section including the within subjects factor gaze direction 
 
As in the previous chapter and in part 1 of this study, it turned out that there was a main effect 
with respect to the within subjects factor gaze direction, F(2, 16)=16.17, p<0.001 (Figure 
3.18), where Scheffé post-hoc tests revealed that gaze upwards (+0.32 deg/s, i.e. a slight 
UBN) was associated with significantly lower average SPV values than gaze straight ahead (-
2.07 deg/s) and gaze downwards (-1.91 deg/s), (both Scheffé post-hoc tests: p<0.001), 
whereas gaze straight ahead and downwards did not significantly differ from each other 
(p=0.95). 
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Figure 3.18 Comparing SPV between gaze straight ahead, upward and downward, across 
both intervals and daytime, measured in upright position with the light switched on. Display 
of mean slow phase velocities along with the standard error bars of the mean. 
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Consistent with the previous chapter, the analysis revealed a significant daytime decrease in 
SPV-values, F(2, 16)=7.18, p<0.01 (Figure 3.19), where average SPV decreased from -2.19 
deg/s at 9am to -0.85 deg/s at 11am to -0.615 deg/s at 1pm. Scheffé post-hoc tests revealed 
that the decrease from 9am to 11am and from 9am to 1pm each had a p-value of p<0.05. 
There was no significant difference between 11am and 1pm (p=0.87). 
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Figure 3.19 Daytime decrease in SPV across all three gaze conditions and both intervals, 
measured in upright position with the light switched on. Display of mean slow phase 
velocities along with the standard error bars of the mean. 
 
None of the other comparisons revealed a significant result. The within subjects factor 
interval (resting in prone position versus resting in upright position) revealed a marginally 
significant finding, F(1, 8)=4.27, p=0.07. According to the descriptive trend, resting in upright 
position (-0.83 deg/s) was associated with lower average SPV-values than resting in prone 
position (-1,61 deg/s). None of the interactions approached statistical significance, neither the 
gaze times interval interaction, F(2, 16)=2.39, p=0.12, nor the gaze times daytime interaction, 
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F(4, 32)=0.89, p=0.48, nor the interval times daytime interaction, F(2, 16)=1.7, p=0.21, nor 
the gaze times interval times daytime interaction, F(4, 32)=1.09, p=0.38. With regard to the 
comparison between cerebellar patients and patients with unknown aetiology, cerebellar 
patients had an average SPV-value of -2.69 deg/s, whilst patients with unknown aetiology had 
an average SPV-value of -0.8 deg/s. This descriptive difference is not significant according to 
the Kolmogorov-Smirnov test (p>0.05). 
 
3.4.2.3. Third section including the within subjects factor body orientation 
 
Consistent with the findings from the study in the previous chapter and from part 1 of this 
study, the analysis with respect to body orientation resulted in a significant main effect, F(2, 
16)=6.31, p<0.01 (Figure 3.20). The Scheffé post-hoc comparisons between upright (-2.07 
deg/s), supine (-0.43 deg/s) and prone (-3.22 deg/s) revealed that only the difference between 
supine and prone position was statistically significant (p<0.01). Comparing upright and 
supine position (p=0.15) and upright and prone position (p=0.36) did not yield a significant 
finding. 
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Figure 3.20 Comparing SPV between upright, supine and prone position, across intervals and 
daytime, measured in gaze straight ahead with the light switched on. Display of mean slow 
phase velocities along with the standard error bars of the mean. 
 
As in previous analyses, there was a significant main effect for the within-subjects factor 
daytime, F(2, 16)=16.04, p<0.001 (Figure 3.21), where average SPV decreased from -3.44 
deg/s at 9am to -1.26 deg/s at 11am and -1.02 deg/s at 1pm. Scheffé post-hoc tests revealed 
that the difference between 9am and 11am (p<0.01) and between 9am and 1pm (p<0.001) was 
statistically significant, whereas the difference between 11am and 1pm was not significant 
(p=0.87). 
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Figure 3.21 Daytime decrease in SPV across all three body positions and both intervals, 
measured in gaze straight ahead with the light switched on. Display of mean slow phase 
velocities along with the standard error bars of the mean. 
 
Among the interactions, the body orientation times interval interaction became statistically 
significant, F(2, 16)=10.46, p<0.01 (Figure 3.22a). Although post-hoc Scheffé tests were not 
significant, the descriptive trend reveals that having rested in upright position is, during the 
test, associated with a lower average SPV-value in upright position (-1.45 deg/s) than in prone 
position (-2.68 deg/s, Scheffé: p=0.1), whereas having rested in prone position is, during the 
test, associated with a lower average SPV-value in prone position (-2.66) than in upright 
position (-3.79, Scheffé: p=0.15). 
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Figure 3.22a Comparing SPV differences across daytime (9am, 11am, 1pm) between the 
within subjects factors interval and position, measured in gaze straight ahead with the light 
switched on. Display of mean slow phase velocities along with the standard error bars of the 
mean, b The same comparison as 3.22a, but without the 9am measurements. 
 
 106 
To have an additional comparison on how the measurements were influenced by the intervals, 
the measurement at 9am (prior to the first resting interval) was skipped and the results were 
analysed across 11am and 1pm. This step was carried out even though the 9am measurements 
prior to the prone position interval (-3.43 deg/s) and the upright position interval (-3.44 deg/s) 
were not significantly different from each other (p=1). The subsequent analysis (across 11am 
and 1pm) confirmed the earlier finding with a significant body orientation times interval 
interaction, F(2, 16)=10.46, p<0.01 (Figure 3.22b). Having rested in upright position is, 
during the test, associated with a lower average SPV-value in upright position (-0.65 deg/s) 
than in prone position (-2.66 deg/s, Scheffé: p<0.01), whereas having rested in prone position 
is, during the test, associated with a descriptively lower average SPV-value in prone position 
(-1.325) than in upright position (-2.22 deg/s, Scheffé: p=0.39). Likewise, when being 
measured in upright position, having previously rested in upright position is associated with a 
significantly lower average SPV-value (-0.65 deg/s) than having previously rested in prone 
position (-2.22 deg/s, Scheffé: p<0.05). When being measured in prone position, having 
previously rested in prone position (-1.325 deg/s) is associated with a marginally significant 
lower SPV-value than having rested in upright position (-2.66 deg/s, p=0.076). 
Going back to the analysis where the 9am measurements were included, the remaining 
comparisons revealed that only the body orientation times daytime interaction became 
statistically significant, F(4, 32)=7.02, p<0.001 (Figure 3.23). At the 9am measurements, i.e. 
prior to the first resting interval, the average SPV-values in all three body positions (upright: -
3.33 deg/s, supine: -1.3 deg/s, prone: -5.68 deg/s) are significantly different from each other, 
as Scheffé post-hoc comparisons revealed a difference of p<0.01 between upright and supine, 
p<0.001 between upright and prone and p<0.000001 between supine and prone. After the first 
resting interval, the decrease of SPV in prone position is relatively pronounced, so that the 
lines between the three body orientations appear almost parallel after the first resting interval 
(i.e. from 11am onwards, see Figure 3.23). When excluding the 9am measurements, the 
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significant body orientation times daytime interaction vanishes, F(2, 16)=0.38, p=0.69, though 
there is still a main effect of body orientation, F(2, 16)=4.15, p=0.035. 
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Figure 3.23 Comparing SPV differences across intervals between the within subjects factors 
body position and daytime, measured in gaze straight ahead and with the light switched on. 
Display of mean slow phase velocities along with the standard error bars of the mean. 
 
Going back to the original analysis (i.e. the one that includes the 9am measurements), there 
were no further significant results. Neither the tests for interval, F(1, 8)=0.07, p=0.8, nor for 
the interval times daytime interaction, F(2, 16)=0.17, p=0.84, nor for the body orientation 
times interval times daytime interaction, F(4, 32)=0.95, p=0.45, approached statistical 
significance. With regard to the comparison between cerebellar patients and patients with 
unknown aetiology, cerebellar patients had an average SPV-value of -4.48 deg/s, whilst 
patients with unknown aetiology had an average SPV-value of -1.17 deg/s. This descriptive 
difference is not significant according to the Kolmogorov-Smirnov test (p>0.05). 
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3.4.3. Discussion 
 
The majority of findings from part 3 of this study as well as the previous chapter were 
confirmed in part 4 of this study. 
The first section of the analysis included the within subjects factor light (fixation 
versus viewing in the dark). Once more it was confirmed that the possibility to fixate (= the 
light is switched on) is associated with a lower DBN than no possibility to fixate (= the light 
is switched off). The same holds true for the confirmation of a daytime decrease in the 
intensity of DBN. 
The second section of this analysis included the within subjects factor gaze direction. 
It confirmed earlier findings of a significant main effect for gaze direction, where upward 
gaze was associated with significantly lower SPV-values than downward gaze or gaze straight 
ahead. Although this finding is consistent with Alexander’s law, it is interesting that 
downward gaze and gaze straight ahead did not significantly differ from each other. 
According to the descriptive findings, gaze straight ahead had even lower SPV-values than 
downward gaze, which is not entirely consistent with Alexander’s law, where slow phase 
velocity decreases when gaze moves away from downward gaze (i.e. the direction of the fast 
phase, Jeffcoat et al., 2008; Robinson et al., 1984). As in the previous analyses, the intensity 
of DBN decreased throughout daytime. 
The third section of this analysis included the within subjects factor body orientation. 
In line with previous findings, there was a significant main effect with regard to body 
orientation, with supine position being associated with the lowest intensity of DBN. However, 
only the difference between supine and prone position was statistically significant, whereas 
upright and supine position and upright and prone position were not significantly different 
from each other. As already known from the previous analyses, the intensity of DBN 
decreased in the course of the day. The vital comparison in part 2 of this study, however, 
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deals with the significant body orientation times interval interaction. Usually (e.g. part 1 of 
this study), being measured in upright position is associated with lower DBN intensity than 
being measured in prone position. Although this difference was not significant in the analysis 
of part 2, the descriptive trend again points into that direction. After the resting positions of 
the patients were varied between prone position and upright position, it turned out that having 
rested in upright position (compared to prone position) is associated with significantly lower 
SPV-values when being measured in upright position, but being measured in prone position 
can also lead to marginally significant lower SPV-values when having rested in prone position 
rather than in upright position. This is also reflected in the descriptive trend. The 
measurements in upright position are not necessarily linked to lower SPV-values than the 
measurements in prone position, as having rested in prone position can lead to descriptively 
lower SPV-values in the prone-position measurements than in the upright position 
measurements. When linking this result to part 2 of this chapter, where it was argued that 
rotation relative to the gravitational vector would be associated with higher DBN than no 
rotation, it becomes clear why a change from prone resting to upwards measurement can 
result in descriptively higher DBN than being measured in prone after having rested in prone, 
although prone position is usually associated with the highest intensity of DBN according to 
Marti et al. (2002). When being assessed in upright, supine and prone, the results are fully in 
line with Marti et al. (2002), and the results where different resting positions are tested (which 
was not subject to the Marti et al. (2002) paper), requires an adjustment in terms of otolithic 
influence that would be new, but could be subsumed under the explanation of gravity-
dependent and gravity-independent components by Marti et al. (2002). The interesting finding 
of this study is that the resting position seems to have an influence on the intensity of DBN 
during the measurements. When considering practical applications of this finding, one could, 
for example, recommend patients to rest in upright position with the light switched off when 
they intend to do office work after the resting period. Alternatively, one could recommend 
 110 
patients to rest in prone position when they intend to work in prone position, swim in prone 
position, get a massage or do gymnastics in prone position after the resting period. The third 
section of this analysis also revealed a significant body orientation times daytime interaction, 
but this interaction is mainly due to differences between the three body positions at the 9am 
measurements. When excluding the 9am measurements and focusing on the measurements 
that were preceded by the different resting intervals, the significant interaction vanishes. 
Only a nonparametric comparison between patients with cerebellar and unknown 
aetiologies was carried out, because the number of two cerebellar patients was considered too 
low to carry out a parametric comparison. Although not significant according to the 
nonparametric Kolmogorov-Smirnov test, it has to be acknowledged, though, that the 
descriptive trend indicates that patients with cerebellar aetiology appear to have stronger 
symptoms of DBN as expressed by a larger average SPV. 
Having looked at the influence of prone position versus upright position during the 
resting intervals, it will now be interesting to look at other positional effects. In part 3 of this 
study, supine position and upright position are compared with each other. 
 
3.5. Replicating the study on daytime dependence of downbeat nystagmus mediated by 
upward versus supine resting position (part 5) 
 
Having compared upright versus prone resting positions in the previous part, the following 
comparison will deal with upright versus supine resting positions. 
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3.5.1. Methods 
 
The method of part 5 overlaps one to one with the method of parts 3 and 4. The only 
differences are with respect to the participants and the intermission between testing. 
 
3.5.1.1. Patients 
 
In part 5, a total number of 10 participants were tested. In the intermissions between testing, 
they rested in either supine position or upright position. In both cases, the light was switched 
off, i.e. they rested in darkness. All patients were identical to parts 2 and 4, with the addition 
of another patient (patient No. 10) who had already participated in parts 1 and 3, so that nine 
out of ten patients were already present in parts 2 and 4 and six patients in parts 1 and 3. 
There is a reason why there was one more patient in this part. Actually, it was planned to 
measure this patient in all three positions: upright, supine and prone. After measuring him in 
upright and supine position, however, he indicated that he was feeling unwell. Therefore, the 
measurement in prone position was not carried out anymore. Consequently, none of the 
comparisons between prone position and another position included this patient. Due to the 
progress of the patient’s disease, it was considered unethical to ask him to return to the 
hospital for another test in prone position. The mean duration of DBN was 6.81 years (range 
3-17 years, see Table 3.5). The patients were 44 to 82 years old, with a mean of 65.5 years 
and a standard deviation of ± 9.31 years. Patients No. 7 and No. 8 had already participated in 
the study of the previous chapter. All other factors and clinical examinations were identical to 
the study in the previous chapter and parts 1 to 4 of this study. 
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Table 3.5 Clinical data of the patients with DBN where upright and supine positions in 
darkness were compared with each other 
No./Sex/ 
Age 
Neuro-ophthalmological findings MRI 
findings 
Aetiology Disease 
duration 
No. 1M, 64 
 
Disturbed visual fixation suppression of 
VOR, non-existing upright opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
Cerebellar 
atrophy 
Cerebellar de-
generation 
3 years 
No. 2F, 69 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and upward opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally, provocation DBN. 
Cerebellar 
atrophy 
Idiopathic 
cerebellar 
ataxia 
17 years 
No. 3M, 69 
 
Deviant SVV, impaired horizontal and 
downward pursuit, saccades with rebound 
after gaze to the right, provocation DBN. 
Normal Unknown 4.5 years 
No. 4F, 60  Disturbed visual fixation suppression of 
VOR, DBN overran horizontal opto-kinetic 
nystagmus, non-existing upward opto-
kinetic nystagmus, deviant SVV, impaired 
horizontal and downward pursuit. 
Normal Unknown 12 years 
No. 5F, 61  Disturbed visual fixation suppression of 
VOR, deviant SVV, provocation DBN, 
vertical saccades and saccades to the left. 
Normal Unknown 5 years 
No. 6M, 44 
 
Disturbed visual fixation suppression of 
VOR, impaired upward opto-kinetic 
nystagmus, impaired horizontal and vertical 
pursuit. 
Normal Unknown 10 years 
No. 7M, 65 
 
Impaired upward opto-kinetic nystagmus, 
impaired horizontal and downward pursuit, 
hypometric upward saccades. 
Normal Unknown 10 years 
No. 8F, 69 
 
Disturbed vertical visual fixation 
suppression of VOR, impaired upward 
opto-kinetic nystagmus, impaired horizontal 
and downward pursuit. 
Normal Unknown 3 years 
No. 9F, 72 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and non-existing 
upward opto-kinetic nystagmus, impaired 
horizontal and downward pursuit. 
Normal Unknown 6 years 
No. 10M, 82  Deviant SVV, non-existing upward opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, provocation downward 
nystagmus. 
Normal Unknown 3.5 years 
 
VOR = vestibulo-ocular reflex; SVV = subjective visual vertical axis, HTT = head-thrust test 
developed by Halmagyi and Curthoys (1988). 
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3.5.1.2. Recording of eye movements 
 
Patients were tested three times on a single day. Each time, patients were monitored in the 
following sequence: (see Figure 3.24). 
1. they were sitting in upright position, 2. they were lying in supine position, 3. they were 
lying in prone position. In the intermissions between testing, people rested in supine position 
and upright position, in both cases with the light switched off. The same patients were 
measured in supine position and upright position, i.e. they came to the hospital twice with a 
delay of approximately one week between these two measurements. The VOG-measurements 
were identical to those in the previous chapter and in parts 1 to 4 of this chapter. 
 
 
                     time 
 9am     Inter-          11am      Inter-   1pm   
       mission           mission               
 
Figure 3.24. An overview describing the testing conditions for all patients. The eye 
movements of the patients were monitored in the following order: 1. sitting in upright position 
in light/dark, 2. lying in supine position in light/dark, 3. lying in prone position in light/dark. 
All measurements took place at 9am, 11am, and1pm. In between the measurements, patients 
were lying in supine position or sitting in upright position, in both cases with the light 
switched off. 
 
3.5.1.3. Data acquisition and calibration 
 
Data acquisition and calibration was identical to the previous chapter and parts 1 to 4 of this 
chapter. 
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3.5.1.4. Statistical data analysis 
 
The statistical analysis consisted of repeated measurement ANOVAs (Statistica 6.1, Statsoft, 
Tulsa OK, USA) with post-hoc Scheffé tests for individual comparisons. The dependent 
variable was slow phase velocity (SPV). The first analysis consisted of the within subjects 
factors light (light on = fixation is possible versus light off = viewing in the dark with no 
possibility to fixate), interval (resting in supine position with the light switched off versus 
resting in upright position with the light switched off) and daytime (9am, 11am, 1pm). The 
second analysis consisted of the within subject factors gaze condition (straight, upwards, 
downwards), interval (resting in supine position with the light switched off versus resting in 
upright position with the light switched off) and daytime (9am, 11am, 1pm). The third 
analysis had the within subject factors body orientation (upright, supine and prone), interval 
(resting in supine position with the light switched off versus resting in upright position with 
the light switched off) and daytime (9am, 11am, 1pm). Due to the low number of patients with 
cerebellar symptoms, the previously explained nonparametric Kolmogorov-Smirnov test for 
two independent samples was applied. The two independent groups were the two different 
aetiologies (cerebellar patients versus patients with unknown aetiology). The two groups were 
compared with respect to their overall SPV-values. 
 
3.5.2. Results 
 
3.5.2.1. First section including the within subjects factor fixation versus viewing in the 
dark 
 
As in the previous chapter, the analysis revealed a significant main effect for the within-
subjects factor light, F(1, 9)=16.04, p<0.01 (Figure 3.25), where fixation on target (= light 
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switched on) resulted in lower average SPV-values than viewing in the dark (-1.84 deg/s vs. -
3.09 deg/s). 
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Figure 3.25 Comparing SPV between light (= patients have the ability to fixate) and darkness 
conditions (= patients cannot fixate) across both intervals (resting upright versus supine) and 
time (9am, 11am, 1pm), measured in upright position with gaze straight ahead. Display of 
mean slow phase velocities along with the standard error bars of the mean. 
 
Consistent with the previous study and the previous parts of this study, there was a significant 
daytime decrease in SPV-values, F(2, 18)=10.33, p<0.01 (Figure 3.26), where average SPV 
decreased from -3.92 deg/s at 9am to -1.69 deg/s at 11am and -1.79 deg/s at 1pm. Scheffé 
post-hoc tests revealed that the decrease from 9am to 11am and from 9am to 1pm each had a 
p-value of p<0.01. There was no significant difference between 11am and 1pm (p=0.98). Note 
that the descriptive trend shows lower SPV-values at 11am than at 1pm. 
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Figure 3.26 Daytime decrease in SPV across both light conditions and both intervals, 
measured in upright position with gaze straight ahead. Display of mean slow phase velocities 
along with the standard error bars of the mean. 
 
Additional significant findings included a light times daytime interaction, where the SPV-
decrease from 9am to 11am was steeper when the measurement took place in darkness (= 
with no possibility to fixate) than with the light switched on (= with the possibility to fixate), 
F(2, 18)=9.63, p<0.01 (Figure 3.27). As revealed by Scheffé post-hoc comparisons, the 
decrease from 9am to 11am and from 9am to 1pm with the light switched on (each p<0.001) 
as well as the decrease from 9am to 11am and from 9am to 1pm with the light switched off 
(each p<0.000001) were statistically significant. Whilst there was a significant difference 
between both 9am measurements (-2.88 deg/s with the light switched on versus -4.96 deg/s 
with the light switched off, Scheffé: p<0.00001), the 11am and 1pm measurements did not 
differ from each other (Scheffé: p>0.05). 
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Figure 3.27 Daytime decrease in SPV between the within subjects factors light and daytime 
and across both intervals, measured in upright position with gaze straight ahead. Display of 
mean slow phase velocities along with the standard error bars of the mean. 
 
If the 9am measurements were excluded, the lines looked almost parallel (see Figure 3.27). 
This apparent absence of a light times daytime interaction was confirmed in the analysis 
where the 9am measurements were excluded, F(1, 9)=0,0025, p=0.96, so that only a main 
effect for light was present, F(1, 9)=8.53, p<0.05. Going back to the original analysis 
(including the 9am measurements), there was a significant interval times daytime interaction, 
F(2, 18)=4.76, p<0.05 (Figure 3.28). The 9am measurements prior to both intervals were 
almost identical (-3.91 deg/s prior to the supine interval and -3.93 deg/s prior to the upright 
interval, Scheffé: p=1), but the decrease in SPV appeared steeper following the resting 
interval in upright position than in supine position (Figure 3.28). When the resting interval 
was in upright position, the decrease from 9am to 11am (p<0.0001) and from 9am to 1pm 
(p<0.00001) was statistically significant, whilst there was no significant difference between 
11am and 1pm (p=0.999). When the resting interval was in supine position, the decrease from 
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9am to 11am (p<0.01) and from 9am to 1pm (p<0.05) was statistically significant, whilst 
there was no significant difference between 11am and 1pm (p=0.94). Comparing the 11am 
measurements after the upright interval (-1.27 deg/s) and the supine interval (-2.11 deg/s) did 
not yield a significant result (Scheffé: p=0.26), whereas the 1pm measurements after the 
upright interval (-1.12 deg/s) and the supine interval (-2.46) were significantly different from 
each other (Scheffé: p<0.05). Excluding the 9am measurements made this interval times 
daytime interaction vanish, F(1, 9)=1.26, p=0.29 and resulted in a marginally significant main 
effect for interval, F(1, 9)=4.63, p=0.06 and no significant main effect for daytime, F(1, 
9)=0.11, p=0.75. 
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Figure 3.28 Daytime decrease in SPV between the within subjects factors interval and 
daytime and across both light conditions, measured in upright position with gaze straight 
ahead. Display of mean slow phase velocities along with the standard error bars of the mean. 
 
Going back to the analysis that included the 9am measurements, none of the other statistical 
tests of this analysis became significant, neither the main effect with regard to the within 
subjects factor interval, F(1, 9)=2.27, p=0.17, nor the test for the light times interval 
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interaction, F(1, 9)=2.37, p=0.16, nor the test for the light times interval times daytime 
interaction, F(2, 18)=0.09, p=0.91. With regard to the comparison between cerebellar patients 
and patients with unknown aetiology, cerebellar patients had an average SPV-value of -4.71 
deg/s, whilst patients with unknown aetiology had an average SPV-value of -1.905 deg/s. This 
descriptive difference is not significant according to the Kolmogorov-Smirnov test (p>0.05). 
 
3.5.2.2. Second section including the within subjects factor gaze direction 
 
As in previous analyses, it turned out that there was a main effect with respect to the within 
subjects factor gaze direction, F(2, 18)=12.42, p<0.001 (Figure 3.29), where Scheffé post-hoc 
tests revealed that gaze upwards (+0.19 deg/s, i.e. with a trend towards UBN) was associated 
with significantly lower average SPV values than gaze straight ahead (-1.84 deg/s) and gaze 
downwards (-1.87 deg/s), (both Scheffé post-hoc tests: p<0.01), whereas gaze straight ahead 
and downwards did not significantly differ from each other (p=1). 
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Figure 3.29 Comparing SPV across both intervals and daytime between gaze straight ahead, 
upward and downward, measured in upright position with the light switched on. Display of 
mean slow phase velocities along with the standard error bars of the mean. 
 
In addition, there was a significant main effect of the within subjects factor interval, F(1, 
9)=6.23, p<0.05 (Figure 3.30a), where having rested upright position was associated with a 
significantly lower average SPV (-0.78 deg/s) than having rested in supine position (-1,56 
deg/s). Because the 9am measurements (before any resting intervals had taken place) have an 
indirect influence on the results and because they were not the same prior to the upright 
resting interval (-1.81 deg/s) and the supine resting interval (-2.34 deg/s), an additional 
analysis was carried out where the 9am measurements were skipped. This step was taken even 
though Scheffé post-hoc tests had not revealed a significant difference between these two 9am 
measurements (p=0.59). The analysis excluding the 9am measurements confirmed the main 
effect of the within subjects factor interval, F(1, 9)=7.6, p<0.05 (Figure 3.30b), where having 
rested in upright position was associated with a significantly lower average SPV (-0.27 deg/s) 
than having rested in supine position (-1,17 deg/s). 
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Figure 3.30a Comparing SPV between the resting intervals supine position and upright 
position, across all gaze directions and time (9am, 11am, 1pm), measured in upright position 
with the light switched on. Display of mean slow phase velocities along with the standard 
error bars of the mean, b The same comparison as 3.30a, but without the 9am measurements. 
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Going back to the findings where the 9am measurements were included, the analysis revealed 
a significant daytime decrease in SPV-values, F(2, 18)=7.13, p<0.01 (Figure 3.31), where 
average SPV decreased from -2.07 deg/s at 9am to -0.73 deg/s at 11am to -0.72 deg/s at 1pm. 
Scheffé post-hoc tests revealed that the decrease from 9am to 11am and from 9am to 1pm 
each had a p-value of p<0.05. There was no significant difference between 11am and 1pm 
(p=1). 
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Figure 3.31 Daytime decrease in SPV across all three gaze conditions and both intervals, 
measured in upright position with the light switched on. Display of mean slow phase 
velocities along with the standard error bars of the mean. 
 
There were no significant results when testing for interactions, neither for the gaze times 
interval interaction, F(2, 18)=0.98, p=0.39, nor for the gaze times daytime interaction, F(4, 
36)=0.77, p=0.55, nor for the interval times daytime interaction, F(2, 18)=0.99, p=0.39, nor 
for the gaze times interval times daytime interaction, F(4, 36)=2.08, p=0.1. With regard to the 
comparison between cerebellar patients and patients with unknown aetiology, cerebellar 
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patients had an average SPV-value of -2.72 deg/s, whilst patients with unknown aetiology had 
an average SPV-value of -0.79 deg/s. This descriptive difference is not significant according 
to the Kolmogorov-Smirnov test (p>0.05). 
 
3.5.2.3. Third section including the within subjects factor body orientation 
 
Consistent with previous findings, the analysis with respect to body orientation resulted in a 
significant main effect, F(2, 18)=8.09, p<0.01 (Figure 3.32). The Scheffé post-hoc 
comparisons between upright (-1.84 deg/s), supine (-0.47 deg/s) and prone (-3.51 deg/s) 
revealed that only the difference between supine and prone position was statistically 
significant (p<0.01). Comparing upright and supine position (p=0.22) and upright and prone 
position (p=0.12) did not yield a significant finding. 
 
-8
-7
-6
-5
-4
-3
-2
-1
0
upright position supine position prone position
Sl
o
w
 
ph
a
s
e
 
v
e
lo
c
ity
 
(°/
s
)
p<0.01
 
Figure 3.32 Comparing SPV between upright, supine and prone positions, across both 
intervals and daytime, measured in gaze straight ahead and with the light switched on. 
Display of mean slow phase velocities along with the standard error bars of the mean. 
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As in previous analyses, there was a significant main effect for the within-subjects factor 
daytime, F(2, 18)=9.14, p<0.01 (Figure 3.33), where average SPV decreased from -3.24 deg/s 
at 9am to -1.285 deg/s at 11am and -1.29 deg/s at 1pm. Scheffé post-hoc tests revealed that 
the difference between 9am and 11am and from 9am to 1pm were both statistically significant 
(p<0.01), whereas the difference between 11am and 1pm was not significant (p=1). 
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Figure 3.33 Daytime decrease in SPV across all three body positions and both intervals, 
measured in gaze straight ahead and with the light switched on. Display of mean slow phase 
velocities along with the standard error bars of the mean. 
 
Among the other tests, there was no significant main effect for the within subjects factor 
interval, F(1, 9)=0.93, p=0.36. Testing possible interactions revealed a marginally significant 
body orientation times interval interaction, F(2, 18)=3.11, p=0.07, a marginally significant 
body orientation times daytime interaction, F(4, 36)=2.52, p=0.06 and a marginally significant 
body orientation times interval times daytime interaction, F(4, 36)=2.135, p=0.096. Testing 
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the interval times daytime interaction did not result in a significant finding, F(2, 18)=0.74, 
p=0.49. The comparison of interest in this chapter deals with the resting position during the 
intervals between testing. Because the body orientation times interval interaction was 
marginal and because the 9am measurements have an indirect influence on the results (even 
though no resting interval had taken place yet at this time of measurement), their SPV-values 
prior to the resting intervals were compared with each other. The 9am measurement prior to 
resting in supine position had an average SPV-value of -3.35 deg/s, whereas the 9am 
measurement prior to resting in upright position had an average SPV-value of -3.13 deg/s. 
Although these values are almost the same (Scheffé: p=0.99), they could have an indirect 
influence, so that a marginally significant finding may turn out significant. As a result, an 
additional analysis was carried out excluding the 9am measurements. This analysis ensured 
that only SPV-values were considered that were assessed after the resting intervals. This new 
analysis indeed revealed that there was a significant body orientation times interval 
interaction, F(2, 18)=7.04, p<0.01 (Figure 3.34). In upright position measurements, having 
previously rested in upright position is associated with a lower average SPV (-0.63 deg/s) than 
after having previously rested in supine position (-2.01 deg/s, Scheffé: p<0.05). In supine 
position measurements, having previously rested in supine position (-0.31 deg/s) and having 
rested in upright position (+0.23 deg/s) show similar average SPV-values (Scheffé: p=0.77). 
When having rested in supine position, the average SPV-values in the supine measurements (-
0.31 deg/s) are significantly lower than in the upright measurements (-2.01 deg/s, Scheffé: 
p<0.01). When having rested in upright position, the average SPV-values in upright 
measurements (-0.63 deg/s) and in supine measurements (+0.23 deg/s) do not significantly 
differ from each other (Scheffé: p=0.33). It is interesting that having rested in upright position 
even shows a slight descriptive trend towards an upbeat nystagmus. 
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Figure 3.34 Comparing SPV differences between the within subjects factors interval and 
position across daytime (11am and 1pm), measured in gaze straight ahead and with the light 
switched on. Display of mean slow phase velocities along with the standard error bars of the 
mean. 
 
Having rested in either supine or upright position does not seem to influence the 
measurements in prone position, as Scheffé post-hoc tests revealed a p-value of p=0.87 when 
comparing the two different resting intervals with respect to prone position measurements. 
With regard to the comparison between cerebellar patients and patients with unknown 
aetiology, cerebellar patients had an average SPV-value of -4.74 deg/s, whilst patients with 
unknown aetiology had an average SPV-value of -1.24 deg/s. This descriptive difference is 
not significant according to the Kolmogorov-Smirnov test (p>0.05). 
 
3.5.3. Discussion 
 
The first section of part 5 predominantly confirmed the results of earlier analyses. The 
possibility to fixate (i.e. when the light is turned on during the measurements) is associated 
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with lower SPV-values than viewing in the dark (i.e. when the light is turned off during the 
measurements and patients therefore lack the chance to suppress DBN by fixation). Moreover, 
it was shown that there is a daytime decrease of DBN intensity. New results included the light 
times daytime interaction, which was due to the fact that the 9am measurements in darkness 
were significantly more negative than the 9am measurements with the light switched on. After 
the first resting interval, this resulted in a steeper decrease of SPV-values for the 
measurements in darkness than for the measurements with the light switched on. When 
excluding the 9am measurements, however, this interaction vanished and the lines looked 
almost parallel. Therefore, one should not over-interpret this interaction. It could be due to 
chance. The explanation of sleep-inertia could also account for this interaction (see previous 
chapter), where it would take the Purkinje-cells up to a few hours to adapt to their full 
functioning. Whilst the possibility to fixate might suppress these effects, no possibility to 
fixate (i.e. when tested in darkness) could result in more severe DBN symptoms particularly 
in the morning hours. It needs to be kept in mind that, the hypothesis with regard to sleep 
inertia is just one possible explanation. Another significant interaction was the interval times 
daytime interaction. In this interaction, the 9am measurements prior to both resting intervals 
(supine versus upright) were almost identical, but the decrease in SPV was steeper following 
the resting interval in upright position than in supine position. This significant interaction was 
indirectly influenced by the 9am measurements, where no resting interval had been taken 
place yet. Therefore, the 9am measurements were excluded in a further analysis, which made 
this interval times daytime interaction vanish. Although the lines between resting intervals in 
supine and upright position looked almost parallel following this step, the exclusion of the 
9am measurements did not create a significant main effect with regard to interval (though 
resting in upright position was associated with marginally significant lower SPV-values than 
resting in supine position). Consequently, there is a tentative trend towards favouring the 
upright position. The formerly significant interval times daytime interaction was 
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predominantly due to a steeper decrease in SPV-values following the interval in upright 
position. This explanation would make sense because people were measured in upright 
position, so an upright resting position would have resulted in a lower number of gravitational 
changes on the day of testing. 
 The second section of part 5 of this study also confirmed earlier findings. Upward 
gaze is associated with significantly lower SPV-values than gaze straight ahead and 
downward gaze, whereas gaze straight ahead and downward gaze do not differ in terms of 
their SPV-values. In addition, there is a daytime decrease of DBN intensity. What was only a 
tentative sign in the first section turned out to be a significant effect in the second section of 
part 5. There was a significant main effect with respect to the within subjects factor interval. 
As far as the SPV-values and therefore DBN intensity was concerned, patients had less 
symptoms after having rested in upright position than after having rested in supine position. 
 As in previous analyses, the third section of part 5 of this study revealed a significant 
main effect of the within subjects factor body orientation. From a descriptive point of view, 
supine position had the lowest SPV-values followed by upright position and prone position, 
but only the difference between supine and prone position was statistically significant. Also 
known from previous analyses, the intensity of DBN decreased during daytime. Although the 
body orientation times interval interaction only became marginally significant, it has to be 
kept in mind that the data included the 9am measurements. These measurements had taken 
place even before the first resting interval occurred. Consequently, an additional analysis was 
carried out, where the 9am measurements were not taken into consideration and where only 
those SPV-values were included that were assessed after the resting intervals. It turned out 
that there was a significant body orientation times interval interaction. When upright position 
measurements were carried out, having previously rested in upright position was associated 
with a lower DBN intensity than having previously rested in supine position. However, when 
having rested in upright position, the SPV-values in upright measurements and in supine 
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measurements do not differ from each other significantly. In supine position measurements, 
having previously rested in supine position and having rested in upright position showed a 
similar intensity of DBN. When having rested in supine position, however, the SPV-values in 
the supine measurements are significantly lower than in the upright measurements. 
As hypothesised in parts 2 and 4 of this study, when being measured in upright 
position, it is better to have previously rested in upright position than to have previously 
rested in supine position. When comparing the two different resting positions prior to supine 
measurements, there is no significant difference, but DBN in supine measurements is less 
pronounced than in upright measurements when having previously rested in supine position. 
These results are in line with the assumption that a rotation relative to the gravitational vector 
makes the intensity of DBN worse than no rotation. 
Only a nonparametric comparison between patients with cerebellar and unknown 
aetiologies was carried out, because the number of two cerebellar patients was considered too 
low to carry out a parametric test with the between subjectes factor aetiology. Although the 
nonparametric Kolmogorov-Smirnov tests were not significant, the descriptive trend shows 
that patients with cerebellar aetiology appear to have stronger symptoms of DBN. 
 
3.6. Replicating the study on daytime dependence of downbeat nystagmus mediated by 
prone versus supine resting positions (part 6) 
 
Having compared upright resting position with prone and supine resting positions 
individually, prone and supine resting positions will now be compared with each other. 
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3.6.1. Methods 
 
The method of part 6 overlaps one to one with the method of parts 1 to 5. The only 
differences are with respect to the participants and the intermission between testing. 
 
3.6.1.1. Patients 
 
All patients were identical to the ones tested in parts 2 and 4. An overview is provided in 
Table 3.6. In part 6, a total number of 9 participants were tested at 9am, 11am and 1pm. In the 
intervals between testing, they rested in either prone or in supine position. In both cases, the 
light was switched off, i.e. they rested in darkness. Five of the patients were the same as in 
part 1, four patients had not been tested in part 1. All nine patients had also been tested in part 
3. The mean duration of DBN was 6.81 years (range 3-17 years, see Table 3.6). The patients 
were 44 to 72 years old, with a mean of 63.67 years and a standard deviation of ± 7.92 years. 
Patients No. 7 and No. 8 had already participated in the study of the previous chapter. All 
other factors and clinical examinations were identical to parts 1 to 5. 
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Table 3.6 Clinical data of the patients with DBN where prone and supine positions in 
darkness were compared with each other 
No./Sex/ 
Age 
Neuro-ophthalmological findings MRI 
findings 
Aetiology Disease 
duration 
No. 1M, 64 
 
Disturbed visual fixation suppression of 
VOR, non-existing upright opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
Cerebellar 
atrophy 
Cerebellar de-
generation 
3 years 
No. 2F, 69 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and upward opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally, provocation DBN. 
Cerebellar 
atrophy 
Idiopathic 
cerebellar 
ataxia 
17 years 
No. 3M, 69 
 
Deviant SVV, impaired horizontal and 
downward pursuit, saccades with rebound 
after gaze to the right, provocation DBN. 
Normal Unknown 4.5 years 
No. 4F, 60  Disturbed visual fixation suppression of 
VOR, DBN overran horizontal opto-kinetic 
nystagmus, non-existing upward opto-
kinetic nystagmus, deviant SVV, impaired 
horizontal and downward pursuit. 
Normal Unknown 12 years 
No. 5F, 61  Disturbed visual fixation suppression of 
VOR, deviant SVV, provocation DBN, 
vertical saccades and saccades to the left. 
Normal Unknown 5 years 
No. 6M, 44 
 
Disturbed visual fixation suppression of 
VOR, impaired upward opto-kinetic 
nystagmus, impaired horizontal and vertical 
pursuit. 
Normal Unknown 10 years 
No. 7M, 65 
 
Impaired upward opto-kinetic nystagmus, 
impaired horizontal and downward pursuit, 
hypometric upward saccades. 
Normal Unknown 10 years 
No. 8F, 69 
 
Disturbed vertical visual fixation 
suppression of VOR, impaired upward 
opto-kinetic nystagmus, impaired horizontal 
and downward pursuit. 
Normal Unknown 3 years 
No. 9F, 72 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and non-existing 
upward opto-kinetic nystagmus, impaired 
horizontal and downward pursuit. 
Normal Unknown 6 years 
 
VOR = vestibulo-ocular reflex; SVV = subjective visual vertical axis, HTT = head-thrust test 
developed by Halmagyi and Curthoys (1988). 
 
3.6.1.2. Recording of eye movements 
 
Patients were tested three times on a single day. Each time, patients were monitored in the 
following sequence: (see Figure 3.35). 
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1. they were sitting in upright position, 2. they were lying in supine position, 3. they were 
lying in prone position. In the intermissions between testing, people rested in supine position 
and prone position, in both cases with the light switched off. The same patients were 
measured in prone position and supine position, i.e. they came to the hospital twice with a 
delay of approximately one week between these two measurements. The VOG-measurements 
were identical to those in the previous chapter and in parts 1 to 5 of this chapter. 
 
 
                     time 
 9am     Inter-          11am      Inter-   1pm   
       mission           mission               
 
Figure 3.35. An overview describing the testing conditions for all patients. The eye 
movements of the patients were monitored in the following order: 1. sitting in upright position 
in light/dark, 2. lying in supine position in light/dark, 3. lying in prone position in light/dark. 
All measurements took place at 9am, 11am, and 1pm. In between the measurements, patients 
were lying in prone position or supine position, in both cases with the light switched off. 
 
3.6.1.3. Data acquisition and calibration 
 
Data acquisition and calibration was identical to the previous chapter and parts 1 to 5 of this 
chapter. 
 
3.6.1.4. Statistical data analysis 
 
The statistical analysis consisted of repeated measurement ANOVAs (Statistica 6.1, Statsoft, 
Tulsa OK, USA) with post-hoc Scheffé tests for individual comparisons. The dependent 
variable was slow phase velocity (SPV). The first analysis consisted of the within subjects 
factors light (light on = fixation is possible versus light off = viewing in the dark with no 
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possibility to fixate), interval (resting in prone position with the light switched off versus 
resting in supine position with the light switched off) and daytime (9am, 11am, 1pm). The 
second analysis consisted of the within subject factors gaze condition (straight, upwards, 
downwards), interval (resting in prone position with the light switched off versus resting in 
supine position with the light switched off) and daytime (9am, 11am, 1pm). The third analysis 
had the within subject factors body orientation (upright, supine and prone), interval (resting in 
prone position with the light switched off versus resting in supine position with the light 
switched off) and daytime (9am, 11am, 1pm). Due to the low number of patients with 
cerebellar symptoms, the previously mentioned nonparametric Kolmogorov-Smirnov test for 
two independent samples was taken as the statistical analysis. The two independent groups 
were the two different aetiologies (cerebellar patients versus patients with unknown 
aetiology). The two groups were compared with respect to their overall SPV-values. 
 
3.6.2. Results 
 
3.6.2.1. First section including the within subjects factor fixation versus viewing in the 
dark 
 
In the first section of part 6, patient No. 4 was missing, because in prone position, she was not 
assessed in the dark. As a result, no comparison for the within subjects factor light (fixation 
versus viewing in the dark) was possible. Unlike the study in the previous chapter, the 
analysis did not reveal a significant main effect for the within-subjects factor light, F(1, 
7)=2.875, p=0.13, although the descriptive trend was consistent with previous findings, 
because the possibility to fixate (= light on) resulted in an average SPV-value of -2.46, 
whereas no possibility to fixate (= light off) had an average SPV-value of -3.23. Consistent 
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with previous findings, there was, however, a significant daytime decrease in SPV-values, 
F(2, 14)=7.15, p<0.01 (Figure 3.36), where average SPV decreased from -4.28 deg/s at 9am 
to -2.28 deg/s at 11am and -1.98 deg/s at 1pm. Scheffé post-hoc tests revealed that the 
decrease from 9am to 11am and from 9am to 1pm each had a p-value of p<0.05. There was no 
significant difference between 11am and 1pm (p=0.9). 
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Figure 3.36 Daytime decrease in SPV across both light conditions and both intervals, 
measured in upright position with gaze straight ahead. Display of mean slow phase velocities 
along with the standard error bars of the mean. 
 
Additional significant findings included a light times daytime interaction, where the SPV-
decrease from 9am to 11am appeared steeper when the measurement took place with the light 
switched off (= with no possibility to fixate) than with the light switched on (= with the 
possibility to fixate), F(2, 14)=4.5, p<0.05 (Figure 3.37). As revealed by Scheffé post-hoc 
comparisons, the decrease from 9am to 11am an from 9am to 1pm with the light switched on 
(each p<0.01) as well as the decrease from 9am to 11am (p<0.0001) and from 9am to 1pm 
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(p<0.00001) with the light switched off were statistically significant. Whilst there was a 
significant difference between both 9am measurements (-3.55 deg/s with the light switched on 
versus -5.01 deg/s with the light switched off, Scheffé: p<0.01), the 11am and 1pm 
measurements did not differ from each other (Scheffé: p>0.5). 
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Figure 3.37 Daytime decrease in SPV between the within subjects factors light and daytime 
and across both intervals, measured in upright position with gaze straight ahead. Display of 
mean slow phase velocities along with the standard error bars of the mean. 
 
If the 9am measurements were excluded, the lines looked almost parallel (see Figure 3.37). 
This apparent absence of a light times daytime interaction was confirmed in the analysis 
where the 9am measurements were excluded, F(1, 7)=0,84, p=0.39, and this, in turn, did not 
result in a main effect for the within subjects factor light, F(1, 7)=0.77, p=0.41. Going back to 
the original analysis (including the 9am measurements), none of the other statistical tests of 
this analysis became significant, neither the main effect with regard to the within subjects 
factor interval, F(1, 7)=0.32, p=0.59, nor the test for the light times interval interaction, F(1, 
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7)=0.34, p=0.58, nor the test for the interval times daytime interaction, F(2, 14)=0.355, 
p=0.71, nor the test for the light times interval times daytime interaction, F(2, 14)=2.28, 
p=0.14. With regard to the comparison between cerebellar patients and patients with unknown 
aetiology, cerebellar patients had an average SPV-value of -5.81 deg/s, whilst patients with 
unknown aetiology had an average SPV-value of -1.85 deg/s. This descriptive difference is 
not significant according to the Kolmogorov-Smirnov test (p>0.05). 
 
3.6.2.2. Second section including the within subjects factor gaze direction 
 
As in the other analyses of this study and the previous one, it turned out that there was a main 
effect with respect to the within subjects factor gaze direction, F(2, 16)=14.75, p<0.001 
(Figure 3.38), where Scheffé post-hoc tests revealed that gaze upwards (+0.12 deg/s, i.e. a 
slight UBN) was associated with significantly lower SPV values than gaze straight ahead (-
2.56 deg/s, Scheffé test: p<0.001) and gaze downwards (-2.35 deg/s, Scheffé test: p<0.01), 
whereas gaze straight ahead and downwards did not significantly differ from each other 
(p=0.93). Unlike the other analyses in the previous parts of this study, none of the remaining 
tests in this analysis revealed a significant finding, neither the test for the within subjects 
factor interval, F(1, 8)=0.02, p=0.9, nor the marginally significant decrease of daytime SPV, 
F(2, 16)=3.21, p=0.07 (the descriptive trend was in line with a daytime decrease: -2.41 deg/s 
at 9am, -1.25 deg/s at 11am and -1.13 deg/s at 1pm), nor the tests for the interactions, where 
the gaze times interval interaction resulted in F(2, 16)=1.22, p=0.32, the gaze times daytime 
interaction in F(4, 32)=0.325, p=0.86, the interval times daytime interaction in F(2, 16)=0.67, 
p=0.52, and finally the gaze times interval times daytime interaction in F(4, 32)=1.4, p=0.255. 
Even when excluding the 9am measurements, as they had taken place before the first resting 
interval, none of these possible main effects and interactions resulted in a significant finding. 
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Figure 3.38 Comparing SPV between gaze straight ahead, upward and downward, across 
both intervals and daytime, measured in upright position and with the light switched on. 
Display of mean slow phase velocities along with the standard error bars of the mean. 
 
With regard to the comparison between cerebellar patients and patients with unknown 
aetiology, cerebellar patients had an average SPV-value of -3.62 deg/s, whilst patients with 
unknown aetiology had an average SPV-value of -1.02 deg/s. This descriptive difference is 
not significant according to the Kolmogorov-Smirnov test (p>0.05). 
 
3.6.2.3. Third section including the within subjects factor body orientation 
 
Consistent with previous findings, the analysis with respect to body orientation resulted in a 
significant main effect, F(2, 16)=4.82, p<0.05 (Figure 3.39). The Scheffé post-hoc 
comparisons between upright (-2.56 deg/s), supine (-0.695 deg/s) and prone (-3.03 deg/s) 
revealed that only the difference between supine and prone position was statistically 
significant (p<0.05). Comparing upright and supine position resulted in a marginally 
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significant finding (p=0.094), whilst the comparison between upright and prone position 
(p=0.84) was not significant. 
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Figure 3.39 Comparing SPV between upright, supine and prone positions, across both 
intervals and daytime, measured in gaze straight ahead and with the light switched on. 
Display of mean slow phase velocities along with the standard error bars of the mean. 
 
As in previous analyses, there was a significant main effect for the within-subjects factor 
daytime, F(2, 16)=8.38, p<0.01 (Figure 3.40), where average SPV decreased from -3.5 deg/s 
at 9am to -1.4 deg/s at 11am and -1.39 deg/s at 1pm. Scheffé post-hoc tests revealed that the 
differences between 9am and 11am and from 9am to 1pm were both statistically significant 
(p<0.01), whereas the difference between 11am and 1pm was not significant (p=1). 
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Figure 3.40 Daytime decrease in SPV across all three body positions and both intervals, 
measured in gaze straight ahead and with the light switched on. Display of mean slow phase 
velocities along with the standard error bars of the mean. 
 
Among the remaining comparisons, only the body orientation times daytime interaction 
became statistically significant, F(4, 32)=11.51, p<0.00001 (Figure 3.41). At the 9am 
measurements, i.e. prior to the first resting interval, the average SPV-values in all three body 
positions (upright: -3.36 deg/s, supine: -1.56 deg/s, prone: -5.59 deg/s) were significantly 
different from each other, as Scheffé post-hoc comparisons revealed a difference of p<0.01 
between upright and supine, p<0.001 between upright and prone and p<0.000001 between 
supine and prone. At the 11am measurements, supine and upright were significantly different 
from each other (p<0.01), at 1pm both upright and supine (p<0.05) and supine and prone 
(p<0.05). From the 9am measurements to the 11am measurements, the decrease of SPV in the 
prone measurements appears steeper than in the upright and supine measurements (i.e. see 
Figure 3.41). After 11am, however, the lines of all three measurements appear almost parallel. 
Only prone position shows a significant SPV-decrease from 9am to 11am and from 9am to 
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1pm (each p<0.000001). To check the influence of the 9am measurements, they were 
excluded in an additional analysis. In this case the significant body orientation times daytime 
interaction vanished, F(2, 16)=0.58, p=0.57 and no further tests gained statistical significance. 
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Figure 3.41 Comparing SPV differences across intervals between the within subjects factors 
body position and daytime, measured in gaze straight ahead and with the light switched on. 
Display of mean slow phase velocities along with the standard error bars of the mean. 
 
Going back to the analysis that included the 9am measurements, there was no significant main 
effect for the within subjects factor interval, F(1, 8)=0.4, p=0.54. Testing possible interactions 
revealed a marginally significant body orientation times interval interaction, F(2, 16)=3.5, 
p=0.055, no interval times daytime interaction, F(2, 16)=0.29, p=0.75 and no body orientation 
times interval times daytime interaction, F(4, 32)=0.4, p=0.8. The comparison of interest in 
this chapter deals with the resting position during the intervals between testing. Because the 
body orientation times interval interaction was marginal and because the 9am measurements 
have an indirect influence on the results (even though no resting interval had taken place yet 
at this time of measurement), their SPV-values prior to the resting intervals were compared 
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with each other. The 9am measurement prior to resting in prone position had an SPV-value of 
-3.43 deg/s, whereas the 9am measurement prior to resting in supine position had an SPV-
value of -3.57 deg/s. Although these values are almost the same (Scheffé: p=0.999), they 
could have an indirect influence so that a marginally significant finding may turn out 
significant. As a result, an additional analysis was carried out excluding the 9am 
measurements. This analysis ensured that only SPV-values were considered that were 
assessed after the resting intervals. As previously mentioned, the analysis without the 9am 
measurements did not reveal any significant finding. Testing the body orientation times 
interval interaction revealed an F-value of F(2, 16)=2.55, p=0.11. Although neither the 
analysis including the 9am measurements (Figure 3.42a), nor the analysis excluding the 9am 
measurements (Figure 3.42b) revealed a significant result, the descriptive trends are shown in 
the figures. According to these descriptive trends, when being measured in upright or supine 
position, it makes almost no difference whether people have rested in supine or prone 
position. When being measured in prone position, however, patients reveal a descriptively 
lower SPV after having rested in prone position as compared to having rested in supine 
position. 
Referring to the comparison between cerebellar patients and patients with unknown 
aetiology, cerebellar patients had an average SPV-value of -5.19 deg/s, whilst patients with 
unknown aetiology had an average SPV-value of -1.21 deg/s. This descriptive difference is 
not significant according to the Kolmogorov-Smirnov test (p>0.05). 
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Figure 3.42a Comparing SPV differences between the within subjects factors interval and 
position, across daytime (9am, 11am, 1pm), measured in gaze straight ahead and with the 
light switched on. Display of mean slow phase velocities along with the standard error bars of 
the mean, b The same comparison as in 3.42a, but without the 9am measurements. 
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3.6.3. Discussion 
 
In contrast to the previous study (chapter 2), the analysis in part 6, section 1 did not reveal a 
significant main effect for the within-subjects factor light, although it needs to be said that the 
descriptive trend of the results was completely in line with previous findings and the 
comparison was almost marginally significant. Consequently, this result did not contradict 
previous findings. The daytime decrease of DBN-intensity was fully in line with previous 
findings. As in part 5 of this study, there was a significant light times daytime interaction, 
which was due to the fact the 9am measurements in darkness were significantly more negative 
than the 9am measurements with the light switched on. After the first resting interval, this 
resulted in a steeper decrease of SPV-values for the measurements in darkness than for the 
measurements with the light switched on. When excluding the 9am measurements, however, 
this interaction vanished and the lines looked almost parallel. As mentioned in part 5 of this 
study, this difference could be due to chance. As an alternative, and more speculative 
explanation, it would also be in line with the effect of sleep inertia. Under this assumption it 
would take the Purkinje-cells up to a few hours to adapt to their full functioning. Whilst the 
possibility to fixate might suppress these effects, no possibility to fixate (i.e. when tested in 
darkness) could result in more severe DBN symptoms particularly in the morning hours. The 
absence of a fixation point and the possible effect of sleep inertia could even produce 
synergistic effects, which could also act as a possible explanation for this finding. 
In the second section of part 6 and consistent with previous analyses, there was a main 
effect with respect to the within subjects factor gaze direction, where gaze upwards was 
associated with less DBN than gaze straight ahead and gaze downwards, whereas gaze 
straight ahead and gaze downwards did not differ in terms of their DBN. In contrast to 
previous analyses, testing for daytime decrease of DBN only revealed a marginally significant 
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finding and none of the possible interactions became statistically significant. The marginally 
significant daytime decrease was not in contrast to previous findings, as the descriptive trend 
of having a daytime decrease remained preserved in this analysis. 
The third section of part 6 confirmed many previous findings, as the analysis with 
respect to body orientation resulted in a significant main effect. Being measured in supine 
position was again associated with the lowest intensity of DBN, though only the difference 
between supine and prone position was statistically significant, whereas the comparison 
between upright and supine position was marginally significant and the comparison between 
upright and prone position not significant. In addition, the body orientation times daytime 
interaction became statistically significant, which was, however, predominantly due to a high 
intensity of DBN in prone position prior to the first resting interval. After the first resting 
interval, the lines between the three body orientations appear almost parallel and the formerly 
significant interaction vanishes when the 9am measurements are excluded. It is difficult to 
interpret why the 9am measurements in prone position show a greater intensity of DBN than 
in the other two positions. In the previous analyses, it was shown that prone position 
measurements often seem to be associated with a higher intensity of DBN. It also turned out 
that DBN is generally highest in the morning hours. Hence, this result might be explained by 
synergistic effects of these two characteristics or even more than two characteristics, e.g. 
when taking a possible effect of sleep inertia into account as well. Because the comparison of 
interest in this chapter deals with the resting position during the intervals between testing, it 
was focused on the test of the body orientation times interval interaction (albeit marginally 
significant only). When excluding the 9am measurements due to the fact that they were 
carried out before the first resting interval, the marginally significant interaction even changed 
from marginal to not significant. Nevertheless, it is worth investigating the descriptive trends. 
They indicate the following: when being measured in supine position, it makes almost no 
difference whether people have rested in supine or in prone position. When being measured in 
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prone position, however, patients reveal a descriptively lower SPV after having rested in 
prone position as compared to having rested in supine position. Consequently, there is at least 
a tentative sign that the resting position has an influence during the measurements. Moreover, 
this descriptive trend stands in line with the significant interactions found in part 4 and part 5 
of this study, where the resting position also had an influence on the position during 
measurement. 
Finally, a nonparametric comparison between patients with cerebellar and unknown 
aetiologies was carried out, because the number of two cerebellar patients was considered too 
low to carry out a parametric comparison with the between subjects factor aetiology. 
Although the nonparametric Kolmogorov-Smirnov test did not turn out to be significant, it 
remains to be said, though, that the descriptive trend indicates stronger DBN symptoms in 
patients with cerebellar aetiology than in patients with unknown aetiology. 
 
3.7. General discussion 
 
This chapter revealed several main findings. First and according to part 1 of this study, it 
turned out that under the usual conditions during daytime (= upright position, no darkness), it 
makes no difference whether patients rest upright with the light switched on or upright with 
the light switched off, though there was a descriptive trend in terms of lower DBN being 
associated with the light-off condition. 
The second finding under these conditions (part 2 of this study) revealed that it is 
better to rest upright than to rest in prone or supine position (all resting positions were in 
darkness). A practical application of this finding is to recommend people to rest upright. 
Third, parts 3 to 6 of this study confirmed the results from the study of the previous 
chapter, i.e. that the intensity of DBN decreases during daytime, that fixation (= light on) 
suppresses the intensity of DBN, that gaze direction and body orientation have an influence 
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on the intensity of DBN (with upward gaze / supine position being associated with the lowest 
intensity of DBN). A lot of information from parts 3 to 6 may appear redundant to the 
previous chapter, but this information was necessary in order to show that the data from both 
studies and under the different conditions are coherent. It compared the same resting position 
(upright) between two conditions (resting with the light switched on or off). The results 
revealed that overall (i.e. taking together measurements in light and darkness), resting upright 
with the light switched off was associated with a lower intensity of DBN than resting upright 
with the light switched on. This result has the practical consequence that it is better to rest 
upright in darkness in case the daily routine of a person requires activities in both light and 
darkness. In addition, this result can be directly related to the discussion of the previous 
chapter, where it was discussed that daytime decrease could be the result of a non-visual error 
signal such as extraocular proprioception (Büttner-Ennever & Horn, 2002) or efference copy 
(Glasauer et al. 2005b; Klier et al. 2008). According to these explanations, it would be the 
case that DBN becomes less because patients were able to adapt throughout the day. Because 
patients were allowed to keep their eyes open and the light switched on during the resting 
intervals in the previous chapter, it was assumed that these conditions might have contributed 
to the adaptation process and alleviated the intensity of DBN. This interpretation stands in 
contrast to the current finding that DBN was less pronounced after patients rested in upright 
position during darkness (compared to resting in upright position with the light switched on). 
It needs to be kept in mind, however, that this finding alone does not contradict the 
explanations of extraocular proprioception or efference copy. It just implies that daytime 
decrease of DBN may not be due to an adaptation process that is supported by having the light 
switched on. In any case, more research will be necessary, and it will be desirable to not only 
compare light versus darkness in upright position, but also in the other resting positions 
(supine/prone). 
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Fourth, this chapter compared the influence of the three different resting orientations 
(each with the light switched off) on the three different measurement positions. It turned out 
that the positions during the resting intervals (upright, supine, prone) do at least have a 
tentative influence on the SPV-values of the different measurement positions (upright, supine, 
prone). This becomes particularly clear in part 4 of this study. After the resting positions of 
the patients were varied between prone position and upright position, it turned out that when 
being measured in upright position, having rested in upright position is associated with a 
significantly lower SPV-value than having rested in prone position. When being measured in 
prone position, having rested in prone position is associated with a marginally significant 
lower SPV-value than having rested in upright position. 
When considering practical applications of this finding, one could, for example, 
recommend patients to rest in upright position when they intend to do office work after the 
resting period. Alternatively, one could recommend patients to rest in prone position when 
they intend to work in prone position, do gymnastics or swim in prone position or receive a 
massage after the resting period. In conclusion, the results of this study are in line with the 
gravitational influences that were proposed by Brandt (1990) and Marti (2002). A body 
rotation in relation to the gravitational vector may have an influence on the otoliths, making 
DBN worse in relation to not rotating. This effect occurs no matter in which direction the 
rotation occurs (e.g. from supine to upright or from prone to upright, as described in part 2 of 
this chapter). 
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4. Comparing 3,4-Diaminopyridine and 4-Aminopyridine in the therapy of downbeat 
nystagmus 
 
As mentioned in the introduction, the aminopyridines 3,4-diaminopyridine (3,4-DAP) and 4-
aminopyridine (4-AP) currently seem to be the most promising pharmacological approaches 
to alleviate the symptoms of DBN. For 3,4-DAP this was demonstrated in a placebo-
controlled trial by Strupp et al. (2003) and for 4-AP by Kalla et al. (2007). What was missing 
so far was a direct comparison between both drugs. This chapter is dedicated to this 
comparison, where the effect of 3,4-DAP versus 4-AP in a group of patients with DBN was 
investigated for the first time in a double-blind study with crossover design (see Kalla et al, 
2011). Thus, the purpose of this work is to analyze DBN before and after administration of 
3,4-DAP / 4-AP and to determine whether both medications differ in terms of slow-phase 
velocity (SPV) changes. The study of this chapter has already been published in Kalla et al. 
(2011), where I shared the first authorship. Since I contributed, among other aspects, the text 
to the Kalla et al. (2011) manuscript and since I am the author of this thesis, there is a partial 
overlap between the text, figures, table and their legends between my thesis and the Kalla et 
al. (2011) article. 
 
4.1. Methods 
 
4.1.1. Patients 
 
In the present study, eight patients (2 males, 6 females) with a history of DBN due to different 
aetiologies were analysed prior to, 45 minutes after and 90 minutes after administration of 
either 4-AP or 3,4-DAP. The aetiologies were cerebellar degeneration (n = 1), cerebellar 
degeneration with bilateral vestibulopathic failure (n = 1), cerebellar ataxia with relatively low 
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placement of cerebellar tonsils (n = 1), idiopathic cerebellar ataxia with cerebellar atrophy 
according to the MRI-scan (n = 1), and unknown DBN (n = 4), see Table 4.1, i.e. there were 4 
patients with cerebellar aetiology and 4 patients with unknown aetiologies. The mean duration 
of DBN was 7.75 years (with a range of 3 to 24 years, see Table 4.1). The patients were 58 to 
76 years old, with a mean of 68 years and a standard deviation of ± 5.93 years. Patients No. 1, 
No. 4, No. 7 and No. 8 had already appeared in the first study (see chapter 2), patients No. 1 
and No. 7 had appeared in parts 1 and 3 of the second study (see chapter 3), and patients No. 
1, No. 6 and No. 7 had appeared in parts 2, 4, 5 and 6 of the second study (see chapter 3). The 
effect of 3,4-DAP versus 4-AP was compared in a double-blind study with crossover design. 
Thus, the purpose of this work was to analyse DBN before and after administration of 
aminopridines and to determine whether both medications would differ in terms of slow-
phase velocity (SPV) changes in our patients, i.e. the same patients received a single capsule 
of 10mg 3,4-DAP and 10mg 4-AP separated by a one week washout period. The patients who 
were administered 3,4-DAP first, received 4-AP after one week and vice versa. The 
assignment to capsules with 3,4-DAP and those with 4-AP was random. 
On both testing occasions, patients’ eye movements were recorded with 3D-
videooculography prior to the administration of the capsule, which was swallowed at 9am. As 
mentioned before, additional recordings took place 45 minutes and 90 minutes after 
administration. In the intervals between the recording, patients rested in an upright position. 
As in previous studies (see the previous two chapters), all patients had a complete clinical 
examination and gave their informed consent prior to their participation. As the previous 
studies, this study was in accordance with the Helsinki II Declaration and approved by the 
local ethics committee of the Medical Faculty of Ludwig-Maximilians-University. 
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Table 4.1 Clinical data of the patients with DBN where 4-AP was compared to 3,4-DAP 
No./Sex/ 
Age 
Neuro-ophthalmological findings MRI 
findings 
Aetiology Disease 
duration 
No. 1M, 64 
 
Disturbed visual fixation suppression of 
VOR, non-existing upright opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally. 
Cerebellar 
atrophy 
Cerebellar de-
generation 
3 years 
No. 2F, 65 
 
Disturbed visual fixation suppression of 
VOR, impaired opto-kinetic nystagmus, 
impaired horizontal and downward pursuit, 
pathological HTT bilaterally, 
Reboundnystagmus after gaze to the left 
Normal Cerebellar de-
generation 
and bilateral 
vestibulo-
pathic failure 
9 years 
No. 3F, 76 
 
Disturbed visual fixation suppression of 
VOR, only saccades and DBN when trying 
to elicit opto-kinetic nystagmus, impaired 
horizontal and downward pursuit. 
Low placement 
of cerebellar 
tonsils, 
malformation of 
the cranio-
cervical 
transition 
Cerebellar 
ataxia with 
relatively low 
placement of 
cerebellar 
tonsils 
24 years 
No. 4F, 66 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal and non-existing 
vertical opto-kinetic nystagmus, impaired 
horizontal and downward pursuit, 
pathological HTT bilaterally. 
Cerebellar 
atrophy 
Idiopathic 
cerebellar 
ataxia 
4 years 
No.5M, 58 
 
Disturbed visual fixation suppression of 
VOR, impaired vertical and horizontal opto-
kinetic nystagmus, impaired horizontal and 
downward pursuit, pathological HTT 
bilaterally 
Normal Unknown  10 years 
No. 6F, 72 
 
Disturbed visual fixation suppression of 
VOR, impaired horizontal opto-kinetic 
nystagmus, impaired horizontal and 
downward pursuit. 
Normal Unknown 6 years 
No. 7F, 69 
 
Disturbed vertical visual fixation 
suppression of VOR, impaired upward 
opto-kinetic nystagmus, impaired horizontal 
and downward pursuit. 
Normal Unknown 3 years 
No. 8F, 74 
 
Horizontal and impaired downward opto-
kinetic nystagmus with DBN when looking 
upwards, impaired horizontal and 
downward pursuit 
Normal Unknown 3 years 
 
VOR = vestibulo-ocular reflex; HTT = head-thrust test developed by Halmagyi and Curthoys 
(1988). Permission for displaying the table was obtained from the publisher or my/our article. 
 
4.1.2. Recording of eye movements 
 
At each of the three testing sessions (before medication, 45 minutes and 90 minutes after 
medication), patients were monitored in upright position (see Figure 4.1). 
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Figure 4.1 Testing conditions for all patients. Eye movements of patients were monitored in 
the following order: 1. sitting in upright position in light/dark, 2. lying in supine position in 
light/dark, 3. lying in prone position in light/dark prior to medication, 45 minutes after 
medication and 90 minutes after medication. In between VOG-measurements, patients were 
sitting upright. 
 
As in the previous two chapters and previous publications (e.g. Spiegel et al., 2009a; Zingler 
et al., 2006), a 30 seconds eye movement recording with 3-D VOG took place in the 
following order: It started with a calibration in 8.5° position, and was followed by: 1. a gaze 
directed straight ahead with fixation turned on, 2. a gaze directed straight ahead in darkness 
(with no possibility to fixate on a fixation point), 3. 17° gaze to the right, 4. 17° gaze to the 
left, 5. 17° gaze upwards 6. 17° gaze downwards. The projection of the target occurred with a 
laser onto a white cardboard placed 60 cm in front of the patient. The horizontal gaze 
directions were only recorded for completeness purposes, e.g. to have a collection of these 
data should they be of interest for future studies, e.g. to generate possible hypotheses on gaze 
direction and medication.  
 
4.1.3. Data acquisition and calibration 
 
Data acquisition and calibration was done in exactly the same way as described in the 
previous two chapters, i.e. eye position was measured with 3D-VOG for 30 seconds, for 
details refer to the introduction of this thesis. The data were analysed off-line applying Matlab 
software (The Mathworks, Natick, MA, USA). The calibrated data were low-pass filtered 
using a digital Gaussian filter. The filter had a bandwidth of 30 Hz. Interactive software 
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allowed to detect and remove saccades and fast phases applying a combined velocity–
acceleration criterion. Consequently, it was possible to exclude detection errors manually. The 
mean slow phase velocity was computed from the de-saccaded data. 
4.1.4. Statistical data analysis 
 
As in the previous two chapters, the statistical analysis consisted of repeated measurement 
ANOVAs (Statistica 6.1, Statsoft, Tulsa OK, USA) with post-hoc Scheffé tests for individual 
comparisons. Again, the dependent variable was slow phase velocity (SPV) of vertical eye 
movements. In line with the previous two studies, the following analyses were separated into 
three sections. The first section included the within subjects factors light (fixation = light on) 
versus viewing in the dark = light off with no possibility to fixate), medication type (3,4-DAP 
vs. 4-AP) and time (before medication vs. 45 minutes after medication vs. 90 minutes after 
medication), the second section the within subjects factors gaze direction (straight ahead, 
upwards, downwards), medication type (3,4-DAP vs. 4-AP) and time (before medication vs. 
45 minutes after medication vs. 90 minutes after medication). In the second section, two 
patients (patients No. 3 and No. 5) were missing because no upward gaze and downward gaze 
measurements had been performed on them. Finally, the third section consisted of the within 
subjects factors body orientation (upright position vs. supine position vs. prone position), 
medication type (3,4-DAP vs. 4-AP) and time (before medication vs. 45 minutes after 
medication vs. 90 minutes after medication). In spite of the fact that there was a low number 
of patients with cerebellar aetiology (n = 4) or unknown aetiologies (n = 4), the between 
subjects factor aetiology was included and a parametric comparison was carried out. The 
inclusion of the between subjects factor stems from the fact that there is an equal number of 
patients in both groups and the F-test is robust to violations of its assumptions as long as there 
is an equal number of patients per group (Bortz, 1993; Spiegel 2002). These assumptions 
include normal distribution and independence of the dependent variable for each analysed 
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combination of values of the independent variables as well as homogenous variances across 
the analysed combinations (Cohen, 1988; Spiegel, 2002). Due to only 4 patients per group, 
the assumption that the dependent variable is normally distributed would be violated here. 
 
4.2. Results 
 
4.2.1. First section including the within subjects factor fixation versus viewing in the 
dark 
 
Considering the medication times time interaction, there was a significant effect between both 
aminopyridines throughout time (pre vs. post 45 vs. post 90), F(2, 14)=8.876, p<0.01. 
Following the administration of 3,4-DAP, average SPV decreased from –5.679 deg/s (pre) to 
–3.29 deg/s (post 45) to –2.962 deg/s (post 90) (with Scheffé post hoc comparisons between 
pre and post 45 as well as between pre and post 90 each revealing a p-value of p<0.01, 
whereas post 45 and post 90 were not significantly different from each other, p=0.98). In 4-
AP, average SPV decreased from –6.037 deg/s (pre) to –1.576 deg/s (post 45) to –1.206 deg/s 
(post 90), with Scheffé post hoc comparisons between pre and post 45 as well as between pre 
and post 90 each revealing a p-value of p<0.00001, whereas post 45 and post 90 were not 
significantly different from each other, p=0.97. The pre-SPV-measurements between both 
medications were not significantly different from each other either (p=0.97), but both post 45 
and post 90 SPV-measurements were significantly better in 4-AP than in 3,4-DAP (each 
Scheffé tests revealing p-values of p< 0.05 for both comparisons). The result is displayed in 
Figure 4.2a. 
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Figure 4.2a Comparing SPV between treatment with 3,4-DAP and 4-AP prior to medication, 
45 minutes after administration of medication and 90 minutes after administration of 
medication, measured across both light conditions in upright position with gaze straight 
ahead, b SPV across both light conditions and both medications prior to medication, 45 
minutes after administration of medication and 90 minutes after administration of medication, 
measured in upright position and gaze straight ahead. Display of mean slow phase velocities 
along with the standard error bars of the mean (in both 4.2a and 4.2b). Figure 4.2a was 
borrowed by my thesis-co-advisor Roger Kalla for research purposes (with my permission). It 
might have appeared on the internet after my thesis was completed (but before it has appeared 
on the web). 
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When excluding the before-medication measurements, the lines look almost parallel and the 
formerly significant medication times time interaction vanishes, F(1, 7)=0.006, p=0.94, 
creating a main effect for the within subjects factor medication, F(1, 7)=7.07, p<0.05, with 4-
AP being associated with a significantly lower average SPV-value (-1.39 deg/s) than 3,4-DAP 
(-3.13). 
Going back to the analysis that included the before-medication measurements, an 
additional significant finding refers to the main effect of time (pre vs. post 45 vs. post 90), 
F(2, 14)=10.72, p<0.01 (Figure 4.2b) with post-hoc Scheffé comparisons between before-
medication and 45 minutes after medication and before-medication and 90 minutes after 
medication each resulting in p-values of p<0.01 (45 minutes vs. 90 minutes after medication 
p=0.93). Moreover, there was a significant main effect with respect to light, F(1, 7)=14.14, 
p<0.01 (Figure 4.3), where fixation on target (= light on) had an average SPV-value of -2.23 
deg/s, whereas no fixation (= light off) had an average SPV-value of -4.69 deg/s. Other 
possible interactions, i.e. light times medication type (F(1, 7)=0.06, p=0.815), light times time 
(F(2, 14)=2.3, p=0.14), light times medication type times time (F(2, 14)=0.96, p=0.41)) did 
not result in statistically significant findings. 
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Figure 4.3 Comparing SPV between light (= fixation on target) and darkness conditions (= no 
fixation), across both medications and time, measured in upright position and gaze straight 
ahead. Display of mean slow phase velocities along with the standard error bars of the mean. 
 
4.2.2. Second section including the within subjects factor gaze direction 
 
Consistent with the knowledge on the influence of gaze direction (see introduction and the 
previous two chapters), there was a significant main effect in terms of gaze direction, F(2, 
10)=9.35, p<0.01, where Scheffé post-hoc tests revealed that upward gaze (-1.16 deg/s) was 
significantly different from downward gaze (-1.89 deg/s, p<0.05) and gaze straight ahead (-
2.16 deg/s, p<0.01). Downward gaze and gaze straight ahead, however, were not significantly 
different from each other (p=0.54). The results of this analysis are displayed in Figure 4.4. 
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Figure 4.4 Comparing SPV between gaze straight ahead, upward gaze and downward gaze, 
across both medications and time, measured in upright position with the light switched on. 
Display of mean slow phase velocities along with the standard error bars of the mean. 
 
In line with the expectation that DBN decreases after the administration of aminopyridines 
(see introduction), the analysis resulted in a significant main effect of time (pre vs. post 45 vs. 
post 90), F(2, 10)=13.48, p<0.01 (Figure 4.5), with significant post-hoc Scheffé comparisons 
between before-medication (-3.55 deg/s) and 45 minutes after medication (-1.18 deg/s, 
p=0.01) and before-medication and 90 minutes after medication (-0.49 deg/s, p<0.01), and no 
significant difference between 45 minutes and 90 minutes after medication (p=0.56). 
 
 158 
-8
-7
-6
-5
-4
-3
-2
-1
0
before medication 45 minutes after medication 90 minutes after medication
Sl
o
w
 
ph
a
s
e
 
v
e
lo
c
ity
 
(°/
s
)
p=0.01
p<0.01
 
Figure 4.5 Comparing SPV across all three gaze conditions and both medications between all 
three measurements (before medication, 45 minutes after medication and 90 minutes after 
medication), measured in upright position with the light switched on. Display of mean slow 
phase velocities along with the standard error bars of the mean. 
 
In contrast to the first section of the analysis, there was a significant main effect in terms of 
medication, F(1, 5)=9.27, p<0.05, where average SPV was lower after the administration of 4-
AP (-1.22 deg/s) than after the administration of 3,4-DAP (-2.25 deg/s). The before-
medication measurements in 3,4-DAP (-3.73 deg/s) and 4-AP (-3.38 deg/s) were almost 
identical (p=0.99). Figure 4.6 displays the main effect in terms of medication. This effect 
main effect of medication even remains preserved when excluding the before-medication 
measurements, F(1, 5)=7.01, p<0.05. 
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Figure 4.6 Comparing SPV between 3,4-DAP and 4-AP, across all three gaze conditions and 
time, measured in upright position with the light switched on. Display of mean slow phase 
velocities along with the standard error bars of the mean. 
 
Going back to the analysis where the before-medication measurements were included, none of 
the tests on interactions became significant, i.e. neither gaze times medication, F(2, 10)=2.12, 
p=0.17, nor gaze times time, F(4, 20)=1.14, p=0.365, nor medication times time, F(2, 
10)=1.73, p=0.23, nor gaze times medication times time, F(4, 20)=0.35, p=0.84.  
 
4.2.3. Third section including the within subjects factor body orientation 
 
Consistent with the findings from the previous two studies, the analysis with respect to body 
orientation resulted in a significant main effect, F(2, 14)=4.54, p<0.05 (Figure 4.7). The 
Scheffé post-hoc comparisons between upright (-2.23 deg/s), supine (-2.02 deg/s) and prone (-
4.12 deg/s) led to an error probability of p=0.96 between upright and supine position, p=0.08 
between upright and prone position and p=0.0501 between supine and prone position. 
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Figure 4.7 Comparing SPV between upright, supine and prone positions, across both 
medications and time, measured in gaze straight ahead with the light switched on. Display of 
mean slow phase velocities along with the standard error bars of the mean. 
 
In line with the expectation that DBN decreases after the administration of aminopyridines 
(see the previous two chapters), the analysis resulted in a significant main effect of time (pre 
vs. post 45 vs. post 90), F(2, 14)=13.85, p<0.001 (Figure 4.8a), with significant post-hoc 
Scheffé comparisons before medication and 45 minutes after medication (p<0.01) or 90 
minutes after medication (p<0.001), and no significant difference between 45 minutes and 90 
minutes after medication (p=0.77). When considering the difference between both 
medications, there was only a marginally significant effect, F(1, 7)=4.14, p=0.08, with 3,4-
DAP resulting in a mean slow phase velocity of -3.175 deg/s and 4-AP in a mean slow phase 
velocity of -2.41 deg/s. 
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Figure 4.8a Comparing SPV between all three measurements (before medication, 45 minutes 
after medication and 90 minutes after medication), across all three body positions and both 
medications, measured in gaze straight ahead with the light switched on, b Comparing SPV 
between both medications and all three measurements (before medication, 45 minutes and 90 
minutes after medication), across all three body positions, measured in gaze straight ahead 
with the light switched on. Display of mean slow phase velocities along with the standard 
error bars of the mean (in both 4.8a and 4.8b). 
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Likewise, the medication times time interaction became marginally significant, F(2, 14)=2.87, 
p=0.09, where both 3,4-DAP (-5.19 deg/s) and 4-AP (-5.44 deg/s) had approximately the 
same before-medication values (p=0.998), but the decrease in descriptive mean slow phase 
velocity values seemed weaker for 3,4-DAP (45 minutes after medication: -2.49 deg/s, 90 
minutes after medication -1.85 deg/s) than for 4-AP (45 minutes after medication: -1.18 deg/s, 
90 minutes after medication -0.6 deg/s), Figure 4.8b. When excluding the before-medication-
measurements due to the fact that they are not exactly the same, the descriptive trend between 
4-AP and 3,4-DAP in Figure 4.8b (45 minutes and 90 minutes after medication) becomes 
statistically different. Overall, this results in a significant main effect with respect to 
medication, F(1, 7)=7.17, p<0.05, where 3,4-DAP has an overall average SPV-value of -2.17 
deg/s and 4-AP an overall average SPV-value of -0.89 deg/s. 
Going back to the analysis where the before-medication measurements were included, 
none of the tests on interactions became significant, neither the body orientation times 
medication interaction, F(2, 14)=2.215, p=0.15, nor the body orientation times time 
interaction, F(4, 28)=1.51, p=0.23, nor the body orientation times medication times time 
interaction, F(4, 28)=0.17, p=0.95. When excluding the before-medication measurements, 
there are no significant interactions either. 
 
4.2.4. Testing the influence of aetiology on the intensity of downbeat nystagmus 
 
It was tested whether there was a significant difference in SPV-values based on the two 
different aetiologies. The two different aetiologies were cerebellar reasons or unknown 
reasons. 
The first analysis neither resulted in a main effect for the between subjects factor 
aetiology, F(1, 6)=0.1, p=0.76, nor an aetiology times light interaction, F(1, 6)=3.09, p=0.13, 
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nor an aetiology times medication interaction, F(1, 6)=2.71, p=0.15, nor an aetiology times 
time interaction F(2, 12)=0.1, p=0.91, nor an aetiology times light times medication 
interaction F(1, 6)=0.04, p=0.84, nor an aetiology times light times time interaction F(2, 
12)=0.61, p=0.56, nor an aetiology times medication times time interaction F(2, 12)=0.3, 
p=0.75, nor an aetiology times light times medication times time interaction, F(2, 12)=0.6, 
p=0.56. Overall, cerebellar patients even had a descriptively lower average SPV-value (-3.245 
deg/s) than the patients with unknown aetiologies (-3.67 deg/s). The inclusion of the between 
subjects factor aetiology did not make any difference with respect to the overall interpretation 
of the results, as the same within subjects factors (light and time) and the same interaction 
(medication times time) were present in the analysis where no between subjects factor had 
been included. 
The second analysis neither resulted in a main effect for the between subjects factor 
aetiology, F(1, 4)=0.0001, p=0.99, nor an aetiology times gaze interaction, F(2, 8)=0.54, 
p=0.6, nor an aetiology times medication interaction, F(1, 4)=1.46, p=0.29, nor an aetiology 
times time interaction F(2, 8)=0.02, p=0.98, nor an aetiology times gaze times medication 
interaction F(2, 8)=1.19, p=0.35, nor an aetiology times gaze times time interaction F(4, 
16)=0.87, p=0.5, nor an aetiology times medication times time interaction F(2, 8)=0.23, p=0.8, 
nor an aetiology times gaze times medication times time interaction, F(4, 16)=1.06, p=0.41. 
Overall, cerebellar patients had almost the same average SPV-value (-1.73 deg/s) as the 
patients with unknown aetiologies (-1.74 deg/s). The inclusion of the between subjects factor 
aetiology did not make any difference with respect to the overall interpretation of the results, 
as the same within subjects factors (gaze, medication and time) and a complete absence of 
interactions were also present in the analysis where no between subjects factor had been 
included. 
The third analysis neither resulted in a main effect for the between subjects factor 
aetiology, F(1, 6)=0.37, p=0.56, nor an aetiology times time interaction F(2, 12)=0.08, p=0.92, 
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nor an aetiology times body orientation times medication interaction F(2, 12)=1.06, p=0.38, 
nor an aetiology times body orientation times time interaction F(4, 24)=0.955, p=0.45, nor an 
aetiology times medication times time interaction F(2, 12)=0.01, p=0.99, nor an aetiology 
times body orientation times medication times time interaction, F(4, 24)=1.97, p=0.13. 
Overall, cerebellar patients had a more pronounced average SPV-value (-3.15 deg/s) as the 
patients with unknown aetiologies (-2.435 deg/s). Although there was no main effect with 
respect to the between subjects factor aetiology, the inclusion of this factor made a difference 
with respect to the overall interpretation of the results. Prior to the inclusion of the between 
subjects factor, there were main effects with respect to body orientation and time and 
marginally significant effects with respect to medication and the medication times time 
interaction. After inclusion of the between subjects factor, there were still significant main 
effects with respect to the within subjects factors body orientation, F(2, 12)=8.44, p<0.01, and 
time, F(2, 12)=12.03, p<0.01, but the marginally significant effect for medication now turned 
out significant, F(1, 6)=10.91, p<0.05 (average SPV of 3,4-DAP: -3.175 deg/s versus average 
SPV of 4-AP: -2.41 deg/s, see Figure 4.9). No exclusion of the before-medication 
measurements were necessary, as 3,4-DAP had even less pronounced average SPV-values at 
the before-medication measurements (-5.19 deg/s) than 4-AP (-5.44 deg/s), so in spite of the 
fact that 4-AP was disadvantaged due to a lower before-medication measurement, the main 
effect nevertheless turned out significant. 
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Figure 4.9 Comparing SPV between 3,4-DAP and 4-AP, across aetiology, body orientation 
and time, measured in gaze straight ahead with the light switched on. Display of mean slow 
phase velocities along with the standard error bars of the mean. 
 
Another finding that differed from the analysis without the between subjects factor is 
that the marginally significant medication times time interaction switched from marginally 
significant to not significant when the between subjects factor was included, F(2, 12)=2.46, 
p=0.13. Furthermore, there were significant interactions involving the between subjects factor 
aetiology. The aetiology times body orientation interaction became significant, F(2, 12)=7.01, 
p<0.01 (Figure 4.10), where the cerebellar patients replicated the trend (upright: -2.52 deg/s, 
supine: -1.36 deg/s, prone: -5.56 deg/s) of the analysis without the inclusion of aetiology as a 
between subjects factor (see Figure 4.7), whereas patients with unknown aetiologies showed a 
completely different pattern of results, with upright position even having a less pronounced 
average SPV-value (-1.94 deg/s) than supine (-2.69 deg/s) and prone (-2.68 deg/s). None of 
the post-hoc Scheffé-tests comparing the two aetiologies in the three different body positions 
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became significant. The only significant post-hoc test was the difference between supine 
position and prone position among cerebellar patients (p<0.01). 
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Figure 4.10 Comparing SPV between patients with cerebellar and unknown aetiologies of 
DBN in the three different body positions. The comparison is across medication and time, 
measured in gaze straight ahead with the light switched on. Display of mean slow phase 
velocities along with the standard error bars of the mean. 
 
The aetiology times medication interaction also turned out significant, F(1, 6)=12.45, 
p<0.05 (Figure 4.11), where the average SPV-value was only more pronounced in 3,4-DAP (-
3.94 deg/s) than in 4-AP (-2.35 deg/s) when patients had cerebellar aetiology (Scheffé: 
p<0.05), whereas 3,4-DAP (-2.41 deg/s) and 4-AP (-2.46 deg/s) had approximately equal 
average SPV-values (Scheffé: p=1) when patients had unknown aetiologies. Other post-hoc 
comparisons did not become significant (p>0.5). 
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Figure 4.11 Comparing the two different medications in terms of SPV-values between 
patients with cerebellar and unknown aetiologies of DBN. The comparison was across body 
orientation and time, measured in gaze straight ahead with the light switched on. Display of 
mean slow phase velocities along with the standard error bars of the mean. 
 
The previously mentioned absence of interactions in terms of body orientation times 
medication, body orientation times time, body orientation times medication times time 
overlapped with the analysis where the between subjects factor aetiology was included and 
the one where it was not included. 
 
4.3. Discussion 
 
Although both 4-AP and 3,4-DAP had previously shown symptom alleviation in DBN, in 
particular an improvement of slow-phase velocity (SPV) over a placebo, both drugs had not 
been compared in terms of their treatment efficacy yet. Consequently, they were compared in 
a double-blind study with crossover design. It turned out that both aminopyridines resulted in 
a significant SPV-decrease, because SPV had become less in both measurements 45 minutes 
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and 90 minutes after administering the medications. This was no new finding, as the 
previously mentioned placebo-controlled trials by Strupp et al. (2003) and Kalla et al. (2007) 
had already shown that 3,4-DAP and 4-AP were associated with a decreased intensity of 
DBN. What is new about this study is that it showed a decreased intensity of DBN even 90 
minutes after the ingestion of the capsule. This complements earlier findings by Strupp et al. 
(2003), who observed a U-shaped curve in terms of DBN intensity, with DBN having the 
lowest intensity from 30 minutes to 45 minutes after ingestion of a 20 mg 3,4-DAP capsule 
and a higher intensity later on (e.g. 90 minutes after ingestion). In the present study, a 10 mg 
ingestion of 3,4-DAP was associated with no higher DBN intensity 90 minutes after ingestion 
than 45 minutes after ingestion. Hence, it is a new finding, but it does not contradict Strupp et 
al. (2003), because the medication was not administered in the same dose, and the U-shaped 
curve in Strupp et al. (2003) was based on a single case, whilst the results in the present study 
were based on 8 patients. Moreover, DBN was assessed by mean peak slow phase velocity in 
Strupp et al. (2003), whereas it was assessed by average slow phase velocity here. What is 
also new about this study is that it is the first that compared both aminopyridines to find out 
whether one is better suited to treat DBN than the other. In the first section including the 
within subjects factor light (fixation versus viewing in the dark), the difference in terms of 
mean SPV was revealed by Scheffé post-hoc comparisons following the significant 
medication (4-AP vs. 3,4-DAP) times time (pre-med vs. post 45 vs. post 90) interaction. 
These significant post-hoc comparisons showed that the decrease in SPV was significantly 
more pronounced for 4-AP than for 3,4-DAP (in both 45 minutes and 90 minutes post-
medication-measurements). At this stage, it is only possible to speculate about the nature of 
this difference. It might be due to a better ability of 4-AP to cross the blood-brain barrier as 
well as a longer half-life (Hayes, 1994; Hayes et al., 2003; Judge & Bever, 2006; Kalla et al., 
2009, Kalla et al., 2011; Leigh, 2003). In order to find supporting evidence for this 
assumption, however, further placebo-controlled studies are necessary, in particular a 
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therapeutic trial over more than 2 post-medication measurements and a detailed 
pharmacological drug-monitoring (e.g. determining the concentration of both medications in 
the serum) including a comparison between both medications with dose efficacy curves. 
There were additional results in the first section of the statistical analysis. The main effect of 
time indicated that across both medications, DBN as indexed by the slow phase velocity 
decreased with time. This was an expected finding, because both Strupp et al. (2003) and 
Kalla et al. (2007) had individually shown in placebo-controlled trials that both medications 
decrease DBN after the medication was administered. Moreover, the effect in this study seems 
to be an effect of medication rather than a mere effect of time (as it used to be in Spiegel et 
al., 2009a), because the decrease occurs very rapidly (45 minutes after drug administration) 
and the time interval between the before-medication VOG and the next VOG was only 45 
minutes, as compared to 2 hours in the study on daytime dependence of DBN (Spiegel et al., 
2009a). This main effect was also seen in the second and third section of this analysis. 
When referring to the influence of fixation, the intensity of DBN was less pronounced 
in light, where people were able to fixate. The ability to fixate is known to be associated with 
a lower intensity of DBN, which was also found in the first two studies of this thesis (chapters 
2 and 3) and appeared in the literature before (e.g. Spiegel et al., 2009a). As a result, this 
finding is consistent with current knowledge. It is important to note that this is a mere main 
effect, i.e. due to the absence of a light times medication interaction, the fixation effect was in 
no way differentially influenced by the two drugs. All other possible interactions in the first 
section of the analysis (light times time or light times medication type times time) did not 
become significant either. Furthermore, it made no difference to the general interpretation of 
the results whether the between subjects factor aetiology was included or not. 
The second section of this analysis included the within subjects factor gaze direction. 
As explained in the introduction and the first two studies, there was a significant main effect 
of gaze direction, where upward gaze was associated with significantly lower mean slow 
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phase velocity values than downward gaze or gaze straight ahead. Although this finding is 
consistent with Alexander’s law, it is interesting that downward gaze and gaze straight ahead 
did not significantly differ from each other. Considering the descriptive findings, downward 
gaze even had a less pronounced mean slow phase velocity than gaze straight ahead, which is 
consistent with the first study of this thesis (chapter 1), but not with Alexander’s law, where 
slow phase velocity decreases when gaze moves away from the direction of the fast phase 
(Jeffcoat et al., 2008; Robinson et al., 1984), i.e. it should be lower instead of higher in gaze 
straight ahead when compared with downward gaze. As in the first section of this analysis, 
DBN significantly decreased from the before-medication measurements to the measurements 
after drug administration (across all three gaze directions). In contrast to the first section of 
the analysis, however, there was a significant main effect in terms of medication, where SPV 
was lower after the administration of 4-AP than after the administration of 3,4-DAP in spite 
of the fact that the before-medication measurements in 3,4-DAP and 4-AP did not differ from 
each other. This underlines that 4-AP seems better suited to alleviate the symptoms of DBN 
than 3,4-DAP. Given that none of the gaze-related interactions in the second section of this 
analysis became significant, the improvement over time and the difference between both 
medications was not affected by gaze-direction. Moreover, it made no difference to the 
general interpretation of the results whether the between subjects factor aetiology was 
included or not. 
The third section of this analysis included the within subjects factor body orientation. 
In line with Brandt (1990), Marti et al. (2002) and the first two studies of this thesis, there was 
a significant main effect with respect to body orientation. However, post-hoc analyses 
revealed that the differences between supine position and prone position and between upright 
position and prone position were only marginally significant, whilst supine and upright 
position did not significantly differ from each other. Hence, the general finding on 
gravitational influence through different body positions on DBN from the previous two 
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studies was confirmed, but the detailed individual comparisons between the different body 
positions lacked confirmation when taking the conventional type one error probability level of 
five percent. Similar to the first two sections of this analysis, DBN decreased after 
administration of the medication, as there was a main effect of time, i.e. irrespective of gaze 
direction and type of medication, DBN was lower after than before aminopyridine 
administration. Turning to a potential difference between both aminopyridines next, a 
marginally significant finding revealed no proof but a descriptive trend that 4-AP was 
associated with lower mean slow phase velocity values than 3,4-DAP. Likewise, the 
medication times time interaction became marginally significant, where the decrease in mean 
slow phase velocity values seemed weaker for 3,4-DAP than for 4-AP after before-medication 
values did not significantly differ from each other. Hence, this finding is not in contrast to the 
findings of the first two sections of this analysis, where advantages of 4-AP over 3,4-DAP 
were raised in terms of DBN alleviation. When excluding the before-medication 
measurements, there was even a significant main effect with regard to medication, where 4-
AP was associated with a lower intensity of DBN than 3,4-DAP. It made sense to exclude the 
before-medication measurements, because they were associated with a descriptively (though 
not significantly) higher DBN intensity for 4-AP than for 3,4-DAP, i.e. the exclusion of the 
before-medication measurements gave 4-AP a fairer comparison with 3,4-DAP. Because none 
of the body-positional interactions in the third section of this analysis became significant 
(neither with nor without the before-medication measurements), the improvement over time 
and the difference between both medications was not affected by body position. 
The third section was the only section where it made a difference to the interpretation 
of the results when the between subjects factor aetiology was included. Although there was no 
main effect with respect to aetiology (with a descriptive trend that average SPV-values were 
more pronounced for cerebellar patients than for patients with unknown aetiologies) and even 
though the majority of interactions including aetiology did not turn out significant, the 
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presence of this between subjects factor nevertheless had important consequences. After 
including the factor aetiology, there was a significant main effect of medication (with 4-AP 
being associated to a lower intensity of DBN). This effect had only been marginally 
significant prior to the inclusion of the between subjects factor. In addition, there were two 
interactions of interest that included the between subjects factor aetiology. The aetiology 
times body orientation interaction indicated that cerebellar patients replicated the trend from 
Marti et al. (2002), which was hypothesised for cerebellar patients in particular, where supine 
position had the lowest intensity of DBN, upright position took the medium position and 
prone position was associated with the highest intensity of DBN. Patients with unknown 
aetiologies showed an entirely different pattern of results, where, from a descriptive point of 
view, upright position was associated with the lowest intensity of DBN, prone position was in 
the middle and supine position had an equal or even vaguely higher intensity of DBN than 
prone position. It is difficult to interpret this type of interaction, as this interaction did not turn 
out significant in previous analyses, e.g. in the first study of this thesis (see chapter 1). 
Moreover, none of those post-hoc tests that compared the three different body positions 
between the two aetiologies became significant. Hence, this interaction might be due to 
chance. It is particularly surprising that the cerebellar patients replicated the pattern of results 
that were mostly achieved with patients not having a cerebellar aetiology in the two previous 
studies, whist the patients with unknown aetiologies showed a different pattern of results. 
Nevertheless, it shows that as far as this analysis is concerned, aetiology made a difference to 
this analysis. This difference becomes even clearer when considering the aetiology times 
medication interaction, where the intensity of DBN was only more pronounced after the 
administration of 3,4-DAP than after the administration of 4-AP in case patients had a 
cerebellar aetiology, whereas administration of 3,4-DAP and 4-AP showed equal effects for 
the unknown aetiologies. Hence, 4-AP might have a particularly positive effect in cerebellar 
patients that is not reflected by 3,4-DAP, although it needs to be kept in mind that both 
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medications show a significant improvement over before-medication DBN and have been 
shown to be better than placebo by Strupp et al. (2003) for 3,4-DAP and by Kalla et al. (2007) 
for 4-AP. Hence, 4-AP might have an additional effect on cerebellar aetiology of DBN, e.g. 
because it is better able to cross the blood-brain barrier (e.g. Hayes, 1994; Hayes et al., 2003; 
Judge & Bever, 2006; Kalla et al., 2009; Kalla et al., 2011; Leigh, 2003). However, due to the 
low number of patients per group (n = 4), one should be cautious and avoid making strong 
claims about aetiology and its effect on the two medications. Nevertheless, there is an 
additional study where 4-AP worked best when DBN was associated with cerebellar atrophy 
(Kalla et al., 2007), so it seems worth to further investigate this issue in the future. 
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5. Conclusion 
 
In this thesis, three aspects of DBN were examined: first, the effects of daytime on the 
changes of its intensity, second the effects of body position on the changes of its intensity 
during daytime, and third, the differential effects of 3,4-DAP versus 4-AP. So far, a cure for 
DBN is not in sight, as there can be many underlying causes, most of them cause a 
progressive loss of cells with cerebellar atrophy. 
As known from previous research (Jeffcoat et al.; 2008, Marti et al., 2008; Robinson et 
al., 1984; for a summary, see Spiegel et al., 2009a), the intensity of DBN is generally weaker 
in gaze upward. As reported in Spiegel et al. (2009a), it is also weaker when people are able 
to fixate (e.g. during daylight or when the light is switched on). In daily life, most activities 
are carried out under conditions where people are able to fixate. However, people rarely 
perform upwards directed gaze all the time. As shown in the first two studies of this thesis, 
however, there are additional characteristics that alleviate the symptoms. The intensity of 
DBN decreases in the course of the day (chapter 1 and Spiegel et al., 2009a). Hence, it would 
be possible to recommend patients to do activities such as office work later during the day 
(after 11am). In the morning hours, one could engage in activities that are less dependent on 
gaze holding. If it is nevertheless necessary to do office work in the morning hours, one might 
recommend to the patients to arrange the screen and the keyboard of the computer in such a 
way that it could be done in supine position (with slight gaze upward), because the studies in 
this thesis confirmed that body position has a significant influence on the intensity of DBN. 
As it turned out, however, the intensity of DBN in various body positions is also mediated by 
the body resting positions prior to the measurement (chapter 2 of this thesis). This became 
particularly clear when patients were tested in upright position (Spiegel et al., 2010). Had they 
previously rested in upright position, their DBN was lower than if they had previously rested 
in prone position. When tested in prone position, their DBN tended to be lower if they had 
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previously rested in prone position as compared to having rested in upright position. This 
indicates that not only the body positions are relevant with respect to DBN intensity, but also 
the changes from previous body position to current body position. As a practical application, 
one could recommend people to rest in upright position if they intend to do office work in 
upright position following the resting period. Alternatively, it is better for them to rest in 
prone position prior to activities in prone position, e.g. prior to gymnastics or swimming. As 
far as resting in upright position is concerned, there was a tentative trend that people should 
rather rest in darkness than with the light switched on, i.e. in contrast to the finding that the 
possibility to fixate suppresses the intensity of DBN, resting should be done with no fixation. 
These results are limited to resting periods in upright position, though, as no comparison 
between resting under light and darkness conditions has been carried out for supine or prone 
position thus far. 
According to literature reviews (e.g. Kalla et al., 2008; Spiegel et al., 2009b; Strupp & 
Brandt, 2006; Strupp et al., 2011a), there also exist pharmacological ways to achieve 
symptom alleviation. Among the most promising pharmacological approaches up to the 
present date are the two aminopyridines 4-AP and 3,4-DAP. This was first demonstrated in 
double-blind and placebo-controlled studies with cross-over design for 3,4-DAP (Strupp et 
al., 2003) as well as for 4-AP (Kalla et al., 2007). The two aminopyridines, however, had not 
been compared thus far. Hence, it was the aim to compare both aminopyridines in terms of 
their efficacy in a double-blind study with cross-over design. In the previous chapter of this 
thesis and Kalla et al. (2011), where I shared the first-authorship, it had been shown in detail 
that 4-AP is more effective than 3,4-DAP. In addition, there was a tentative trend that it was 
particularly effective for cerebellar patients. This is no surprising result, though, as it had been 
reported to better cross the blood-brain barrier and to have a longer half-life than 3,4-DAP 
(Hayes, 1994; Hayes et al., 2003; Judge & Bever, 2006; Kalla et al., 2009; Kalla et al, 2011; 
Leigh, 2003). One should, however, avoid drawing bold conclusions on the basis of this 
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result, as the number of eight patients in this study was relatively low (with four cerebellar 
patients and four patients with DBN due to other aetiologies). Further studies with more 
patients would be necessary to confirm this finding, especially a placebo-controlled trial with 
more than two post-medication measurements and a detailed pharmacological drug 
monitoring. Nevertheless and in spite of the low number of patients having been involved in 
this study, there seems to be a clear effect favouring 4-AP over 3,4-DAP. Until further clinical 
trials have been completed, one could recommend patients with DBN to take 4-AP. 
According to a literature review (Judge & Bever, 2006) it is still unclear whether one of the 
two aminopyridines shows more toxicity, but clinical observations have revealed that 4-AP is 
associated with less adverse side effects than 3,4-DAP (personal communication, Andreas 
Sprenger, 26 March 2009). Hence, it makes sense to recommend 4-AP to patients with DBN 
as long as no new findings on adverse reactions or toxicity are reported. 
To derive further insights on what could be recommended to patients, additional 
studies will be necessary. It has to be kept in mind, though, that only a small number of 
patients have DBN-symptoms, so it is difficult to conduct large clinical trials with many 
patients. Moreover, it would be too stressful for many patients to undergo a large number of 
different trials. For that reason, this thesis focused on different alternatives with as many 
patients as were available. Based on the results obtained so far, a number of recommendations 
can already be made to these patients. In spite of the fact that larger trials with additional 
variations are necessary, the discussion of the main results in each chapter has shown that 
many findings were quite robust to variations, especially the daytime improvement of DBN, 
the effect of fixation as well as the effect of gaze direction and body orientation. There was 
also some evidence that gravity has an influence on DBN, as the intensity of DBN in the 
different body positions was mediated by the body positions during the resting intervals. This 
could have been the result of the patients’ otoliths exerting a stabilizing influence on otolith-
related central vestibular neurons (Spiegel et al., 2010). Hence, these three clinical studies 
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along with their sub-studies have added a few insights. They also gave rise to new hypotheses 
that can be tested in future studies on DBN-treatment. One promising new way of treating 
DBN is 4-AP in its sustained released form (AmpyraTM, Biogen Idec, Cambridge MA, USA) 
and case studies on individual patients under the supervision of Michael Strupp have already 
provided positive effects on the reduction of slow phase velocity and the improvement of 
ataxia. The sustained released form had been thoroughly tested in patients with multiple 
sclerosis by Goodman et al. (2008). Based on the case observations by Strupp and his 
colleagues, there is a good chance that it will also successfully alleviate symptoms in patients 
with DBN.  
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